Editorial Board Profiles
Owoicho Adogwa, MD, MPH
Owoicho Adogwa, MD, MPH, is an Assistant Professor in the Department of Neurological Surgery at UT Southwestern Medical Center. He focuses on the treatment of spinal diseases, with primary expertise in adult and pediatric scoliosis, degenerative spinal pathologies, and spinal oncology. He is a specialist both in advanced minimally invasive and traditional open techniques.
After earning his medical degree at Vanderbilt University School of Medicine, Dr Adogwa completed his residencies in neurological surgery at Duke University Medical Center and Rush University Medical Center. During his residency at RUSH, he completed an advanced complex spine and minimally invasive spine surgery fellowship under internationally renowned spine surgeons Vincent Traynelis, MD, and Richard Fessler, MD Post-residency, he completed an adult and pediatric deformity fellowship at Washington University in St. Louis, where he trained under the direction of world-renowned surgeons Munish Gupta, MD, Keith Bridwell, MD, Michael Kelly, MD, Jacob Buchowski, MD, and others. Dr Adogwa then pursued additional surgical training in advanced osteotomy techniques in Lyon, France, under the tutelage of Pierre Roussouly, MD, and in Accra, Ghana, under the mentorship of Oheneba Boachie, MD (founder of FOCOS Hospital and past president of the Scoliosis Research Society).
Given this background, Dr Adogwa is one of only a few surgeons in the world who is cross-trained in both orthopedic spine surgery and neurosurgery, which has provided him with unique qualifications to treat patients with complex spinal conditions, bringing to each patient the expertise necessary to evaluate and, if required, surgically treat disorders of the spine.
Dr Adogwa is a prolific surgeon-scientist, having published more than 180 peer-reviewed scientific papers and book chapters and presented as an invited speaker, program faculty, or guest lecturer at more than 160 scientific meetings across the world.
He has served on the editorial board of numerous scientific journals, including as Deputy Editor of The Spine Journal, and is a reviewer for more than 20 neurosurgery and orthopedic journals.
He has held numerous leadership positions in neurosurgery and spine surgery organizations and is a member of the Congress of Neurological Surgeons, the North American Spine Society, the American Association of Neurological Surgeons, the Lumbar Spine Research Society, AO Spine, the Scoliosis Research Society, the Texas Medical Association, the Dallas Medical Association, the American College of Surgeons, and the Council of State Neurological Societies. Dr Adogwa has no conflicts of interest.
Manish K. Aghi, MD, PhD
Dr Manish K. Aghi completed MD-PhD training at Harvard Medical School and subsequently completed neurosurgery residency at Massachusetts General Hospital. After completing his neurosurgical residency, he joined the faculty at the University of California at San Francisco (UCSF) in 2008. He received his board certification in Neurological Surgery in 2010 and was promoted to Associate Professor in Neurosurgery at UCSF in 2012.
At UCSF, Dr Aghi has developed a busy neurosurgical practice focusing on adult brain tumors, particularly pituitary tumors and gliomas. He also heads a productive basic science laboratory that has been NIH funded since he arrived at UCSF. His lab's primary focus is the glioblastoma microenvironment and its role in therapeutic resistance, with a secondary focus being the molecular etiology of pituitary adenomas. He has directed a number of phase I-II clinical trials for glioblastoma and has published over 100 refereed clinical and scientific articles on brain tumors. He is currently a faculty member in the UCSF graduate division of biomedical sciences, and he directs the Center for Minimally Invasive Skull Base Surgery at UCSF.
Disclosures: Dr Aghi has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Manmeet Ahluwalia, MD
Manmeet Ahluwalia, MD, is an Associate Professor in the Department of Medicine, Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM) where he subspecializes in treatment of patients with brain tumors and brain metastases. He is the Director, Brain Metastasis Research Program and the Associate Director, Clinical Trials, Operations in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center of the Neurological Institute of Cleveland Clinic. He is the Section Head of NeuroOncology Outcomes and is a staff in the Taussig Cancer Institute, Cleveland Clinic and has joint appointment in the Developmental Therapeutics Program, Case Comprehensive Cancer Center.
Dr Ahluwalia's research focuses on the development of new therapies for patients with brain tumors and brain metastases. He is currently leading several clinical trials involving new targeted therapies as well as treatments targeting tumor blood vessels (angiogenesis) and cancer stem cells. His results have been presented nationally and internationally and have resulted in over 70 editorials, peer-reviewed manuscripts, and book chapters.
Dr Ahluwalia serves as an Associate Editor on the Tumor Section of Neurosurgery, the official Journal of the Congress of Neurological Surgeons (CNS). He is the Associate Editor of ASCO Post, the newsletter of ASCO. He is the Section Editor of NeuroOncology for HemOnc Today. He serves as a reviewer on multiple journals including Cancer, NeuroOncology, Cancer Research, Journal of NeuroOncology, Expert Reviews in Neurotherapeutics, BMC Cancer, Molecular Cancer Research,Expert Review of Anticancer Therapy, Expert Opinion in Pharmacotherapy, and Journal of Neurology & Neurophysiology.
Dr Ahluwalia received his MD degree from the Maulana Azad Medical College, University of Delhi. He completed his residency at Fairview General Hospital and fellowship training at the Roswell Park Cancer Institute.
Disclosures: Dr Ahluwalia consults for Abbvie, Bayer, Varian Medical Systems, VBI Vaccines, Flatiron, Karyopharm, and Elsevier; he has received honorarium from Prime Education and Elsevier; has received royalties from Wiley; he has conducted contracted research for Abbvie, Astrazeneca, BMS, Novocure, Pharmacyclics, Incyte, Merck, and Bayer; he owns stocks in Mimivax and Doctible.
Ellen L. Air, MD, PhD
Ellen L. Air, MD, PhD, is Co-Director for Functional Neurosurgery at Henry Ford Health System with a faculty appointment at the Wayne State University School of Medicine. Dr Air completed her B.A. from Northwestern University. She earned both her MD and PhD in Neuroscience at the University of Cincinnati. She completed her neurosurgical residency at the University of Cincinnati Medical Center, and specialty fellowship training in Epilepsy and Functional Neurosurgery at the University of California at San Francisco. Dr Air's focus is in the neurosurgical treatment of Movement Disorders, Epilepsy and Pain. In addition to maintaining an active research program, she dedicates herself to the education of medical students and residents. She serves on the Editorial Board of AANS Neurosurgeon and the Education Committees of both the CNS and International Movement Disorder Society.
Disclosures: Dr Air receives research support from Medtronic.
Ali Alaraj, MD
Ali Alaraj, MD, is an attending Neurosurgeon at the University of Illinois at Chicago Medical Center and Associate Professor of Neurological Surgery and Bioengineering at the College of Medicine at the University of Illinois at Chicago. He is currently the Endovascular Neurosurgery Section Chief at the Department of Neurosurgery. Dr Alaraj is dual-trained in open Vascular and Endovascular Neurosurgery. He is an elected admission to Alpha Omega Alpha (AOA) honor medical society, and has received an Alpha Omega Alpha (AOA) teaching award as a junior attending. His clinical practice includes treating patients with ischemic and hemorrhagic stroke. His medical expertise includes neurocritical care, treating patients with brain aneurysms, arteriovenous malformations, complex dural arteriovenous fistulas, carotid cavernous fistulas, carotid artery and intracranial vessels stenosis. He has more than 120 published peer-reviewed articles and textbook chapters and is an ad-hoc reviewer for more than 10 peer-reviewed medical journals. He is an invited speaker for multiple local and national specialty meetings. He is the author of the "Comprehensive Healthcare Simulation: Neurosurgery". Dr Alaraj research interests include outcomes of management of brain aneurysms and arteriovenous malformations, quantitative cerebral flow measures, and computational quantification of intracranial flows by angiography, in addition to virtual reality simulation in neurosurgical training. He is currently holding an active National Institute of Health research grant to study intracranial flow by large scare computational fluid dynamics.
Disclosures: Dr Alaraj is a consultant for Cerenovous and has an active NIH grant for research.
Dr Rushna Ali
Dr Rushna Ali was born in Karachi, Pakistan and is a graduate of the Aga Khan University.
Her neurosurgical residency was at Henry Ford Hospital in Detroit, MI, and she completed her training with a fellowship in Epilepsy and Functional Neurosurgery from Vanderbilt University in Nashville, TN. She is currently a Clinical Instructor at Michigan State University and Director of Restorative and Functional Neurosurgery at Spectrum Health Medical Group in Grand Rapids, MI.
Dr Ali has a special interest in extratemporal epilepsy and is currently working on developing a surgical decision making algorithm. She is also studying the role of neuromodulation in stroke recovery.
Dr Ali is a member of the AANS, CNS, WSSFN, NANS and ASSFN.
Jason W. Allen, MD, PhD
Jason W. Allen, MD, PhD is an Associate Professor of Radiology and Imaging Sciences and Neurology at Emory University and an Associate Professor of Biomedical Engineering at Georgia Institute of Technology. He is the Director of the Neuroradiology Division and the Medical Director of the Center for Systems Imaging at Emory University.
Dr Allen earned both his MD and PhD in Neuroscience from Georgetown University. He then completed a combined Neurology/Radiology/Neuroradiology Program at New York University School of Medicine and is board-certified in both Diagnostic Radiology and Neurology, as well as having a Certificate of Additional Qualification in Neuroradiology. His previous research involved cell culture and animal models of traumatic brain injury (TBI), focusing on elucidating the underlying pathophysiologic mechanisms of neuronal injury and investigating novel therapeutic agents. Dr Allen's current research interests are focused on characterizing the alterations in advanced neuroimaging metrics in the setting of neuronal injury, including stroke, TBI, and neurodegenerative disorders, as well as the diagnosis and prognosis of cerebrovascular disease, such as subarachnoid hemorrhage, cerebrovascular reserve, and internal carotid webs. His laboratory is funded through multiple foundational and NIH grants. He is active in many radiological societies and is currently a member of the American Society of Functional Neuroradiology executive committee.
Disclosures: Dr Allen has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Ron L. Alterman, MD
Ron L. Alterman, MD, is Professor of Neurosurgery at Harvard Medical School and Chief of the Division of Neurosurgery within the Roberta and Stephen R. Weiner Department of Surgery at Beth Israel Deaconess Medical Center (BIDMC). Dr Alterman received his Bachelor of Arts magna cum laude from the University of Pennsylvania and his Medical Doctorate with distinction (AOA) from the Albert Einstein College of Medicine. Following a general surgery internship at Washington University in St. Louis, he completed his Neurosurgery Residency training at Montefiore Medical Center in New York. He was the first fellow in Stereotactic and Functional Neurosurgery at New York University (1995) after which he joined the NYU Neurosurgery Faculty. In 1998 he moved to New York's Beth Israel Medical Center where he established the busiest deep brain stimulation program in the New York Tri-State region. In 2002 he earned his M.B.A. with Honors from Columbia Business School. In 2003, he served at Walter Reed Army Hospital in Washington, DC in support of Operation Iraqi Freedom and was honorably discharged from the U.S. Army Reserve Medical Corps at the rank of lieutenant colonel in 2008. In 2004, Dr Alterman moved to the Mt. Sinai School of Medicine as Director of Functional and Restorative Neurosurgery. Under his leadership, functional neurosurgery at Mount Sinai became internationally recognized for the excellence of its clinical, academic, and educational programs and Dr Alterman rose to the rank of Professor. Dr Alterman became Chief of the Division of Neurosurgery at BIDMC in 2011. Under his leadership, BIDMC Neurosurgery has doubled its faculty and grown its clinical volume >50%. Centers of excellence have been established in Functional neurosurgery, Neuro-oncology, and Vascular/Endovascular Neurosurgery. As a result, BIDMC was awarded a new Neurosurgery Residency Program in 2016. Dr Alterman has received numerous honors throughout his career, including the Young Neurosurgeon Award from the World Society for Stereotactic and Functional Neurosurgery and the President's Award from the Dystonia Medical Research Foundation. Along with Robert Martuza, Antonio Chiocca, and Alan Cohen he is a founding member of the Neurosurgery Department at Harvard Medical School. He is Secretary Treasurer of the American Society for Stereotactic and Functional Neurosurgery, a member of the Executive Committee of the World Society for Stereotactic and Functional Neurosurgery and a section editor for Youman's Textbook of Neurosurgery.
Disclosures: Dr Alterman receives consulting fees from Medtronic and honoraria from Elekta and BrainLab.
Dr Sepideh Amin-Hanjani
Dr Sepideh Amin-Hanjani is tenured Professor and Residency Program Director in the Department of Neurosurgery at the University of Illinois at Chicago (UIC), where she also serves as Co-Director of Neurovascular Surgery. She holds NIH funding as PI for an R01 funded multi-site international study of blood flow in vertebrobasilar disease, and has authored over 100 publications and 25 book chapters. She is past chair of the AANS/CNS Cerebrovascular Section, and a current Member at Large of the CNS Executive Committee, also serving as Co-Vice Chair of the AANS/CNS Joint Guidelines Committee and the CNS Guidelines Committee. She is an elected member of the Society of Neurological Surgeons, a Fellow of the American Heart Association and American College of Surgeons, and serves as a Medical Advisory Board Regional Co-director for the Brain Aneurysm Foundation.
Disclosures: Dr Amin-Hanjani has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Peter Angevine, MD, MPH
Peter Angevine, MD, MPH, is an Assistant Professor in the Department of Neurological Surgery at the College of Physicians and Surgeons of Columbia University in New York, New York. He received his medical degree from Columbia University and completed a residency in Neurological Surgery at the Neurological Institute of New York at New York Presbyterian Hospital in New York City. He subsequently completed a fellowship in Spine Surgery in the Department of Orthopaedic Surgery at Washington University in St. Louis. He returned to Columbia as a faculty member and completed his Masters in Public Health. He serves as the Quality Chair of the Department of Neurological Surgery.
Dr Angevine’s clinical subspecialties include spinal deformity surgery, spinal column tumors, spinal radiosurgery, and complex spinal revision surgery. His research interests are clinical outcomes for spinal surgery and study design and analysis.
Dr Angevine has published on a variety of spinal surgery topics and has served as a peer reviewer for several academic journals. He has also served as an invited guest editor and section editor for neurosurgery journals and textbooks. He is an active member of several neurosurgical and spinal surgery societies, and he regularly directs and teaches courses for these organizations and serves actively on several committees.
Disclosures: Dr Angevine has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Jeffrey E. Arle, MD, PhD
Jeffrey E. Arle, MD, PhD, FAANS, attended Columbia University and received a BA in Neuroscience in 1986 and gained his MD, along with his PhD in Biomedical Science, in 1992 from the University of Connecticut School of Medicine. He completed his internship in general surgery, followed by his neurosurgery residency, at the Hospital of the University of Pennsylvania in 1999. He completed a double Fellowship in both Epilepsy and Movement Disorder Surgery at the New York University Medical Center in 1997. Dr Arle has been practicing primarily as a Functional and Spine neurosurgeon at the Beth Israel Deaconess Medical Center (BIDMC) in Boston since 2012 where he is Associate Chief of the Division of Neurosurgery and Associate Professor of Surgery at Harvard Medical School. He is now also Chief of Neurosurgery at Mt. Auburn Hospital in Cambridge, another Harvard teaching hospital. Dr Arle joined the BIDMC from Lahey Clinic in Burlington, MA, where he was a senior staff neurosurgeon for over 12 years and an Associate Professor of Neurosurgery at Tufts University. He also served as Lahey Clinic's Director of Functional Neurosurgery and Director of Neurosurgery Research. Dr Arle’s clinical and research interests include neuromodulation, epilepsy, pain, neuroprosthetics and complex spine disorders. His research centers on computational modeling and analysis of neural circuitry and function of all modes of neuromodulatory devices and therapies, developing novel implantable devices for interfacing with the nervous system, and streamlining the techniques for device implementation. Recent publications are on the cover of Neuromodulation. Dr Arle has also obtained two patents in field of neuromodulation devices. Dr Arle is certified by the American Board of Neurological Surgery. He is also a Member-Fellow of the American Association of Neurological Surgeons and a member of numerous societies including the North American Neuromodulation Society, the Congress of Neurological Surgeons, the International Society of Intraoperative Neurophysiology, the International Neuromodulation Society, the American Society for Stereotactic and Functional Neurosurgery, the World Society for Stereotactic and Functional Neurosurgery, the Movement Disorders Society, the American Epilepsy Society, and the International Society for Restorative Neurology. Dr Arle serves on the Executive Board of the Joint AANS-CNS Pain Section and the Advocacy and Policy Committee of the NANS. In addition, he serves as an Associate Editor for the journal Neurosurgery, and is a frequent reviewer for Neuromodulation. In 1992, Dr Arle was awarded the Upjohn Award Excellence in Research by the University of Connecticut School of Medicine. Later, in 2004, he was honored with the Doctors of Excellence award by the National Dystonia Foundation for his clinical excellence. More recently, Dr Arle along with Dr Jay Shils, PhD, has edited the widely available text from Elsevier/Academic Press titled Essential Neuromodulation and is in the process of editing a second companion text Innovative Neuromodulation to become available in 2015-2016.
Disclosures: Dr Arle is a consultant for Abbott, Boston Scientific, Medtronic, and Livanova; he is on the Scientific Advisory Board for Wenzel Spine Research; he receives funding from Abbott Medical Monitor for a clinical study and Saluda.
Dr Adam S. Arthur
Dr Adam S. Arthur is an Associate Professor of Neurosurgery at the University of Tennessee Department of Neurosurgery and the Semmes-Murphey Neurologic and Spine Clinic. He joined the Department as a fellow in Cerebrovascular and Endovascular Neurosurgery in 2002 and completed a two year combined fellowship there prior to joining the faculty. He received his medical degree from the University of Virginia and completed neurosurgical residency training at the University of Utah, where he also completed a Masters in Public Health, specializing in clinical trial design.
Dr Arthur’s neurosurgical practice is focused on the open surgical and endovascular management of cerebrovascular disease, with particular focus on the treatment of aneurysms, arteriovenous malformations, and both hemorrhagic and ischemic stroke. He works in one of the busiest multidisciplinary cerebrovascular practices in the country. He is the director of the fellowship in cerebrovascular and endovascular neurosurgery in Memphis and has been instrumental in improving training opportunities for residents and fellows both locally and nationally.
Dr Arthur has served in a number of capacities for the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the Southern Neurosurgical Society, and The Society for Neurointerventional Surgery. His research efforts have been focused on improving treatment options for patients with cerebral aneurysms and stroke. He is currently leading an international clinical trial for a new treatment for aneurysms.
Disclosures: Dr Arthur is a consultant for Balt, Johnson & Johnson, Leica, Medtronic, Microvention, Penumbra, Scientia, Siemens, and Stryker; he receives research support from Cerenovus, Microvention, Penumbra, and Siemens; he is a shareholder of Bendit, Cerebrotech, Endostream, Magneto, Marblehead, Neurogami, Serenity, Synchron, Triad Medical, and Vascular Simulations.
Perry Ball, MD
Perry Ball, MD, was born and raised in New York City. He attended Columbia University where he majored in Anthropology and rowed on the Heavyweight Crew. He received his medical degree from Dartmouth. He completed an Internship in General Surgery at the University of Michigan and then returned to Dartmouth for residency in Neurological Surgery and fellowship in Critical Care Medicine. He subsequently spent a year of spine fellowship at the University of New Mexico. Upon completion of training, he began at Dartmouth as an Assistant Professor of Surgery and Anesthesiology and attending neurosurgeon and intensivist. He was subsequently promoted to Associate Professor and then Professor. He became Program Director of the Neurological Surgery Residency in 2016. He is the author of more than 60 peer reviewed journal articles, reviews and text book chapters. He has been a member of the Editorial Review Board of Neurosurgery. He served in Medical Corps of the U.S. Army Reserve and attained the rank of Colonel. He was decorated for meritorious service during deployments to Iraq and Germany. He is a member of Alpha Omega Alpha, the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the Neurosurgical Society of America, the Society of Neurological Surgeons, the New England Neurosurgical Society, the Society of Critical Care Medicine, the Neurocritical Care Society and is a fellow of the American College of Surgeons.
Disclosures: Dr Ball has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Disclosures: Dr Barbagallo has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Fred G. Barker II, MD
Fred G. Barker II, MD, completed a neurosurgical residency at Massachusetts General Hospital, followed by fellowships in Skull Base and Microvascular Neurosurgery at University of Pittsburgh under Drs Peter Jannetta and Laligham Sekhar, and in Neuro-Oncology at UCSF under Drs Michael Prados and Charles Wilson. Since then he has practiced as a tumor neurosurgeon at Massachusetts General Hospital, specializing in skull base and posterior fossa surgery.
He has served as Surgical Vice-Chair of the Alliance Cancer Cooperative Group since its founding in 2011, and presently also serves on the Coordinating Committee of the American Brain Tumor Consortium and the NCI Brain Malignancies Steering Committee. He has been a member of the FDA Oncology Drug Advisory Committee panel (on bevacizumab for glioblastoma) and of the FDA Neurological Devices panel. He is currently Chair of the AANS/CNS Section on Tumors.
Current interests include designing and conducting clinical trials in neurosurgery, ranging from novel designs for randomized controlled trials to smaller designs for the era of precision tumor medicine.
Disclosures: Dr Barker has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
David F. Bauer, MD, MPH
David F. Bauer, MD, MPH, is Associate Professor of Surgery and Pediatrics at Baylor College of Medicine / Texas Children’s Hospital in Houston, Texas. He is a graduate of Johns Hopkins University and the University of Michigan Medical School. He completed internship and residency at University of Alabama at Birmingham, followed by fellowship in pediatric neurosurgery at University of Washington / Seattle Children’s Hospital. As a former Assistant Professor of Surgery and Pediatrics at Dartmouth-Hitchcock Medical Center, he was director of pediatric neurosurgery. While at Dartmouth, he completed a Masters in Public Health at the Geisel School of Medicine at Dartmouth in 2019. After transitioning to Houston, he is currently the co-director of craniofacial surgery at Texas Children’s Hospital with a second focused practice in the treatment of complex pediatric spine and spinal cord tumors and complex pediatric spine deformity. He is chair of the national guidelines committee for the Pediatric Section of the AANS/CNS, and he serves on the CNS Guidelines committee and the AANS/CNS Joint Guidelines Review Committee. He has helped with the production and review of guidelines in multiple organizations including PALSI, AES, AAP, AAN, CNS, and AANS. He is an active member of the AAP, ASPN, ACS, CNS, and AANS. SCOPUS Author ID: 2988567
Disclosures: Dr Bauer has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Emine Bayman is an associate professor of Biostatistics at The University of Iowa, where she is the Deputy Director of the Clinical Trials Statistical and Data Management Center (CTSDMC). She also holds a secondary appointment at the Department of Anesthesia, University of Iowa where she has worked for more than 10 years as a faculty. Dr Bayman has a PhD in Biostatistics from the University of Iowa with research interests in Bayesian statistics, design of multi-center clinical trials, and prediction models of post-surgical chronic pain.
Disclosures: Dr Bayman has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Bernard Bendok
Dr Bernard Bendok is currently Professor of Neurological Surgery, Otolaryngology and Radiology as well as the Director of the Skull Base Vascular Neurosurgery, Neurointerventional Surgery and Neurovascular Radiosurgery programs at Northwestern University’s Feinberg School of Medicine and Northwestern Memorial Hospital in Chicago as well as the Surgical Co-director of the Neurological ICU. Dr Bendok graduated from Northwestern University’s Feinberg School of Medicine and completed his neurosurgical training at Northwestern Memorial Hospital with a focus on microsurgical approaches to neurovascular and skull base pathologies. He received the AANS/CNS Mullan Neuroendovascular Fellowship Award and completed a Neuroendovascular Surgery fellowship at the State University of New York at Buffalo with the internationally acclaimed endovascular pioneer Dr L. Nelson Hopkins. Dr Bendok then spent a decade working with the internationally renowned vascular neurosurgeon H. Hunt Batjer, focusing on the microsurgical treatment of complex neurovascular and cranial base diseases. Dr Bendok’s clinical practice is currently focused on the microsurgical, interventional and radiosurgical management of neurovascular and skull base pathologies. His research has focused on clinical trials and innovations in vascular and skull base neurosurgery. His educational efforts have been focused on multimedia approaches to neurosurgical education and simulation training. He is currently working with national neurosurgical organizations to develop a validated simulation curriculum for neurosurgery residents. Dr Bendok has published over 200 peer-reviewed papers and 50 chapters, and is a member of Alpha Omega Alpha. Dr Bendok serves on the executive committees of the Congress of Neurological Surgeons and the Cerebrovascular Section of the AANS and CNS. He directs the educational committees for both organizations. Dr Bendok has given over 175 national and international invited presentations and has co-edited three textbooks and one journal supplement. His research has been funded by the Eleanor Wood-Prince Grant Initiative, the Erika Keeney Foundation, the Blu Bird Foundation, the Brain Aneurysm Foundation, and the NIH.
Disclosures: Dr Bendok receives research funding from Microvention.
Jeffrey Blount, MD
Jeffrey Blount, MD, is Professor and Chair of the Section of Pediatric Neurosurgery at Children’s of Alabama and the University of Alabama at Birmingham (UAB). The Pediatric Section in Birmingham is one of the consistently busiest and academically productive programs in Pediatric Neurosurgery in North America. A highly sought fellowship program in Pediatric Neurosurgery has been in effect since 1999 and the graduating fellows have consistently filled faculty positions at the best academic Pediatric Neurosurgery programs in North America. Dr Blount was born in Ann Arbor, Michigan and grew up in the Capital District (Albany) of New York State. He attended Washington and Lee University where he graduated Magna Cum Laude and with membership in Phi Beta Kappa. He graduated from the University of Rochester School of Medicine and was elected to Alpha Omega Alpha. He pursued residency and Chief Residency at the University of Minnesota Hospitals and Clinics under the direction of Drs. Roberto Heros, Stephen Haines, Robert Maxwell and Edward Seljeskog. He takes great pride in that he was the last resident hired by Dr Shelly N Chou at Minnesota. After residency, Dr Blount served in the US Navy as a Staff Neurosurgeon at Naval Medical Center, San Diego. Following this he pursued a fellowship in Pediatric Neurosurgery at the Hospital for Sick Children, University of Toronto under the direction of Drs. James Rutka and James Drake. Dr Blount came to Birmingham immediately after fellowship and has remained there for the duration of his career. He has served at Children’s of Alabama as the Chief of the Medical Staff as well as appointments on the Credentialing Committee, Clinical Outcomes Committee and Quality Assurance Committee. Within the Department of Neurosurgery at UAB he serves on the Clinical Competency Committee and Faculty Promotion Committee and was appointed Chair of the Pediatric Section in 2017. He is an active member of the AANS, the CNS, the Neurosurgical Society of America, the American Society of Pediatric Neurosurgery, the International Society of Pediatric Neurosurgery, the Pediatric Section, the American Epilepsy Society and the Spina Bifida Association of America. Dr Blount served as delegate and Secretary of the Accreditation Council of Pediatric Neurosurgery Fellowships (ACPNF) and as the Chair of the Professional Advisory Board of the Spina Bifida Association of America. He is a graduate of the Penry mini-fellowship in Pediatric Epilepsy and of the Dartmouth Institute Certificate in the Fundamentals of Value-based Health Care. He is a member of the editorial board of the Journal of Neurosurgery, Pediatrics. Dr Blount’s clinical and academic interests center on the surgical treatment of epilepsy in children and the management of patients with neural tube defects (Spina Bifida) across the life span. He has over 130 published articles, 7 book chapters and has been visiting Professor at 5 Neurosurgery Departments. He is pursuing a Master’s Degree in Public Health at UAB in Clinical Outcomes and Health Economics related to children with neurologic disabilities. In his free time Dr Blount enjoys skiing, fishing, swimming, playing the guitar, reading and travel with his family. He resides in Birmingham with his wife Dana and his family.
Disclosures: Dr Blount has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Gavin W. Britz
Dr Gavin W. Britz is Professor and Chairman of the Department of Neurosurgery at Houston Methodist Hospital, Co-Director of the Methodist Neurological Institute, and Professor of Neurological Surgery at Weill Cornel Medical College, NY. He came to Houston from Duke University Medical Center in North Carolina where he served as Director of the Cerebrovascular Center and Associate Professor of Neurosurgery. Earlier in his career, he worked at Harborview Medical Center while serving as Associate Professor of Neurosurgery and Radiology at the University of Washington School of Medicine in Seattle. He completed his internship at Johns Hopkins Hospital and his residency at the University of Washington in Seattle. He specializes in the treatment of cerebrovascular diseases and skull base tumors and also runs a basic science laboratory evaluating the cerebral microcirculation.
Disclosures: Dr Britz has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Samuel R. Browd, MD, PhD
Samuel R. Browd, MD, PhD, is Professor of Neurological Surgery at the University of Washington andAttending Neurosurgeon at Seattle Children’s Hospital, Medical Director of the Seattle Children’s Sports Concussion Program, Director of Hydrocephalus, and Surgical Director of the Tone Management Program. Dr Browd is adjunct Professor of Bioengineering and affiliate faculty of the Foster School of Business. Dr Browd serves as an Unaffiliated Neurologic Consultant to the NFL and as an independent neurologic consultant to the Seattle Seahawks. Dr Browd completed a combined MD and Ph.D at the University of Florida studying neuroplasticity and learning. Dr Browd’s current research interests include concussion, hydrocephalus, and biomedical engineering solutions in Neurological surgery and sports safety. Dr Browd has co-founded four venture backed biomedical start-up out of the UW where he serves as chief medical officer. Dr Browd serves as a UW Presidential Entrepreneurial Faculty Fellow and is on the advisory board of CoMotion, the commercialization arm of the UW. Dr Browd teaches at the Foster School of Business and lectures internationally on biomedical innovation and commercialization. Dr Browd was recognized as the University of Washington School of Medicine inventor of the year for 2016.
Disclosures: Dr Browd is co-founder, CMO, owns equity, is a member of the Board of Directors, and has intellectual property in VICIS, Inc., Aqueduct Neuroscience, Inc., Navisonics, Inc., and Propriovision, Inc.; he is an advisor, owns equity, and has intellectual peropty in Therma Neurosciences Inc.; he is an advisory and owns equity in MDMetrix, Inc.; he is an advisory, is a member of the Board of Directors, and owns equity in Betr, Inc.
Ollie Burton is a third-year graduate entry medical student at the University of Warwick and current Co-President of its Surgical Society, previously completing a degree in Cellular & Molecular Biology. He is an aspiring academic neurosurgeon with particular interests in medical education and widening participation in medicine.
Disclosures: Ollie Burton has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dan Cahill is an Assistant Professor of Neurosurgery at the Massachusetts General Hospital, Harvard Medical School. As a surgeon-scientist, Dr Cahill’s clinical practice is focused on the care of brain tumor patients, optimizing national clinical trials of therapy for these patients, and training neurosurgical residents in the diagnosis and treatment of these cancers.
Dr Cahill was born and raised in Connecticut, attending Yale College and then moving to Baltimore to attend Johns Hopkins Medical School, receiving his MD/PhD degrees in 2001. His PhD thesis was in Human Genetics, under advisors Ken Kinzler and Bert Vogelstein. He then completed surgical internship and neurosurgery residency training at the Massachusetts General Hospital in 2008, and was a postdoctoral fellow in the neuropathology laboratory of David Louis. He joined the faculty of the MGH Brain Tumor Center in 2011, where he is currently in active practice.
His clinical practice is highly focused in an academic environment, performing approximately 150 tumor neurosurgical procedures annually. He sees patients in the MGH Brain Tumor Center in the Yawkey Center for Outpatient Care, and his research laboratory is located in the Simches Research Building Brain Tumor Research Center.
The long-term goal of his research work is to advance genomic findings related to human brain tumors into the clinic, to achieve improvements for our treatment of patients with these cancers. By understanding the mechanism by which molecular genomic alterations drive the formation, progression, and treatment resistance of these cancers, therapeutic strategies to exploit this knowledge can be developed to improve outcomes for these patients.
His group has made key observations regarding the molecular mechanisms of chemoresistance in human glioblastomas, as combined radiation and alkylating chemotherapy temozolomide have become the standard-of-care. More recently, his group has identified a tight linkage between IDH1 mutation in malignant astrocytomas and prolonged survival after surgical resection, a finding that can guide the personalization of therapy for patients with this type of brain tumor.
Disclosures: Dr Cahill receives an honoraria from Merck and is a consultant for Lilly.
Bo Cai, PhD
Bo Cai, PhD, is tenured Professor of Biostatistics in Department of Epidemiology and Biostatistics at University of South Carolina. His research focuses on developing more efficient and robust methods for analyzing various data. Dr Cai is the PI and co-investigator on multiple extramural projects funded by NSF, NIH, and CDC. So far he has over 100 peer-reviewed publications. Dr Cai is an editorial board member of several journals. He is an elected member of International Statistical Institute (ISI).
Disclosures: Dr Cai has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr. Andrew P. Carlson
Dr. Andrew P. Carlson is an Assistant Professor of Neurosurgery at the University of New Mexico, the Department Director of Research, and the Surgical Director of the UNM Comprehensive Stroke Center. Research interests include cerebral physiology after brain injuries including subarachnoid hemorrhage, stroke, and traumatic brain injury with a particular interest in the emerging field of Spreading Depolarization physiology. In addition, he has interest in cerebrovascular and complex cranial approaches and techniques and research methodology with over 70 peer reviewed publications. He is an active member and alternate chair for the UNM Institutional Review Board. He has received NIH and DOD funding for clinical trial research and is nationally involved in multiple randomized trials. He serves on the JNS Editorial Board, the AANS/CNS Joint Guidelines Committee, the ABPN Neurocritical Care Examination Committee, and the ABNS Neurocritical Care Examination Committee. As a Methodology reviewer, Dr Carlson has a Master’s Degree in clinical research. In addition, he has extensive experience in Evidence-based Medicine, Guidelines review, and systematic review methodology. He has been involved in design and steering committees for several international clinical trials including MISTIE, NEWTON, and ENCASE.
Disclosures: Dr Carlson is a shareholder for Cerebroscope and has received research funding from NIH/NIGMS, UNM Clinical Translational Science Center, UNM Center for Brain Recovery and Repair, LANL, IRRAS, Polyganics, and Edge Therapeutics.
Luigi Maria Cavallo, MD, PhD
Luigi Maria Cavallo, MD, PhD, was born on July 28th, 1971, in Milan. Medical degree cum laude, in 1996, with an experimental thesis on “Reoperation on malignant gliomas”, at the “Università degli Studi di Napoli Federico II”. Residency in Neurosurgery completed cum laude in 2001 with a thesis on “Sellar reconstruction after endoscopic endonasal transsphenoidal surgery: results on a series of 170 cases”, published in Neurosurgery. Since 2002, he works as neurosurgeon at the Federico II University Hospital in Naples. Assistant professor since 2012 and Associate professor in 2018. In December 2004, PhD degree in “Surgical sciences and advanced diagnostic and therapeutic technologies”. "Guidetti" prize for young neurosurgeons - 2001 Edition. “Involvement of RET/PTC1 rearrangement in human pituitary adenomas”; ENEA prize for the best poster presentation. 11th Meeting of the European Neuroendocrine Association. Sorrento (Napoli), 24-27 April, 2004; “A.NE.MA” prize. (A.NE.MA) onlus: associazione per la ricerca in neurochirurgia e chirurgia maxillo-facciale per giovani chirurghi. Edizione 2007; SINch research prize – 2011 Edition. “Nuove metodiche di ricostruzione nella chirurgia endoscopica endonasale del basicranio”. Member of the scientific committee of several congresses and hands-on workshops about endoscopic endonasal surgery. Author of more than 200 publications of neurosurgical interest, most of them on peer-reviewed international journal and of 32 book chapters. Invited lecturer in more than 70 International courses, meetings and congresses. He has performed more than 1400 endoscopic endonasal transsphenoidal pituitary surgeries and more than 400 endoscopic endonasal skull base surgeries for different intracranial lesions including craniopharyngiomas, meningiomas, clival chordomas and other rarer tumors. Beside this, he has performed as first or second surgeon, more than 800 neurosurgical procedures on the main pathologies of surgical interest of the Central and Peripheral Nervous System. Research activity has been focused, predominantly, in: endoscopic skull base anatomy; endoscopic endonasal pituitary and skull base surgery; brain tumors; trigeminal neuralgia.
Disclosures: Dr Cavallo has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Michael Chan, MD
Michael Chan, MD, is an Associate Professor of Radiation Oncology at the Wake Forest School of Medicine where he specializes in treatment of patients with primary brain tumors and brain metastases. He is the Co-Director of the Gamma Knife Program at Wake Forest, and also serves as the residency director for the Department of Radiation Oncology.
Dr Chan’s research focuses on modeling of brain metastasis behavior and patterns of failure, radiation-induced cognitive decline, and the use of genomics to guide radiation oncology-based decision-making for both primary and metastatic brain tumors. His research has led to over 70 peer-reviewed manuscripts and book chapters.
Dr Chan received his MD degree from NYU School of Medicine and completed his Radiation Oncology residency training at Tufts Medical Center. He serves as an Associate Editor on the Radiation Oncology Section of Neurosurgery, the official journal of the Congress of Neurological Surgeons.
Disclosures: Dr Chan has served as a consultant for Monteris Medica; he also received an honorarium from Elekta for giving a course on intracranial applications of stereotactic radiotherapy.
Edward Chang is a neurosurgeon-scientist with expertise in treating intractable epilepsy, pain, movement disorders, and brain tumors. He specializes in advanced brain mapping methods, including awake craniotomy for speech and motor mapping, to safely perform surgery in the brain. His laboratory develops innovative technologies to preserve and restore speech, movement, and cognition.
Dr Chang is faculty in the Center for Integrative Neuroscience at UCSF. He co-directs the Center for Neural Engineering at UC Berkeley and UCSF, which brings together engineering, neuroscience, neurology, and neurosurgery to develop devices to restore function for patients with neurological disabilities such as paralysis and speech disorders.
Disclosures: Dr Chang has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Clark Chen
Dr Clark Chen is a neurosurgeon with dedicated interest in oncology and a leader in the study of DNA repair and genetic alterations in brain tumors.
He received his BS in biology from Stanford University, his MS in epidemiology from Columbia University, and his MD, PhD from Harvard Medical School. He subsequently completed his neurosurgery training at the Massachusetts General Hospital, including a clinical fellowship in radiosurgery and a second fellowship on stereotactic neurosurgery. In his thesis work, Dr Chen studied under Dr Richard Kolodner to understand how cells maintain chromosomal stability. He then carried out his post-doctoral work with Dr Alan D’Andrea at the Dana Farber Cancer Institute to understand the pertinence of chromosomal stability in glioblastoma.
He currently serves as the Chief of Stereotactic and Radiosurgery and the Vice-Chairman of Research and Academic Affairs, Neurosurgery, University of California, San Diego.
Dr Chen’s clinical interests include minimally invasive neurosurgery, radiosurgery, gene therapy, and functional stereotaxis.
Dr Chen is the recipient of several highly competitive research awards including the Damon Runyon Fellowship Award, the Burroughs Wellcome Foundation Career Award in Medical Sciences, the Sontag Foundation Distinguished Scientist Award, the Doris Duke Foundation Clinical Scientist Award, and the Forbeck Scholar award.
Disclosures: Dr Chen is a part of the Varian speakers bureau; he is a member of the Tocagen Advisory Board; he is a consultant for MRI Intervention; and he receives research support from Medtronic.
Peng Roc Chen
Peng Roc Chen is an Associate Professor in Neurosurgery, with a joint appointment in Radiology at McGovern Medical School at UT Health Houston. He specializes in Cerebrovascular/Endovascular Neurosurgery and Skull base Neurosurgery. He currently is the Director of Weatherhead Cerebrovascular/Endovascular fellowship. Dr Chen received his MD degree from Sun Yat-Sen University of Medical Sciences in China. He completed his residency in Neurosurgery at Brigham and Women’s Hospital & Children’s Hospital, Harvard Medical School in Boston. Subsequently, he did his Neuroendovascular fellowship at Brigham and Women’s Hospital in Boston and Thomas Jefferson University in Philadelphia; and open Cerebrovascular & Skull base fellowship at Barrow Neurological Institute in Pheonix, Arizona. Dr Chen’s clinical practice is mainly focused on surgical and endovascular treatments for intracranial aneurysms, brain arteriovenous malformation (AVM), arteriovenous fistula (AVF), cavernous malformation, cerebral revascularization for intracranial and extracranial carotid occlusive diseases (including carotid endarterectomy, stenting, and extracranial-intracranial bypass), surgeries for skull base tumors including acoustic neuroma. Dr Chen has been named as one of the Best Doctors in Houston annually since 2013. Besides his busy clinical practice, with funding from Weatherhead Foundation and Dipola Family Fund, he is currently directing two multicenter prospective randomized trials: Intra-arterial Vasospasm Trial (iVAST) and Sedation vs. General Anesthesia for Acute Stroke Intra-arterial Thrombestomy (SEGA). He also participates in several other important clinical trials including SanBio Stem Cells (SB623) Implant in post stroke patients, Stem Cells (ALD 401) IA implant in Stroke patients (phase I), WEB, and MISTIE, etc. His basic science laboratory at McGovern Medical School at UT Health Houston is focused on brain AVM research. In addition to his clinical practice and research, he dedicates large amount of time to train fellows and residents in cerebrovascular and endovascular neurosurgery.
Disclosures: Dr Chen receives research grant support from Stryker.
Dr E. Antonio Chiocca
Dr E. Antonio Chiocca is a neurosurgeon-scientist who has had continuous NIH peer-reviewed funding for over 15 years. His research program has focused on the biology of malignant gliomas, one of the deadliest cancers in humans, and exploring the use of biological agents as novel glioma therapeutics.
He has authored or co-authored over 200 peer-reviewed publications and has been a member and/or officer of multiple national medical societies and is a current member of the Institute of Medicine of the National Academies and the National Advisory Council of the National Institutes of Neurological Disorders and Stroke (NINDS). He was Chairman of the Department of Neurological Surgery at the Ohio State University Wexner Medical Center from 2004-2012.
He is currently Chair and Neurosurgeon-in-Chief in the Department of Neurosurgery at the Brigham and Women's Hospital and the Harvey W. Cushing Professor of Neurosurgery at Harvard Medical School.
Disclosures: Dr Chiocca is currently an advisor to Advantagene Inc., Alcyone Biosciences, Insightec Inc., Sigilon Therepeutics, and DNAtrix Inc.; he has equity interest in DNAtrix; he has advised Oncorus, Merck, Tocagen, Ziopharm, Stemgen, NanoTx., Ziopharm Oncology, Cerebral Therapeutics, Genenta, Merck, Janssen, Karcinolysis, and Shanaghai Biotech; he has received research support from the NIH, the U.S. Department of Defense, the American Brain Tumor Association, the National Brain Tumor Society, the Alliance for Cancer Gene Therapy, the Neurosurgical Research Education Foundation, Advantagene, NewLink Genetics, and Amgen; he is a named inventor on patents related to oncolytic HSV1.
Dean Chou is a graduate of the University of California Berkeley, majoring in Biochemistry. He attended medical school at UCSF, did residency at The Johns Hopkins Hospital, and undertook a spine fellowship at The Barrow Neurological Institute. He joined the faculty at UCSF after fellowship and has been there since 2004.
He specializes in complex spine surgery, with special interests in deformity and tumor surgery. His research interests include the role of minimally invasive applications in historically large, open procedures.
Disclosures: Dr Chou is a consultant for Globus and Medtronic; he receives royalties from Globus.
Timothy Cloughesy, MD
Timothy Cloughesy, MD, is a Professor of Neurology at the David Geffen School of Medicine at UCLA. He received his BA degree with Honors in Chemistry in 1983 at University of California, Santa Barbara, and his MD degree in 1987 at Tulane University. He completed his Neurology Residency at University of California, Los Angeles and fellowships in Clinical Neurophysiology (UCLA 1991-1992) and Neuro-Oncology (Memorial Sloan Kettering Cancer Center 1992). Dr Cloughesy is board certified in Neurology and Clinical Neurophysiology. He joined the faculty of the David Geffen School of Medicine at UCLA in 1992 with the Department of Neurology. He is the director of the Neuro-Oncology Program at UCLA and the Director of the Henry Singleton Brain Cancer Research Program. He is a member of the Brain Research Institute and Jonsson Comprehensive Cancer Center at UCLA.
Dr Cloughesy is listed with The Best Doctors in America and Castle Connolly’s America’s Top Doctors since 2001 and Castle Connolly’s America’s Top Doctors for Cancer since 2005. Dr Cloughesy was awarded with the Preuss Award in Clinical Neuro-Oncology in 2003 from the American Academy of Neurology. He receives research funding from the National Institutes of Health, National Cancer Institute, Ben and Catherine Ivy Foundation, Brain Tumor Funder’s Collaborative, Accelerate Brain Cancer Cure, in addition to many prominent private and family foundations. He is on the editorial board for Neurosurgery and Neurooncology and Vice Chair of NBTS Medical Advisors. Dr Cloughesy is the co-Founder and President of Art of the Brain at the UCLA Foundation whose mission is to raise money for advanced brain cancer research at UCLA, to raise public awareness of this deadly disease, and spotlight the talent, strength and courage of our brain cancer patients.
Dr Cloughesy’s research has focused on clinical trials in brain cancer using targeted molecular therapies with novel clinical trial design and biomarkers in brain cancer. He provided principal leadership for the approval of bevacizumab for recurrent glioblastoma. This was the first drug approved for recurrent glioblastoma in over 30 years. He is recognized as a world expert in brain cancer research and has been asked to lead several first-in–human studies to treat glioblastoma. He has developed a brain cancer bioinformatics database, which combines clinical outcomes, imaging, and molecular analysis to enhance translational research, and has the goal of using biomarkers to provide individualized care for brain cancer patients. He has authored or co-authored over 230 peer-reviewed articles on brain cancer.
Disclosures: Dr Cloughesy has a patent on compositions and methods for treating cancer; he is a consultant for Bayer, Del Mar Pharmaceuticals, Tocagen, Karyopharm, GW Pharma, Kiyatec, Abbvie, Boehinger Ingelheim, VBI, Dicephera, VBL, Agios, Merck, Roche, Genocea, Celgene, Puma, Lilly, BMS, Cortice, Wellcome Trust, Novocure, Novogen, Boston Biomedical, Sunovion, Human Longevity, Insys, ProNai, Pfizer, Notable labs, and Medqia; he has contracts with UCLA for the Brain Tumor Program and Amgen, Abbvie, DNAtrix, Beigene, BMS, AstraZeneca, Kazia, Agios, Boston Biomedical, Deciphera, Tocagen, Orbus, AstraZenica, and Karyopharm; he owns stock in Notable Labs; he is a member of the board for the 501c3 Global Coalition for Adaptive Research
Michael "Micky" Collins, PhD
Michael “Micky” Collins, PhD, is an internationally renowned expert in sports-related concussion. A leading clinician and researcher, Dr Collins serves as director and a founding member of the UPMC Sports Medicine Concussion Program. Established in 2000, it was the first program of its kind; more than a decade later, it remains the largest research and clinical program focused on the assessment, treatment, rehabilitation, research, and education of sports-related mild traumatic brain injury in athletes of all levels. Dr Collins’ expertise attracts elite and professional athletes from around the world seeking the comprehensive care he provides and the multidisciplinary approach he helped to introduce. The program has roughly 18,000 patient visits annually at five different locations across Pittsburgh, with a sixth scheduled to open in Summer 2015. Dr Collins and his UPMC program colleagues attract patients embodying youth, high school, collegiate and pro athletes with concerns about safe return to play and clinical management of sports concussion.
Besides his extensive clinical experience, Dr Collins also has been a lead author and investigator on numerous groundbreaking studies of high school and college athletes published in JAMA, Neurosurgery, American Journal of Sports Medicine and Pediatrics, among others. He has been the lead author or co-author on more than 80 peer-reviewed research articles, and has delivered more than 350 presentations at national and international scientific meetings. Dr Collins currently has upward of $6 million in funding for his research efforts from entities including the NFL-GE Head Health Challenge, National Institutes of Health, Major League Baseball, and the United State Army Special Operations Command. National and local media frequently interview him as an expert source.
Dr Collins has been an instrumental source across the nation in developing concussion-management policy in youth sports, state legislation on youth safety, the Centers for Disease Control’s concussion toolkit, and pioneering targeted treatment pathways for his patients. He is a co-founder of ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing), the most widely used computerized sports-concussion evaluation system that has become a standard of care in nearly all organized sports at all levels. As a result, he is a leader in educating and implementing the proper usage of such baseline and post-injury neurocognitive testing as one tool to help determine an injury’s severity and recovery for safe return to play.
In addition to training thousands of physicians and certified athletic trainers in the diagnosis, management, and treatment of sports-related concussion, he advises and is a consultant to numerous athletic organizations and teams – including the NFL Steelers, the NHL Penguins, other NFL teams, numerous MLB clubs, several NCAA programs (Florida, Florida State, Louisiana State and Michigan State, to name a few), USA Rugby, and Cirque De Soleil. He serves as an Associate Editor of the journal Neurosurgery and the Journal of Sports Neurology. Dr Collins is also on the editorial board of such publications as Brain Injury Professional and theJournal of Athletic Training.
A graduate of the University of Southern Maine with a bachelor’s degree in psychology and biology in 1991, Dr Collins earned a master’s degree in psychology in 1995 and doctorate degree in clinical psychology in 1998 at Michigan State University.
Among numerous national and international honors over the past decade, Dr Collins was named an Irish-America Healthcare and Life Sciences Top 50 Honoree in 2014. In 2010, he received the National Council on Brain Injury annual award for outstanding research and advocacy. In 2009, he was bestowed the Kenneth L. Knight Award for outstanding research. In 2007, the National Academy of Neuropsychology honored him with the Annual Butters Award for the best manuscript. An athlete himself, Dr Collins reached the 1989 NCAA Baseball College World Series, and ran in the 2012 Pittsburgh Marathon.
Disclosures: Dr Collins is a co-developer, shareholder, and board member of ImPACT Applications, Inc.
Dr Daniel Curry
Dr Daniel Curry is a pediatric neurosurgeon with a particular interest in advancing minimally invasive treatment of pediatric epilepsy. He has developed Stereotactic Laser Ablation or MR-guided Laser Interstitial Thermal Therapy, LITT, for pediatric epileptic syndromes such as hypothalamic Hamartoma, Tuberous Sclerosis Complex, Focal Cortical Dysplasia, Periventricular Nodular Heterotopia and for corpus callosotomy. His research interests include research in minimally invasive epilepsy surgery and in basic mechanisms of the stimulatory treatment of pediatric dystonia. He is a member of the medical advisory boards for the Hope for Hypothalamic Hamartoma, the TSC Alliance, and the Epilepsy Foundation.
Disclosures: Dr Curry is an advisor for Medtronic Inc. and Monteris Medical.
William T. Curry
William T. Curry is the Director of Neurosurgical Oncology at Massachusetts General Hospital and an Associate Professor of Neurosurgery at Harvard Medical School. His surgical practice focuses on the management of neoplasms of or in the central nervous system, with a particular emphasis on cranial base lesions. He is proficient in endoscopic and open techniques for the treatment of benign and malignant tumors, and he is a valued instructor at regional and national operative courses. In addition, Dr Curry is involved in investigation in neuro-oncology – he is the Director of the Translational Brain Tumor Immunotherapy Laboratory at Massachusetts General Hospital. Dr Curry graduated from Cornell University Medical College in 1997. He was a surgical intern and a resident in neurosurgery at Massachusetts General Hospital from 1997–2003, at which time he chose to stay, accepting a faculty position in their Brain Tumor Center.
Disclosures: Dr Curry has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Teodoro Forcht Dagi
Dr Teodoro Forcht Dagi is a Distinguished Scholar and Professor at Queen’s University Belfast in Northern Ireland and holds additional faculty appointments at Harvard University and at the University of Prince Edward Island. A graduate of Columbia College and the Johns Hopkins Schools of Medicine and Public Health, he trained in neurosurgery at the Massachusetts General Hospital and the Neurosurgical Unit of the Guy’s, Maudsley and King’s College Hospitals in London. He was a Neuroresearch Foundation Fellow, Mendeleyeff Traveling Fellow, and Fellow of the Society of Health and Human Values. He was selected as the Joseph P. Kennedy Jr, Fellow at Harvard University and studied under William Curran at Harvard Law School. He later received an MBA from Wharton and the DMedSc from Queen’s University Belfast.
Teo’s basic research was focused on single cell studies of the limbic system and cerebellar outflow pathways. His clinical interests have been focused on neuro-oncology, craniofacial and base of skull surgery, traumatic brain and spinal cord injury, pain of malignant origin, and neuro intensive care. In addition, he has worked extensively in the history of neurosurgery, medical ethics, translational surgery, neurosurgical innovation, and international disaster assistance.
Teo created the first curriculum in translational science at the Georgia Institute of Technology and helped steer the Program in Biomedical Entrepreneurship at the Harvard-MIT Program in Health Sciences and Technology. He served as a director of the American Association of Neurological Surgeons. He was a director of the Wharton School and serves as an Overseer of the Beth Israel Deaconess Medical Center. He is an advisor to Broadview Ventures, and chairs three early stage companies in the areas of cancer resistance, non-invasive brain monitoring, and digital health.
He has chaired the scientific advisory board for Dupont, Royal Bank of Canada, and Lunbeck USA, and sat as a director of numerous publicly and privately held companies, and several not-for-profit organizations. He serves on the faculty of the Venture Capital Institute of the National Venture Capital Association. Dr Dagi has raised several biomedical venture capital funds that helped create over $6 billion in enterprise value.
He has authored or co-authored over 150 chapters and articles and seven books. He serves currently as a Section Editor of Neurosurgery and an editor of the Journal of Clinical Ethics. Among other distinctions, he has been honored by Fellowship in the College of Critical Care Medicine, the Dixon Medal and Lectureship, the Zverina Lectureship, Fellowship ad hominem in the Royal College of Surgeons, Edinburgh, and the US Humanitarian Service Medal.
Disclosures: Dr Dagi has an ownership interest and serves as CEO of Boston Neurosciences, a Non-invasive neuromonitoring company; he advises the LeDucq Foundation and Broadview Ventures; he is a Director of CV6 TechNologies, CellAegis, Salutramed, Tharos, Ltd., Ateria, Ltd., and healthEgames; he consults for Takeda and Shire Pharmaceuticals and Prismic; he has direct and indirect ownership interests in several pharmaceutical companies but does not directly manage his investment portfolio and does not personally trade them; he is involved in mentoring early stage companies and advising venture capital funds; he is a faculty member of the National Venture Capital Association and teaches courses in entrepreneurship at the AANS and the ACS.
Carlos A. David
Carlos A. David is an Associate Professor of Neurosurgery at Tufts University School of Medicine and Director of Cerebrovascular and Skull Base Surgery at Lahey Hospital and Medical Center, in Burlington, Massachusetts. He also serves as Co-director of the neuroscience ICU and associate program director for the Tufts-NEMC Neurological residency training program. Dr David graduated with a major in Biochemistry from the University of Miami in 1986. He completed medical school AOA from the University of Miami School of Medicine in 1990. He completed his internship and neurosurgical residency at Jackson Memorial Hospital and an 18 month clinical fellowship in Cerebrovascular and Skull Base at the Barrow Neurological Institute from 1996 through 1997 under Dr Robert Spetzler. He joined the neurosurgery department at Lahey Hospital and Medical Center in 2000. Dr David specializes in the surgical treatment of cerebrovascular disorders of the brain and spinal cord and skull base tumors. He has particular interest in the treatment of intracranial aneurysms and cerebral bypass surgery, as well as tumors of the lateral skull base and jugular foramen. Dr David’s research focuses on the morphological differences between ruptured and unruptured aneurysms, 3D modeling of AVM’s, and evaluation of the efficacy and cognitive effects of cerebral bypass surgery for ischemic occlusive disease. Dr David also has a strong interest in education and teaching methods for both residents and medical students. Dr David is past Vice Chair of the Cerebrovascular Section and member of the executive board for the North American Skull base Society. He is also an active member of the Congress of Neurological Surgeons and American Association of Neurological Surgeons.
Disclosures: Dr David owns personal stock in Kogent Surgical, Elum Technologies, and NextGen Biologics.
Gavin Davis, MBBS, FRACS
Gavin Davis, MBBS, FRACS, is a neurosurgeon in Melbourne, Australia. He obtained his medical degree from the University of Melbourne, and completed advanced neurosurgical training (residency) at the Austin Hospital, Monash Medical Centre, St Vincent’s Hospital and Royal Children’s Hospital, Melbourne, being awarded Neurosurgical Fellowship of the Royal Australasian College of Surgeons in 1998. He then completed a neurosurgical fellowship at Queen’s Medical Centre, Nottingham, UK, and a Peripheral Nerve Fellowship with Dr David Kline at LSUMC in New Orleans, USA (1999). He was appointed consultant neurosurgeon to the Austin Hospital and Cabrini Hospital in Melbourne, and is adjunct Professor at the University of Notre Dame Australia and adjunct Clinical Professor at Monash University. He is a member of the Neurosurgical Society of Australasia, the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. His clinical practice includes general neurosurgery, peripheral nerve surgery and sports concussion. He commenced clinical research in sports concussion in 2001, working collaboratively with Dr Paul McCrory, and then joined the International Concussion in Sport Group (CISG) where he has been an integral leader in the research output, including development of specific tools and recommendations for the management of concussion in children and adolescents. His collaborative concussion research is at the Murdoch Children’s Research Institute, Melbourne, and the Florey Institute of Neuroscience and Mental Health, Melbourne. He is an honorary member of the Australian Football League Concussion Working Group, and has advised numerous national and international sporting codes on the development of concussion management guidelines. Ongoing clinical research is in the diagnosis, assessment and management of sport related concussion in both adult and pediatric athletes.
Disclosures: Dr Davis is a member of the International Concussion in Sport Group and an honorary member of the Australian Football League Concussion Working Group and has attended meetings organized by sporting organizations including the NFL (USA), NRL (Australia), and FIFA (Switzerland); however, he has not received any payment, research funding, or other monies from these groups other than for travel costs; he is a shareholder in 9Lives Inc.
Jeffrey Dawson received his academic degrees from Brigham Young University and Harvard University, and is a Professor of Biostatistics at the University of Iowa College of Public Health (CPH). He has served as Director of Graduate Studies in Biostatistics, a Faculty Senate member, a member of the Institutional Review Board, and the chair of the CPH Faculty Council. He has collaborated with over 20 departments in the health sciences, and is particularly known for his research in elderly and neurologically impaired drivers, as well as in cardiovascular research. His methodological interests include longitudinal data, time series data, and clinical trials. His outreach activities include educational, research, and public health efforts in Haiti, Mexico, and the Dominican Republic. He has served as the CPH Associate Dean for Faculty Affairs since 2011.
Disclosures: Dr Dawson has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Franco DeMonte
Dr Franco DeMonte is a professor of neurosurgery at The University of Texas MD Anderson Cancer Center, where he holds the Mary Beth Pawelek Chair in Neurosurgery. He also holds joint appointments as Adjunct Professor of Neurosurgery at Baylor College of Medicine in Houston and Professor of Head and Neck Surgery at MD Anderson Cancer Center.
He received his college and medical school education at the University of Western Ontario in London, Canada, and received his MD, cum laude, in 1985. He completed a surgical internship at Victoria Hospital in London, Canada, and was a resident in neurosurgery there from 1986 to 1991. In 1992 he completed his fellowship in skull base surgery at Loyola University-Stritch School of Medicine from 1991 to 1992. Dr DeMonte joined the faculty at MD Anderson in 1992 as an Assistant Professor of neurological surgery. He became a full professor in 2004.
Dr DeMonte is a member of the American Academy of Neurological Surgeons, The Society of Neurological Surgeons, the Congress of Neurological Surgeons, the American Association of Neurological Surgeons, the Tumor Section of the AANS/CNS, and the Society of University Neurosurgeons. He is a past president of the North American Skull Base Society and the Houston Neurological Society. He is a fellow of the Royal College of Surgeons of Canada (1991) and the American College of Surgeons (1996). His clinical and educational activities have been recognized through his national and international presentations on skull base tumors and neurosurgical oncology as well as by several teaching awards and inclusion in Best Doctors in America and America’s Top Doctors.
Disclosures: Dr DeMonte has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Luis Alberto Domitrovic
Luis Alberto Domitrovic was born and raised in Corrientes, Argentina where he obtained his medical degree. After that, he completed his Neurosurgery residency in the Hospital de Clinicas, University of Buenos Aires. In 2013, he moved to Spain where he did the Radiology residency. In 2018 he obtained the European Society of Neuroradiology-Diagnostic and Interventional (ESNR) diploma in Neuroradiology. He is currently working in Málaga (Spain) as a radiologist. He has clinical interest in Endovascular Neurosurgery and Neuroradiology. He is also interested in medical visual communication and education, making medical illustrations for books, papers and presentations. Outside the hospital, Luis passions largely revolve around playing piano, traveling and eating Vietnamese food.
Disclosures: Dr Domitrovic has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Rose Du
Dr Rose Du graduated summa cum laude with a Bachelor of Arts in Physics from Harvard University. She subsequently entered Harvard Medical School’s MD/PhD program and received her PhD in Physics from the Massachusetts Institute of Technology, where she studied protein folding. She completed her internship and residency at the University of California at San Francisco, after which she undertook a cerebrovascular fellowship with Dr Arthur Day at the Brigham and Women’s Hospital.
After completing her training, she joined the faculty at the Brigham and Women’s Hospital. She was board certified by the American Board of Neurological Surgery in 2011 and is Associate Professor of Neurosurgery at Harvard Medical School and Director of Cerebrovascular Surgery at the Brigham and Women’s Hospital.
Dr Du has received research funding from the National Institutes of Health and other foundations. Her research interests include the genetics of stroke and cerebral aneurysms, as well as other cerebrovascular diseases. She has published over 100 peer-reviewed papers and book chapters. She is a reviewer for numerous journals including Neurosurgery, Journal of Neurosurgery, Journal of Neurology, Neurosurgery, and Psychiatry,and Stroke. She has been active in the CNS/AANS Cerebrovascular Section and serves as the Meetings Section Editor of the Website Committee.
Disclosures: Dr Du has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Hugues Duffau, MD, PhD
Hugues Duffau, MD, PhD, is Professor and Chairman of the Neurosurgery Department in the Montpellier University Medical Center and Head of the INSERM 1051 Team “Plasticity of the central nervous system, human stem cells and glial tumors” at the Institute for Neurosciences of Montpellier, France.
He is an expert in the awake cognitive neurosurgery of slow-growing brain tumors, a routine which he has developed over twenty years. His fundamental approach is centered on the concepts of the brain connectomics and neuroplasticity, breaking with the traditional localizationist view of cerebral processing.
For his innovative work in neurosurgery and neurosciences, he was awarded Doctor Honoris Causa several times, and he was the youngest recipient of the prestigious Herbert Olivecrona Award from the Karolinska Institute in Stockholm. He has written four textbooks and over 280 publications in international journals ranging from neurosurgery to fundamental neurosciences, including cognitive sciences and brain plasticity, for a total of more than 14,000 citations and with an h-index of 62.
He is a member of Editorial boards of many journals (Brain and Language, Neurosurgery and Neuro-oncology) and ad-hoc reviewer for 82 journals (640 reviewing) including: New England Journal of Medicine, Lancet Oncology, Nature Medicine, Nature Reviews Neuroscience, Nature Reviews Neurology, Annals of Neurology,Brain, Cerebral Cortex, Trends in Cognitive Science, Current Biology, etc. He is a member of many societies including the French National Committee of University, the French National Academy of Surgery, the Young Neurosurgeons Award Committee of the World Federation of Neurosurgical Societies, and the Scientific Committee of the European Association for Neuro-oncology, etc.
Disclosures: Dr Duffau has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Bree Eaton, MD
Bree Eaton, MD, is a board certified radiation oncologist in the Department of Radiation Oncology at Emory University School of Medicine in Atlanta, GA. Dr Eaton specializes in the use of proton therapy and the treatment of pediatric cancers as well as adult brain and spine tumors. Dr Eaton graduated suma cum laude from Denver University with a BS in Cognitive Neuroscience, and completed medical school at the Medical University of South Carolina. Dr Eaton completed her Radiation Oncology Residency at Emory University and then went on to complete a fellowship in Pediatric Proton Radiotherapy and Clinical Research at Massachusetts General Hospital/Harvard University Medical School in Boston, MA. Dr Eaton has been extensively involved in clinical research evaluating the use of radiotherapy in pediatric and adult malignancies. She serves on the NRG Oncology Patient Centered Outcomes Research Committee and is a member of the American Society of Therapeutic Radiation Oncology and the American Society of Clinical Oncology.
Disclosures: Dr Eaton has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Tarek El Ahmadieh
Tarek El Ahmadieh is originally from Lebanon and completed his medical training at the Beirut Arab University. After finishing his surgical internship at the American University of Beirut, he moved to Chicago, Illinois and spent 3 years as a post-doctoral research fellow at the Northwestern University Feinberg School of Medicine under Dr Hunt Batjer and Dr Bernard Bendok. During this research fellowship, Dr El Ahmadieh was given the opportunity to take a leadership role in a multicenter, randomized, controlled clinical trial (HEAT) and worked on projects for the CNS which included simulation in neurosurgery. He helped develop the microanastomosis training module and the NOMAT score along with Dr Bernard Bendok and Dr Salah Aoun. Dr El Ahmadieh moved to Dallas and is currently a neurosurgery resident at the University of Texas Southwestern Medical Center. In addition to his clinical responsibilities, Dr El Ahmadieh is interested in scholarly publishing. He and his resident colleagues introduced a reinvigorated focus on research within the program and organized quarterly meetings to plan, coordinate, and discuss resident research projects. Dr El Ahmadieh also serves as a reviewer for several neurosurgical journals. Dr El Ahmadieh has special interest in brain and spinal tumors. He enjoys classical music and travel.
Disclosures: Dr El Ahmadieh has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Najib El Tecle, MD
Najib El Tecle, MD, is a neurosurgery resident at St. Louis University Hospital in St. Louis, MO. He completed his medical studies at the Lebanese University, Faculty of Medical Sciences where he also studied computer science. He earned a Master’s in Biomedical Engineering from Northwestern University, McCormick School of Engineering and is currently completing a Master’s in Business Administration at the Johns Hopkins University, Carey Business School.
Dr El Tecle is a motivated and dedicated physician, he is interested in spine surgery and neurosurgical oncology. His research is focused on the use of artificial intelligence in robotic surgery and surgical robotics. Dr El Tecle is committed to education and has contributed to the neurosurgical field through numerous publications.
Dr El Tecle enjoys traveling with his wife Christine and his daughter Yara.
Dr Girish Fatterpekar
Dr Girish Fatterpekar is an associate professor of radiology and associate section chief of neuroradiology at NYU Langone Medical Center, New York. He did his medical school and radiology training at King Edward Memorial College in Mumbai, India and then moved to the United States. He completed his neuroradiology fellowship from Mount Sinai Medical Center, New York.
Dr Fatterpekar has received several research awards, including Cum Laude, Magna Cum Laude, and Summa Cum Laude awards from the ASNR and RSNA and the Norman E. Leeds award for the best scientific paper from ENRS. He has also received numerous teaching awards, including the Outstanding Teacher Award from Mount Sinai School of Medicine for 2008 and 2009 and the Attending of the Year for 2010. He has also received the Teacher of the Year Award from NYU Langone Medical Center for 2015.
His main areas of interest are brain tumor and temporal bone imaging. A well-known international speaker, his scholarly work includes more than 80 peer- and non-peer-reviewed articles as well as more than 30 invited articles and book chapters. He is also the author of 3 books and a reviewer for 7 journals.
Dr Fatterpekar has been the section editor for AJNR Case of the Week and Case of the Month, has served on the Education Program Committee of ASHNR, the Scientific Program Committee of ASNR, and has been the president of the Eastern Neuroradiological Society.
Disclosures: Dr Fatterpekar has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Michael Fehlings
Dr Michael Fehlings is Head of the Spinal Program at the Toronto Western Hospital, University Health Network. Dr Fehlings is a Professor of Neurosurgery at the University of Toronto, holds the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration, is a Scientist at the McEwen Centre for Regenerative Medicine, and a McLaughlin Scholar in Molecular Medicine. In the fall of 2008, Dr Fehlings was appointed the inaugural Director of the University of Toronto Neuroscience Program (which he held until June 2012) and Co-Director of the newly formed University of Toronto Spine Program. In addition, he is the Associate Scientific Director of the NeuroDevNet Network Centre of Excellence, which is focused on finding improvement treatments for children with neurodevelopmental disorders. In 2014, Dr Fehlings was appointed Vice Chair Research, Department of Surgery at the University of Toronto.
Dr Fehlings combines an active clinical practice in complex spinal surgery with a translationally-oriented research program focused on discovering novel treatments for the injured brain and spinal cord. This is reflected by the publication of over 500 peer-reviewed articles (h-index 60) chiefly in the area of central nervous system injury and complex spinal surgery. Dr Fehlings leads a multi-disciplinary team of researchers that is examining the application of stem cells, nanotechnology, and tissue engineering for CNS repair and regeneration. He is also a principal investigator in the Christopher and Dana Reeve Foundation North American Clinical Trials Network, chair of the internationally renowned AOSpine North America network, and leads several international clinical research trials.
Dr Fehlings has received numerous prestigious awards including the Gold Medal in Surgery from the Royal College of Physicians and Surgeons (1996), nomination to the Who’s Who list of the 1000 most influential scientists of the 21st century (2001), the Lister Award in Surgical Research (2006), the Leon Wiltse Award from the North American Spine Society for excellence in leadership and/or clinical research in spine care (2009), the Olivecrona Award (2009) – the top award internationally for neurosurgeons and neuroscientists awarded by the Nobel Institute at the Karolinska Institute in Stockholm for his important contributions in CNS injury repair and regeneration, the Reeve-Irvine Research Medal in Spinal Cord Injury (2012), the Golden Axon Leadership Award (2012), the Mac Keith Basic Science Lectureship Award for significant contributions to the basic science of cerebral palsy and childhood onset disabilities (2012), and was the Mayfield Lecturer (2012). In 2012, Dr Fehlings served as the 40th President of the Cervical Spine Research Society (CSRS) – the only Canadian to do so – and was honored with the CSRS Presidential Medallion for outstanding leadership and contributions to cervical spine research. In 2013, Dr Fehlings was honored with the Queen Elizabeth II Diamond Jubilee Medal presented to him by the Honourable Stephen Harper, the H. Richard Winn Prize from the Society of Neurological Surgeons, the Jonas Salk Award for Scientific Achievements from the March of Dimes Canada and the Henry Farfan Award from the North American Spine Society.
Dr Fehlings is active in many medical societies and journal editorial boards including Journal of Neurosurgery: Spine (Past-Chairman Editorial Board), Journal of Neurotrauma (Editor, Special Topics),Neurosurgery (Associate Editor), and Spine, where he holds the position of Deputy Editor-in-Chief.
Disclosures: Dr Fehlings is a consultant for Fortuna Fix.
Ricardo B. V. Fontes, MD, PhD
Ricardo B. V. Fontes, MD, PhD, is an Associate Professor of Neurosurgery at Rush University Medical Center, in Chicago, IL. He obtained his MD and PhD degrees and completed his first neurosurgery residency at the Universidade de Sao Paulo, in his native Brazil. He then completed a fellowship in complex and minimally-invasive spine surgery at Rush University Medical Center, followed by a second neurosurgery residency at the same institution.
His clinical and academic focus is adult and pediatric spinal deformity and spine surgery in the medically-complex patient. He has over 100 publications, won several academic awards, lectured extensively and is a member of several national and international professional organizations. More important than these academic achievements, however, Dr Fontes most enjoys teaching neurosurgery residents in the OR, helping patients who were deemed too complex or too frail to be operated on and outdoor cooking with family and friends.
Disclosures: Dr Fontes is a consultant for Globus Medical.
Dr Daryl Fourney
Dr Daryl Fourney completed his medical school and residency training in Neurosurgery at the University of Saskatchewan in 2001. He did a fellowship in neurosurgical oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas from 2001-2002. He has a special interest in brain tumors as well as complex spinal disorders including tumors of the spine.
He has authored more than 80 published peer-reviewed articles and book chapters. He directed the residency training program in Neurosurgery at the University of Saskatchewan from 2003-2013. He was President of the Canadian Spine Society from 2007-2009. He was Annual Meeting Chair for the American Association of Neurological Surgeons and Congress of Neurological Surgeons Joint Section on Disorders of the Spine and Peripheral Nerves in 2012.
Disclosures: Dr Fourney has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Daniel W. Fults, MD
Daniel W. Fults, MD, is the M. Peter and Robyn Heilbrun Professor of Neurosurgery at the University of Utah School of Medicine. His clinical interests are surgical treatment of brain tumors.
Raised in Houston, Dr Fults graduated from the University of Texas at Austin and Southwestern Medical School in Dallas. He completed neurosurgical training at Wake Forest University in Winston-Salem, North Carolina and postdoctoral work in molecular biology at the University of North Carolina in Chapel Hill.
The main force attracting him to neurosurgery has always been the critical need for research in the field. He runs an active laboratory program on the molecular biology of brain tumors with a recent focus on genetically engineered mouse models of the pediatric brain tumor medulloblastoma. Dr Fults attributes his enjoyable career in academic neurosurgery to support from his wife, Carol Gibson Fults, and their two daughters, Erin and Robin.
Disclosures: Dr Fults has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Michael Ganz, MS, PhD
Michael Ganz, MS, PhD, is a Senior Research Scientist with Evidera’s Retrospective Observational Studies team in Lexington, Massachusetts. Evidera, formerly a division of United BioSource Corporation (UBC), was acquired by Symphony Technology Group and established as an independent portfolio company in July 2013. Dr Ganz’s responsibilities at Evidera include scientific leadership and operational management of various initiatives in multiple therapeutic areas, including retrospective database analyses, multimodal patient and physician surveys, clinical and economic models, and strategic outcomes research plans.
Dr Ganz specializes in various aspects of health services research, including applied health economics, policy analysis and program evaluation, and the management and analysis of health-related survey data. He has worked extensively with large national health surveys, such as the Medical Expenditure Panel Survey and the National Health Interview Survey, as well as with Medicare data, large health insurance claims and electronic health records databases, and smaller surveys of targeted populations. Dr Ganz has also conceptualized and developed clinical-economic and budget impact models in a number of indications including autoimmune disorders, cardiology, mental health and neurology, metabolic disorders, oncology, respiratory disorders, urinary disorders, and women’s health.
Dr Ganz has published on cost-effectiveness and on the epidemiology, utilization, and expenditure patterns of a number of health conditions and special populations in peer-reviewed journals, such as the American Journal of Public Health, Archives of Pediatrics and Adolescent Medicine, Blood Transfusion, Health Economics, Ophthalmology, Pediatrics, Urology, and Value in Health. Prior to joining Evidera, Dr Ganz was on the faculty of Harvard School of Public Health, where he conducted publicly and privately funded research on health behavior decision-making, as well as healthcare utilization and expenditures of special populations. Dr Ganz also teaches an introductory health economics course at Drexel College of Medicine in Philadelphia, Pennsylvania.
Dr Ganz has a PhD in Sociomedical Sciences and an MS in Biostatistics, both from Columbia University in New York, as well as a BS in Economics from UCLA. He maintains an appointment as an Adjunct Assistant Professor at the Harvard School of Public Health, where he has developed and continues to teach courses in the analysis of secondary data. He is also an active referee for a number of economic and clinical journals, serves on the editorial board of ISRN Public Health, and is a member of numerous public health and health economics associations.
Disclosures: Dr Ganz is an employee of Evidera, which provides consulting and other research services to pharmaceutical, medical device, and other related businesses; in his salaried position, he works with a variety of companies and clients and is precluded from receiving payment or honoraria directly from these organizations for services rendered.
Peter C. Gerszten, MD, MPH
Peter C. Gerszten, MD, MPH, is the Peter E. Sheptak Professor of Neurosurgery at the University of Pittsburgh. Dr Gerszten joined the Department of Neurological Surgery and the UPMC Spine Services Division in 1999. He received his undergraduate degree from the University of Virginia and completed his medical degree at the Johns Hopkins School of Medicine. He completed his residency in neurological surgery at the University of Pittsburgh Medical Center. Dr Gerszten obtained a master of public health degree from the University of Pittsburgh Graduate School of Public Health. He completed a fellowship in spinal surgery at the University of Pittsburgh Medical Center.
Dr Gerszten specializes in disorders of the spine, focusing on spinal neoplasms. His clinical interests include minimally invasive approaches to the treatment of spinal disorders and spinal tumors. Dr Gerszten’s area of clinical research is the application of outcomes research to spinal surgical interventions. He is a pioneer in the field of spine radiosurgery.
Dr Gerszten currently serves on the editorial boards of Neurosurgery, The Spine Journal, and The Journal of Radiosurgery and SBRT.
Disclosures: Dr Gerszten is a consultant for Medtronic and Zimmer Biomet.
Dr Zoher Ghogawala
Dr Zoher Ghogawala is the Charles A. Fager Chairman of Neurosurgery at Lahey Hospital & Medical Center in Burlington, Massachusetts as well as Associate Professor of Neurosurgery at Tufts University School of Medicine. He is also the co-Director of the Lahey Comparative Effectiveness Research Institute.
Dr Ghogawala received his undergraduate degree magna cum laude at Harvard in 1987. He then studied medicine and graduated from Harvard Medical School with an MD magna cum laude (high honors) in 1991. He completed his neurosurgical training at the Massachusetts General Hospital. He then affiliated his practice with Cornell University School of Medicine and subsequently was placed on the neurosurgical faculty at Yale University. He was also Director of the Wallace Clinical Trials Center at Greenwich Hospital.
Dr Ghogawala holds several leadership positions with national neurosurgery and orthopaedic surgery organizations. Dr Ghogawala serves on the Executive Committee for the Congress of Neurological Surgeons as well as the AANS/CNS joint section on disorders of the spine and peripheral nerves. He is also currently on the board of directors for the North American Spine Society (NASS) and the Cervical Spine Research Society (CSRS).
Dr Ghogawala leads multiple non-industry funded, peer-reviewed clinical trials that aim to understand the effectiveness of spinal procedures. He is a national leader in understanding the cost-effectiveness of surgical procedures. He recently received an award from the NIH for his comparative effectiveness research. He is currently national PI for the PCORI-sponsored Cervical Spondylotic Myelopathy- Surgery study comparing ventral versus dorsal surgical approaches. He served as National PI on the recently completed SLIP study – a randomized controlled trial that compared lumbar laminectomy alone to lumbar laminectomy plus instrumented pedicle screw fusion for treating grade I lumbar spondylolisthesis. Dr Ghogawala’s research has attracted millions of dollars in external funding. He has authored more than 50 peer-reviewed scientific papers, has delivered more than 100 invited lectures, and has been visiting professor at 9 universities over the last few years. He has recently published a textbook called The Evidence for Neurosurgery. Overall, Dr Ghogawala’s career is dedicated to determining how to improve quality of life with an evidence-based approach to neurosurgery.
Disclosures: Dr Ghogawala owns shares and contributes intellectual property to GN2.0-Nidus (AI medical data company).
Dr Steven Glassman
Dr Steven Glassman is a pediatric and adult spinal deformity surgeon. He is Professor of Orthopaedics at the University of Louisville and Past President of the Scoliosis Research Society. He has published extensively regarding clinical outcomes and economic value in adult spinal deformity. He has won numerous rewards including the SRS Hibbs prize, NASS Outstanding Paper Award, and AANS/CNS Meritorious Service Award.
Disclosures: Dr Glassman is a consultant for Medtronic and K2M; he receives royalties and has a patent with Medtronic; he is an employee and receives research funding from Norton Healthcare.
Dr Alexandra J. Golby
Dr Alexandra J. Golby is Professor of Neurosurgery and Radiology at Harvard Medical School and Director of Image-guided Neurosurgery and clinical fMRI at Brigham and Women’s Hospital in Boston. She is also Principal Investigator of the Golby Lab, a surgical brain mapping laboratory. She graduated from Yale University and received her MD from Stanford University School of Medicine. She was a resident in Neurosurgery at Stanford and Chief Resident at BWH/Boston Children’s Hospital, graduating in 2002.
Dr Golby has special clinical interests in surgery for patients with brain tumors, and her research at the Golby Lab focuses on functional brain mapping and tumor delineation using a variety of techniques to guide neurosurgical planning and intra-operative decision-making. She co-directs the Advanced Multi-modality image guided OR (AMIGO) at BWH, part of the National Center for Image Guided Therapy (NCIGT).
Disclosures: Dr Golby has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Felicia C. Goldstein
Felicia C. Goldstein is a Professor of Neurology (Neuropsychology Program) at Emory University School of Medicine. She received her PhD at Emory University and did postdoctoral fellowships at the Emory Center for Rehabilitation Medicine and the University of Texas Medical Branch in Galveston.
Dr Goldstein is Board Certified in neuropsychology by the American Board of Professional Psychology/American Board of Clinical Neuropsychology, and is a Fellow of the American Psychological Association. She is a Member of the Scientific Merit Review Board of the VA Rehabilitation Research and Development Service’s TBI & Stroke Subcommittee, and has served as a Co-Investigator and Outcomes Co-Director of a NIH-sponsored multicenter clinical trial to determine the efficacy of Progesterone for acute traumatic brain injury.
Dr Goldstein’s research focus involves cognitive disorders including memory and executive functioning that are associated with normal and pathological aging.
Disclosures: Dr Goldstein has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Jorge Gonzalez-Martinez, MD, PhD
Jorge Gonzalez-Martinez, MD, PhD, is a staff neurosurgeon at The Cleveland Clinic. He holds the academic position of professor of neurological surgery at Cleveland Clinic Lerner College of Medicine. He is subspecialized in Epilepsy Surgery and Functional Neurosurgery.
Disclosures: Dr Gonzalez-Martinez is a consultant for Zimmer Biomet.
Liliana Goumnerova was born in Jakarta, Indonesia in 1956. Her early years were spent in different parts of the world, including Indonesia, Ceylon (now Sri Lanka), Brazil, Italy and Bulgaria and finally settled in Toronto, Canada. She graduated from the University of Toronto School of Medicine in 1980 and completed her internship at the University of Toronto in 1981, followed by residency at the University of Ottawa from 1981-1986. Further training included a year as a fellow in pediatric neurosurgery at the Hospital for Sick Children in Toronto, Canada (1987-1988) where she was strongly influenced by the 3 Hs - Drs. Hoffman, Humphreys and Hendrick. Her research interests led her to spending two years as a Dana Research Fellow in the laboratory of Dr Mark Greene at the University of Pennsylvania studying protein tyrosine kinases. Upon completion of her research fellowship in 1990 she took a position in the Department of Neurosurgery at Childrens Hospital in Boston and has remained there since. She is currently an Associate Professor in Surgery at Harvard Medical School and Director of Clinical Pediatric Neurosurgical Oncology at Childrens Hospital/Dana Farber Cancer Institute. She is board certified by the Royal College of Physicians and Surgeons, Canada in Neurosurgery, ABNS and the American Board of Pediatric Neurosurgery. Her clinical interests are in the management of pediatric brain tumors and neuroendoscopy; and in the development of quality improvement measures for neurosurgery. She is the Director for Quality Improvement in the Department of Neurosurgery and is actively involved in multiple committees addressing issues of physician performance and development of outcome measures for surgeons and neurosurgery. Her research interests focus on understanding the biology of medulloblastoma and she continues that work with collaborators at Childrens Hospital and the Dana Farber Cancer Institute. Through that work, novel markers for predicting outcome and modifying treatment of medulloblastoma have been identified. Dr Goumnerova is a member of the major national neurosurgical organizations and is active in the Joint Section for Pediatric Neurosurgery and the American Society for Pediatric Neurosurgery. Her outside interests are in classical piano performance and music, international travel and modern art.
Disclosures: Dr Goumnerova has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Matthew Gounis, PhD
Matthew Gounis, PhD, is a biomedical engineer and Professor of the Department of Radiology, University of Massachusetts Medical School. He co-founded the New England Center for Stroke Research at UMASS in 2006.
For nearly 20 years, Dr Gounis has performed research on the minimally invasive treatment of cerebrovascular disease with a focus on device technology, disease modeling, and image guided surgery. Dr Gounis and his team of researchers have been instrumental in bringing new imaging and medical device technology from the bench to the clinic. Dr Gounis has more than 60 peer-reviewed journal papers and is the 2010 recipient of the prestigious Y.C. Fung Award from the American Society of Mechanical Engineers.
In addition to being the 2014-2015 Chair of the Bioengineering Division of the American Society of Mechanical Engineers, Dr Gounis serves as the Basic Science Assistant Editor for the Journal of Neurointerventional Surgery, on the Editorial Board of the journal Stroke, and as the Co-Chair to the AHA Bioengineering Clinical Study Group.
Disclosures: Dr Gounis is a consultant on a fee-per-hour basis for Cerenovus, Imperative Care, Mivi Neurosciences, Phenox, Route 92 Medical, and Stryker Neurovascular; he holds stock in Imperative Care and Neurogami; he receives research support (via institution) from the NIH, the United States—Israel Binational Science Foundation, Anaconda, Cerenovus, Ceretrieve, Cook Medical, Gentuity, Imperative Care, InNeuroCo, Magneto, Microvention, Medtronic Neurovascular, MIVI Neurosciences, Neuravi, Neurogami, Philips Healthcare, Rapid Medical, Route 92 Medical, Stryker Neurovascular, Syntheon, ThrombX, and the Wyss Institute.
Gerald Arthur Grant, MD
Gerald Arthur Grant, MD, is a native of Rockaway, New Jersey. He graduated magna cum laude with a Bachelor of Arts degree from Duke University in 1989 and then completed his medical education at Stanford University School of Medicine in 1994. He was a neurosurgery intern and resident at the University of Washington with Dr Richard Winn from 1994-2001. During his dedicated research time, he was awarded an American Heart Association Postdoctoral fellowship as well as an Individual National Research Service Award from the NIH. Following his chief residency, he completed his Pediatric Neurosurgery Fellowship at Children’s Hospital in Seattle from 2001-2002.
In 2002, Dr Grant fulfilled his commitment with the United States Air Force as part of a Health Professions Scholarship Program. He was Chief of Neurosurgery at Wilford Hall Medical Center, Lackland Air Force Base Texas. He was the USAF neurosurgical Consultant for Aerospace medicine from 2003-2006. Dr Grant deployed to Landstuhl Regional Medical Center, Germany and Balad Air Base, Iraq, as Chief of Neurosurgery, in support of Operation Iraqi Freedom. Dr Grant attained the rank of Lieutenant Colonel and was awarded a Meritorious Service Medal prior to his separation. He was then appointed as Associate Professor of Neurosurgery and Pediatrics with tenure at Duke University.
He is a Diplomat of the American Board of Neurological Surgery and is also board certified in Pediatric Neurosurgery by the American Board of Pediatric Neurological Surgery. He has a specialized clinical interest in pediatric brain tumors, epilepsy, and trauma. His laboratory efforts focus on molecular characterization of the blood-tumor barrier previously funded by the AANS (NREF grant) as well as a Career Development Award from the NCI (Spore-Duke).
Dr Grant moved to Stanford in August 2013 and was recently appointed as Division Chief of Pediatric Neurosurgery at Stanford University on September 1, 2014. He is married to Nicole and has 3 children, Colin (14), Rachel (12), and Elliot (10). His outside interests include tennis and Duke Basketball.
Disclosures: Dr Grant is a consultant for Integra Life Sciences on an ad hoc basis.
J. Timothy Greenamyre, MD, PhD
J. Timothy Greenamyre, MD, PhD, is the Love Family Professor and Vice-Chair of Neurology, Chief of Movement Disorders, and Director of the Pittsburgh Institute for Neurodegenerative Diseases (PIND) and the American Parkinson Disease Association Advanced Center for Parkinson’s Disease Research at the University of Pittsburgh. He is a member of the Executive Advisory Board of the Michael J. Fox Foundation, and a member of the scientific advisory committee of the Parkinson’s Disease Foundation. He has been listed as one of the ‘Best Doctors in America’ since the mid-1990s. He is editor-in-chief of the scientific journal Neurobiology of Disease and of MedLink Neurology.
Disclosures: Dr Greenamyre has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Michael W. Groff, MD
Michael W. Groff, MD, is the Director of Spinal Neurosurgery at the Brigham and Women’s Hospital. He earned his MD at the University of Pittsburgh and then went on to the Mount Sinai Hospital in New York for internship and residency training in Neurological Surgery. He completed his training at the Medical College of Wisconsin with a fellowship in Spinal Surgery.
Dr Groff is actively involved in national neurosurgical societies. He is a past-Chairman of the AANS/CNS joint section of the spine and peripheral nerves, the national neurosurgical spine organization. He is also active in the American Association of Neurological Surgeons (AANS) and NeuroPoint Alliance. He is an active participant and study group author in the Spine Oncology Study Group.
His academic interests include process improvement, health services research, outcome measures, and guideline development. Dr Groff provides the full gamut of spine care with a special focus on Oncology and Cervical Spine disorders.
Disclosures: Dr Groff receives royalties and provides consulting for Depuy Spine, Biomet Spine, Nuvasive, and SpineArt.
Robert E. Gross
Robert E. Gross earned his MD and PhD, and completed his neurosurgical residency at Albert Einstein College of Medicine, with fellowship training in functional and stereotactic neurosurgery at University of Toronto and epilepsy surgery at Yale University. He is a Professor of Neurosurgery, Neurology, Neuroscience and Biomedical Engineering at Emory University. He directs the Emory Neuromodulation and Technology Innovation Center (ENTICe), and the Translational Neuroengineering Research Lab, which focuses on neuromodulation for epilepsy, including closed-loop feedback strategies. Dr Gross’s clinical research program focuses on neuromodulation and novel surgical techniques for movement disorders, depression, epilepsy and memory.
Disclosures: Dr Gross is a consultant for Medtronic, Abbott, Neuropace, Boston Scientific, MRI Interventions, SanBio, Zimmer Biomet, Voyager Therapeutics, and AiM Robotics; he has received research grants from Medtronic, Abbott, Neuropace, Boston Scientific, MRI Interventions, SanBio, and Voyager Therapeutics; he has received honorarium from Zimmer Biomet; he owns stock in Nia Therapeutics.
Richard S. Grossman
Richard S. Grossman is Professor of Economics at Wesleyan University in Middletown, Connecticut and a Visiting Scholar at the Institute for Quantitative Social Science at Harvard University. He is the author of Unsettled Account: The Evolution of Banking in the Industrialized World since 1800 (Princeton University Press, 2010) and WRONG: Nine Economic Policy Disasters and What we Can Learn From Them, which was published in November 2013 by Oxford University Press.
He teaches classes in American and European Economic History, Macroeconomics, and Money and Banking. He graduated magna cum laude from Harvard College, holds an MSc Econ degree in Economic History from the London School of Economics and Political Science of the University of London, and AM and PhD degrees in Economics from Harvard University.
Prior to joining the faculty at Wesleyan, he worked as an international economist at the United States Department of State. He has held visiting faculty appointments at Harvard, Yale, and the Hebrew University of Jerusalem, and has received research support from the National Science Foundation and the German Marshall Fund of the United States, and was a 2013 Fellow of the John Simon Guggenheim Memorial Foundation. He has worked and consulted on Wall Street and has testified as an expert witness in federal court.
He has been published in the American Economic Review, Journal of Economic History, Journal of Money, Credit, and Banking, andJournal of Financial and Quantitative Analysis, and other scholarly journals. His op-eds have appeared in the Wall Street Journal,Boston Globe, USA Today, and other newspapers and he has appeared on local, national, and foreign radio and TV.
Disclosures: Dr Grossman has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Clement Hamani
Dr Clement Hamani did his medical training and earned his PhD in Experimental Neurology and Neurophysiology at the Federal University of São Paulo, Brazil. He completed his Neurosurgical Residency in 2002 at the University of São Paulo, followed by a fellowship in Functional Neurosurgery at the Toronto Western Hospital.
Dr Hamani is currently an Associate Professor of Neurosurgery at the University of Toronto. His main research interests are in the field of the neurosurgical treatment of movement disorders, epilepsy, pain, and psychiatric disorders.
Disclosures: Dr Hamani has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Ricardo A. Hanel, MD, PhD,
Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Lyerly Neurosurgery and Baptist Health, is Endowed Chair of Stroke and Cerebrovascular Surgery & director of Baptist Neurological Institute at Baptist Medical Center Jacksonville. He is internationally known for his skills in treating brain aneurysms, acute stroke and cerebrovascular conditions with ground breaking, minimally invasive techniques performed from inside the blood vessel.
He specializes in endovascular neurosurgery, brain aneurysms, brain & spinal arterial venous malformations, brain & spinal arterial venous fistulas, acute stroke intervention, cerebrovascular disease and skull base neurosurgery.
Dr Hanel obtained his medical degree from Universidade Federal do Paraná in Brazil and did his fellowships at the State University of New York at Buffalo and the Barrow Neurological Institute in Phoenix.
Disclosures: Dr Hanel receives research grant support from Medtronic, Stryker, Microvention, and Codman; he is a consultant for Medtronic, Stryker, Cerenovous, Microvention, Balt, and serves on a speakers bureau; he is a major stock shareholder of Neurvana, Elum, Endostream, 3 Rivers Medical, Synchron, Rist, Cerebro Tech, and InNeuroCo.
Dr Odette Harris
Dr Odette Harris is an Associate Professor of Neurosurgery at Stanford University School of Medicine and Director of Brain Injury for Stanford Medical Center. Dr Harris manages and coordinates the medical and surgical care of all patients suffering from traumatic brain injury that are admitted to the Stanford System. She focuses on implementing and streamlining current treatment algorithms aimed at improving the outcomes of this growing population. The primary focus is specific not only to mortality, but to functional outcome improvements. Dr Harris works in a collaborative manner with colleagues in Surgical Trauma, Neuro-Critical Care, Nursing, Rehabilitation, and all related Specialties. She is the Associate Chief of Staff, Polytrauma at the Veterans Affairs Palo Alto Health Care System. As a Polytrauma Center, the Veterans Affairs Palo Alto Health Care System encompasses Operations Iraqi and Enduring Freedom, the Polytrauma Rehabilitation Center and Comprehensive Rehabilitation Centers, The Polytrauma Network Sites, The Polytrauma Transitional Program, the Regional Amputation Center and the Assistive Technology Center. The administrative, clinical, research and educational/training efforts related to these multiple and varying programs are her responsibility as the Associate Chief of Staff, Polytrauma. Dr Harris is also the Site Director and Principal Investigator of the Defense Veterans and Brain Injury Center (DVBIC). The Veterans Affairs Palo Alto Health Care System is one of 5 VA sites. The administrative and educational efforts for the organization are her responsibility as the Site Director and Principal Investigator. The primary focus of DVBIC is TBI-specific evaluation, treatment, and follow-up care for all military personnel, veterans, and their dependents. This encompasses TBI-specific research, training, and education. Dr Harris graduated from Dartmouth College and received her MD degree from Stanford University School of Medicine. She received numerous academic and research awards at both institutions. She did her internship and residency at Stanford University Medical Center Stanford, California. She also earned a Masters of Public Health, Epidemiology from the University of California, Berkeley. Upon completing her neurosurgical residency, Dr Harris was awarded the William VanWagenen Fellowship from the American Association of Neurological Surgeons. She completed her research related to this fellowship at the University of the West Indies in Kingston, Jamaica where she also serves as Visiting Consultant in Neurosurgery. Dr Harris has authored several scientific articles and books, is a member of several Editorial Boards and National Committees, and has won numerous academic, research, and humanitarian awards including the Congress of Neurological Surgeons Clinical Fellowship Award, the American Association of Neurological Surgeons Spinal Cord/Spinal Column Injury Award and the Western Neurosurgical Society Resident Award for research on minor traumatic brain injury. Her research efforts have also been recognized by the government of Jamaica, where she was awarded the National Road Safety Council Award for outstanding contribution in traumatic brain injury. Dr Harris is a member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons.
Disclosures: Dr Harris has no conflicts of interest or disclosures relevant to service on the Editorial Review Board
Dr David Hasan
Dr David Hasan is a professor in the Department of Neurosurgery and Otolaryngology at the University of Iowa. A cerebrovascular neurosurgeon-scientist, he devotes 30% of his professional work effort to translational and experimental laboratory research. His long-term goal is to understand the role of inflammation in the pathophysiology of cerebral aneurysms and devise effective anti-inflammatory treatment strategies that will reduce the risk of aneurysm growth and rupture. His laboratory is one of very few labs that studies both human and animal models of cerebral aneurysm simultaneously and complimentary to each other to understand the mechanisms of aneurysm formation, growth and rupture. To date, Dr Hasan’s research has specifically focused on studying novel ideas, charting in unknown scientific territories, and challenging unfounded clinical dogmas that dictate clinical aneurysm management practices. To that effect, his published research work has involved studies of human subjects with cerebrovascular disease and mechanisms of aneurysm formation and rupture in a murine model of cerebral aneurysms. Additionally, he has had the privilege of mentoring several medical, graduate, and post-doc students in addition to neurosurgical residents and junior faculty from different countries around the world.
Disclosures: Dr Hasan has an R01 grant from the NIH/NINDS.
Dr Olabisi Sanusi
Dr Olabisi Sanusi is a Nigerian born board eligible neurosurgeon practicing in Lansing, MI. Dr Sanusi received her medical degree from Pennsylvania State College of Medicine and was inducted into the medical honor society Alpha Omega Alpha for high achievement and her exemplary nature. She went on to complete her residency at Northwestern Memorial Hospital in Chicago. After completing two chief years during residency, she went on to complete a skull base fellowship at the Oregon Health and Science University in Portland, Oregon. Dr Sanusi is married and has a son. In her spare time, Dr Sanusi enjoys listening to audiobooks.
Benjamin Huang, MD, MPH
Benjamin Huang, MD, MPH, is a clinical associate professor of radiology and the director of the Neuroradiology Fellowship Program at the University of North Carolina in Chapel Hill, North Carolina. Dr Huang completed a diagnostic radiology residency and neuroradiology fellowship at the University of North Carolina. Following fellowship, Dr Huang joined the radiology faculty at the University of North Carolina in 2007. He is on the editorial board of the American Journal of Neuroradiology and serves on the scientific program committee of the Radiological Society of North America. His interests include imaging of the skull base and temporal bones.
Disclosures: Dr Huang has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Judy Huang
Dr Judy Huang is an Associate Professor of Neurosurgery and joined the faculty of the Johns Hopkins University School of Medicine in 2002, with a special interest in Cerebrovascular surgery. She received her medical degree from the Columbia University College of Physicians and Surgeons. Her neurosurgery residency training was completed at the Neurological Institute of New York. During residency, she pursued translational research on neuroprotection with a focus upon inflammatory mechanisms of stroke. Currently, Dr Huang is the Residency Program Director, as well as the Fellowship Director for Cerebrovascular Neurosurgery. In 2005, she was appointed as the Vice Chair and Chief of Cerebrovascular Neurosurgery at the Johns Hopkins Bayview Medical Center. From 2007-2013 she served as Director of Medical Student Education.
Dr Huang’s clinical subspecialty practice is devoted primarily to the microsurgical treatment of cerebrovascular diseases, with particular focus on cerebral aneurysms, arteriovenous malformations, dural arteriovenous fistulas, and intracerebral hemorrhages. Dr Huang’s clinical research is focused upon arteriovenous malformations, intracerebral hemorrhage, and aneurysmal subarachnoid hemorrhage. Her bibliography includes over 60 journal publications and book chapters.
Dr Huang has received awards for research, teaching, and clinical excellence. These include the NREF Young Clinician Investigator Award and the New York Neurosurgical Society Charles Elsberg Award. She has received a number of teaching awards, including the Otenasek Teaching Award from her residents. Her peers have voted her for inclusion in America’s Top Doctors. She has also been recognized for outstanding patient care with Patients’ Choice awards and induction into the Miller-Coulson Academy for Clinical Excellence. Her strong commitment to education and training has led her to mentor numerous undergraduates, medical students, neurosurgical trainees, and visiting neurosurgeons from around the world. She is often invited to lecture internationally, particularly throughout Taiwan and China. Dr Huang has served on a number of committees of the American Association of Neurological Surgeons, Neurosurgical Society of America, and Joint Cerebrovascular Section of the AANS/CNS.
Disclosures: Dr Huang owns stock interest in Longeviti and Neuro Solutions.
Dr R. John Hurlbert
Dr R. John Hurlbert was born in Kinistino, Saskatchewan on May 7, 1960. He attended high school and spent his first two years of university in Regina majoring in biochemistry. He graduated from medical school at the University of Saskatchewan in Saskatoon in June of 1995. After a rotating internship at the Regina General Hospital, he spent the next 10 years in Toronto, Ontario in his Neurosurgical Residency and completed a PhD in Spinal Cord Injury research. He completed two complex spine surgery fellowships, one at the Toronto Western Hospital with Michael Fehlings, and one at the Barrow Neurological Institute with Volker Sonntag.
His first and only posting to date has been with the Division of Neurosurgery and the Faculty of Medicine at the University of Calgary, where he is currently an Associate Professor. He holds a cross-appointment with the Division of Orthopedic Surgery and is the founding chairman of the University of Calgary Spine Program. He is also the founding president of the Canadian Spine Society and the immediate past Exam Chair in Neurosurgery for the Royal College of Physicians and Surgeons of Canada. He has been the Neurosurgery Residency Program director at the University of Calgary since 2005.
Dr Hurlbert’s clinical interests encompass spinal cord injury and complex cervical decompression and reconstruction. His research efforts are directed towards spinal cord injury and degenerative spine disease. He hopes that methylprednisolone is becoming a distant part of his past.
He has a son and a daughter at university in Calgary and lives vicariously through their accomplishments. Although he enjoys downhill skiing to help stay active in the Great White North during 6-month winters, his heart is in surfing along the coast of Southern California and Australia.
Disclosures: Dr Hurlbert has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Peter Hutchinson, BSc (Hons), MBBS, PhD, FRCS (Surg Neurol)
Peter Hutchinson, BSc (Hons), MBBS, PhD, FRCS (Surg Neurol), is Professor of Neurosurgery, NIHR Research Professor, and Head of the Division of Academic Neurosurgery within the Department of Clinical Neurosciences, University of Cambridge. He holds an Honorary Consultant Neurosurgeon post at Addenbrooke’s Hospital. He has a general neurosurgical practice with a sub-specialist interest in the management of neurotrauma. He has a research interest in head injury. His research utilizes multimodality monitoring technology (measurement of pressure, oxygenation, and chemistry) to increase our understanding of the pathophysiology of brain injury, and we now use this technology to monitor patients routinely in intensive care. Professor Hutchinson also leads the international RESCUE studies evaluating the role of decompressive craniectomy in traumatic brain injury. He has co-authored over 200 publications and is joint editor of the book Head Injury – A Multidisciplinary Approach. He is a Fellow and Director of Clinical Studies, Robinson College, University of Cambridge. Other appointments include: Royal College of Surgeons of England Specialty Lead for Neurosurgery; Member of the Academic and Research Committee of Royal College of Surgeons of England; Vice-President of the European Association of Neurosurgeons; Chair of the British Neurotrauma Group; Member of the Secretary of State for Transport’s Honorary Medical Advisory Panel on Driving and Disorders of the Nervous System; Member of the Trauma Audit Research Network Executive; Member of the NICE Head Injury Guidelines Group; Chief Medical Officer Formula One British Grand Prix.
Disclosures: Dr Hutchinson has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Pascal Jabbour, MD
Pascal Jabbour, MD, is an Associate Professor of Neurological Surgery and the Chief of the Division of Neurovascular and Endovascular Neurosurgery in the Department of Neurological Surgery at the Sidney Kimmel Medical College at Thomas Jefferson University. He is a dually-trained neurosurgeon in open and endovascular techniques.
Dr Jabbour is a very active speaker, lecturing on various neurovascular topics nationally and internationally. He has authored more than 230 papers in peer-reviewed journals.
Dr Jabbour serves on the editorial board and is a reviewer for multiple neurosurgical journals. He is the author of a comprehensive textbook, Neurovascular Surgical Techniques, and a 2 volume Neurosurgery Clinics of North America on Neurovascular topics.
Dr Jabbour is a graduate of the Saint Joseph University School of Medicine in Beirut. He completed his residency in neurosurgery at the University of Colorado and Thomas Jefferson University Hospital and his fellowship at Thomas Jefferson University.
Disclosures: Dr Jabbour is a consultant for Medtronic and Microvention.
Dr Christina Jackson
Dr Christina Jackson is a neurosurgery resident at the Johns Hopkins Hospital. She completed her undergraduate training at The University of Texas at Austin before completing her MD at Harvard Medical School. As Harvard Medical School, Dr Jackson completed a Harvard research fellowship where she worked on uncovering alterations to the immune phenotype of glioma patients and found the sequestration of lymphocytes in the bone marrow through the downregulation of T cell surface sphingosine 1-phosphate receptor 1 expression. She has a strong interest in benign, malignant, and skull base tumors. During residency, she completed an enfolded CAST-certified neurosurgical oncology fellowship and a NIH F32 post-doctoral fellowship furthering the understanding of and discovering strategies to overcome the immunosuppressive glioma tumor microenvironment with the goal of designing more tailored immune based therapies using single cell RNA sequencing. Dr Jackson will be pursuing a post-residency skull base fellowship at the University of Pittsburgh. Her long-term goal is to be a technically excellent skull base and brain tumor neurosurgeon and to continue to harness the immune system to develop novel therapies for central nervous system malignancies through scientific research and clinical trials.
George Jallo is Professor of Neurosurgery, Pediatrics and Oncology, and Director of Pediatric Neurosurgery at Johns Hopkins. He received his undergraduate degree from George Washington University and his medical degree from the University of Virginia. He completed his neurosurgery residency training at NYU-Bellevue Medical Center and his pediatric fellowship at the Institute for Neurology and Neurosurgery, Beth Israel Medical Center in New York. He was recruited to Johns Hopkins University in 2003 to help expand the Division of Pediatric Neurosurgery.
He is considered one of the leading experts in brainstem and spinal cord tumors. His research laboratory was the first to develop animal models for these brainstem and spinal cord tumors. He developed the tumor cell lines, the small animal model, and the imaging and assessment modalities for these rare tumors. He then introduced novel delivery modalities for targeted therapy. This includes polymers, gels, and low-flow local delivery for these tumors. He has explored chemotherapeutic agents, radiation sensitizers, and modified agents to improve the survival for these tumors.
He has published more than 200 peer-reviewed publications, numerous book chapters, and has edited 4 books.
Disclosures: Dr Jallo is a consultant for Integra LifeSciences.
Maribeth H. Johnson, MS
Maribeth H. Johnson, MS, is an Assistant Professor in the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia at Augusta University. She graduated from the University of Georgia with an MS in Statistics in 1992 and has been employed at MCG since 1993. She has experience analyzing all types of medical data from basic science experiments to longitudinal observational epidemiological studies. She has co-authored over 120 peer-reviewed manuscripts and has been a co-investigator on many NIH grants.
Disclosures: Dr Johnson has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Disclosures: Dr Kasper has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Michel Kalamarides, MD, PhD
Michel Kalamarides, MD, PhD, is Professor of Neurosurgery and Chairman of the Department of Surgery, Research and Innovation in Pitie-Salpetriere Hospital – Sorbonne University in Paris, France. He is a group leader in the team Genetic and Development of brain tumors, part of the INSERM U1127 at the Brain and Spine Institute (Piti-Salpetriere). Its research group is working on meningioma, particularly using mouse models to dissect the mechanisms of meningioma initiation and progression. He is an expert in vestibular schwannoma and meningioma surgery. He is leading the French NF2 reference clinical center and the French NF2 network and is active in the NF2 international network. He is an ad-hoc reviewer for many journals and is a member of many societies including the French society of Neurosurgery and the AANS.
Disclosures: Dr Kalamarides has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Monika Killer-Oberpfalzer, MD
Monika Killer-Oberpfalzer, MD, is a fully trained neurosurgeon who is specialized in neurointerventional therapy. Her clinical skills and scientific interests are focused on diagnosis and treatment of cerebrovascular diseases and spinal vascular malformations.
Dr Killer grew up in Vienna, Austria and graduated in 1993 as MD (Doctor medicinae universae) from the University of Vienna, Medical School. During her neurosurgical residency, she was also trained in neurointerventional procedures by Prof Bernd Richling in Vienna in 1994 and 1998 by Prof Alex Berenstein in New York. She received her license as Specialist in Neurosurgery from the Austrian Medical Chamber in 1999 and her International Master (MSc) for Neurovascular Diseases in 2002 from Université Paris Sud-Faculté de Médecine de Bicêtre.
Since 2004, Dr Killer has been the attending Neurointerventionalist at Christian Doppler Clinic Salzburg, Austria, Paracelsus Medical University. Since 2009, Dr Killer has been an Associate Professor in Neurointervention at Paracelsus Medical University Salzburg and since 2011 has been Head of the Research Institute of Neurointervention at the Department of Neurology, Paracelsus Medical University.
Disclosures: Dr Killer receives research grants from Microvention and Terumo (via institute).
Albert H. Kim
Albert H. Kim is Director of the Brain Tumor Program and Associate Professor in the Departments of Neurological Surgery, Genetics, Neurology, and Developmental Biology at Washington University School of Medicine. He also serves as the Surgical Director of the Pituitary Center and is Co-Leader of the Neurorestorative Therapy Group at the Hope Center for Neurological Disorders. His clinical focus is the management of complex brain tumors, both malignant and benign. Dr Kim is an NIH R01-funded Principal Investigator of a laboratory which focuses on understanding the molecular mechanisms that drive tumor cell behavior in aggressive brain tumors. Dr Kim has made fundamental as well as translational discoveries in the field of brain tumors, including glioblastomas, meningiomas, and pituitary tumors. He has authored more than 85 peer-reviewed articles and book chapters, in high-profile biomedical journals including Cell, Science, Cell Reports, PNAS, and Neuro-Oncology. He has also served in leadership positions in the AANS/CNS Section on Tumors, the Society for Neuro-Oncology, and the Southern Neurosurgical Society.
Disclosures: Dr Kim is a consultant for Monteris Medical and has received research grants from Monteris Medical, Stryker, and Collagen Matrix.
Dong H. Kim, MD
Dong H. Kim, MD, is currently Professor and Chairman of the Department of Neurosurgery at University of Texas Medical School and Director of the Mischer Neuroscience Institute at Memorial Hermann Hospital.
Dr Kim was born in Seoul, Korea. His family immigrated to the US when he was seven years old. He graduated from Stanford University with a dual degree in Biology and the Humanities. He obtained his MD at the University of California, San Francisco Medical School. After general surgery training at Harvard, he completed his neurosurgery residency under Dr Charles Wilson at UCSF. He went on to complete a fellowship in cerebrovascular and skull base surgery with Dr Arthur Day at the University of Florida.
Dr Kim has held faculty and hospital appointments at Harvard Medical School, Brigham and Women's Hospital, the Dana-Farber Cancer Institute, Cornell University Medical College, The New York Hospital, and Memorial Sloan Kettering Cancer Center. In October 2007, Dr Kim moved from Boston to Houston to assume his current position.
His clinical practice is focused on the treatment of cerebrovascular disease, brain tumors, Chiari malformations, and trigeminal neuralgia. His research interests include identifying genetic defects leading to intracranial aneurysms, the development of stem cell therapy following neural injury, and novel approaches to quality paradigms and outcomes research. He is the recipient of grants from the National Institutes of Health and the American Stroke Association.
Dr Kim received the Partners in Excellence Award at Brigham and Women's Hospital in 2005 and 2006. He was awarded the President's Gold Circle Award from Memorial Hermann Hospital in 2008 and the Breakthrough of the Year Award for Growth in 2009, also from Memorial Hermann. He was named as a Top Doctor in US News and World Reports from 2011-Present. He has also been named to Castle Connolly's Best Doctors, America's Top Surgeons, and Houstonia Magazine's Best Doctors lists.
Disclosures: Dr Kim receives grant support as a PI for the NIH, Vivian L. Smith Foundation for Neurologic Research, and is a scientific advisor for Colubris MX and XCath.
Lawrence R. Kleinberg, MD
Lawrence R. Kleinberg, MD, is an Associate Professor, Co-Director of Sterotactic Radiosurgery, and Director of the Cyberknife Program. He graduated from Yale Medical School 1989 and completed his Radiation Oncology training Sloan Kettering Cancer Cent 1993, He has practice Radiation Oncology at Johns Hopkins Hospital since then. His research interest are Radiosurgery for brain and spine tumors, improving outcome for glioblastoma and combining radiotherapy and immunotherapy.
Disclosures: Dr Kleinberg has performed consulting for Novocure, Arbor, and Accuray; he is a part of the advisory board for Novocure.
Dr Petra M. Klinge
Dr Petra M. Klinge received her medical degree (MD) at the University in Kiel in 1993. After completing her neurosurgical residency in Hannover Medical School, Germany, in 2002, Dr Klinge has held the position of Senior Physician and Assistant Professor of Neurosurgery at the International Neuroscience Institute in Hannover, Germany. Dr Klinge joined the Neurosurgery Foundation and the Warren-Alpert Medical School at Brown University, Providence, Rhode Island, as an Attending Neurosurgeon in May 2009 and received the degree of an Associate Professor of Neurosurgery at the Warren-Alpert Medical School at Brown University in December 2009. Dr Klinge is an internationally renowned clinician for diagnosing and neurosurgical treatment of patients with Hydrocephalus. She continues her research activities in collaboration with the Department of Clinic Neurosciences at Brown University, working on the unifying concept of dementias and cognition related pathology in Hydrocephalus in the adult population. Dr Klinge was President of the International Society for Hydrocephalus and CSF Disorders from May 2010 to 2012. In addition to complex adult and pediatric hydrocephalus, her practice at Brown University and Rhode Island Hospital and Hasbro Childrens Hospital includes patients with associated developmental Cerebrospinal fluid disorders, such as spina bifida, Chiari malformation, and tethered cord syndrome. Dr Klinge’s scientific interests are “Chiari malformation and cognition”, the pathophysiology of the “occult tethered cord syndrome” and “adult-onset tethered cord”. To that extend, Dr Klinge conducts translational clinical research on CSF disorders in collaboration with the Vet medical school at Michigan State University and Tufts University. As a member of the Scientific Advisory Board of the Chiari&Syringomyelia Foundation and Scientific member of the Consortium of the International Ehlers Danlos Society, Dr Klinge promotes pioneering research in the field of CSF disorders, through various educational symposiums (i.e. Brown Medical School CSF disorder symposium) , webinars and national conferences. Dr Klinge is also an active member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeon, and since 2016, Dr Klinge holds the position of a full rank professor of neurosurgery and in 2017was promoted to director of Pediatric Neurosurgery and Director of the cerebrospinal fluid center of the brain and spine at Rhode Island Hospital and at the Brown Medical School (https://www.lifespan.org?petra-m-klinge-phd).
Disclosures: Dr Klinge has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Michel Kliot
Dr Michel Kliot is an Attending Neurosurgeon and Director of the Peripheral Nerve Center at Northwestern Memorial Hospital, and a Professor of Neurological Surgery at Northwestern University’s Feinberg School of Medicine.
Dr Kliot’s academic background includes: Harvard (BA/MA); graduate work in neurobiology at Stanford; Yale (MD); general surgery internship at Columbia College of Physicians and Surgeons; neurosurgical residency at the Neurological Institute of New York; and peripheral nerve fellowships at the University of Toronto and LSU Medical Center in New Orleans. He was an attending neurosurgeon at the University of Washington from 1991 to 2011, where he rose to the rank of Professor as well as the Director of the Peripheral Nerve Center. He then moved to the University of California, San Francisco in 2012 where he spent two and half years heading up their peripheral nerve effort before moving to Northwestern Medicine.
Dr Kliot’s goal as a physician is to provide state-of-the-art healthcare in a compassionate, efficient, and cost-effective manner by leveraging Northwestern Memorial Hospital’s considerable resources, which include state-of-the-art high resolution magnetic resonance and ultrasound imaging techniques, superb neurologists who are adept at performing electrodiagnostic tests such as EMG and nerve conduction studies, an extremely experienced intraoperative electrophysiological monitoring team to help identify injured nerves while minimizing damage to functioning nerves, as well as world class neuropathologists, neuroradiologists, orthopedic surgeons, plastic surgeons, pain experts, and rehabilitation specialists.
His research efforts are focused on using non-invasive imaging techniques to reduce the need for exploratory surgery and improve clinical decision-making. He is also very interested in understanding at a molecular level why many peripheral nerve tumors stop growing for very long periods of time.
His clinical interests (Peripheral Nerve Injuries and Diseases in Adults and Children) include:
Nerve Entrapment Syndromes: Carpal tunnel syndrome, Ulnar nerve entrapment at the elbow, Thoracic outlet syndrome, Suprascapular Nerve Entrapment, Pronator Teres Syndrome, Radial Tunnel Syndrome, Guyon’s Canal Entrapment, Pyriformis syndrome, Meralgia paresthetica, Peroneal Nerve Entrapment, and Tarsal Tunnel Syndrome; Peripheral Nerve Tumors and Other Masses: Schwannomas, Neurofibromas, Patients with Neurofibromatosis Type I and II, Patients with Schwannomatosis, and Ganglion cysts; Traumatic Nerve Injury: Nerve damage requiring repair with or without grafting, Brachial plexus injuries in adults, Brachial plexus injuries in newborns and children, and Peripheral nerve injuries throughout the body; Diagnostic Procedures: Nerve Biopsies and Muscle Biopsies; and Pain: Surgery on local nerve pathology generating pain.
Disclosures: Dr Kliot has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
William E. Krauss
William E. Krauss was born in Oak Park, Illinois on October 17, 1961 to Kathryn Suzanne Krauss and Carl William Krauss. He was raised in the Chicago area. He graduated from Loyola Academy in 1979. At Loyola, he was co-captain of the varsity football team. He won the Robert Skoglund Award, given to the school’s top scholar-athlete. He graduated from Harvard College with honors with a degree in Biology in 1983. He received his MD from the Columbia College of Physicians and Surgeons in 1987.
Following a general surgery internship at the Columbia Presbyterian Medical Center (1987-1988) and a Dana Research Fellowship (1988-1989), he completed a residency in neurological surgery at the Neurological Institute of New York (1989-1993). His mentors at Columbia included Bennett Stein, Don Quest, Jost Michelsen, Robert Solomon, Peter Carmel, and Kal Post. He completed a six-month fellowship in spinal surgery at the Medical College of Wisconsin in 1994 under Sanford Larson.
In 1993, David Piepgras hired him to the faculty in the Department of Neurological Surgery at the Mayo Clinic in Rochester, Minnesota. After spending most of his adult life in Boston and New York, he returned to the Midwest. He currently holds the rank of Associate Professor of Neurological Surgery. In 2001, he received the Mayo Fellows Association Teacher of the Year Hall of Fame Award for consistent excellence in resident education. He is Director of Resident Education at Mayo. His subspecialty is complex spine surgery. His current clinical and research interests focus on spinal cord tumors, spinal cord vascular malformations, outcomes from spinal surgery, craniocervical disorders, and resident education. He is a member of the AANS, CNS, and Scoliosis Research Society.
He married Joan Collins in 1998. Joan is a registered nurse specializing in pediatric intensive care. They have 3 teenage children: Bill Jr (b. 1992), Emma (b. 1993), and Sarah (b. 1995). His hobbies include cycling/triathlon, skiing, winter sports, woodworking, and his FLSFT.
Disclosures: Dr Krauss has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Abhaya V. Kulkarni
Dr Abhaya V. Kulkarni is a pediatric neurosurgeon and Professor of Surgery at the Hospital for Sick Children, Toronto, a Scientist at the SickKids Research Institute, and Program Director for the Neurosurgery Residency Program at the University of Toronto. He obtained his MD from the University of Toronto in 1994 and graduated in 2002 from the Toronto Neurosurgery Residency Program. He then completed his PhD in Clinical Epidemiology at McMaster University. After a pediatric neurosurgery fellowship at Hospital Necker Enfants Malades in Paris, he began his faculty appointment at the Hospital for Sick Children in 2003.
Dr Kulkarni’s research focuses on health outcome assessments in pediatric neurosurgery, with special emphasis on hydrocephalus. He is a site investigator for the North American Hydrocephalus Clinical Research Network and has received research funding from several national and international funding agencies. He serves on the Clinical Guidelines Committee of the AANS/CNS. Dr Kulkarni has published over 130 peer-reviewed manuscripts on a range of topics in neurosurgery.
Disclosures: Dr Kulkarni has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Shekar Kurpad
Dr Shekar Kurpad is Professor of Neurosurgery and Director of the Spinal Cord Injury Center at the Medical College of Wisconsin (MCW). His clinical practice focuses on the surgical treatment of patients with degenerative and traumatic conditions of the spine and spinal cord, as well as benign and malignant tumors of the spinal column and spinal cord. His laboratory currently focuses on the development of novel MRI-based imaging biomarkers for spinal cord injury (SCI) and cervical spondylotic myelopathy. He has been involved in SCI research since 2001 after being awarded the William P.Van Wagenen Fellowship by the AANS. His experience in this field of research includes earlier work involving stem cells for regeneration of the spinal cord, which he began as a postdoctoral fellow at the Karolinska Institutet; the establishment of an SCI research laboratory at the MCW from 2002 (endowed since 2010); funding to study the mechanisms of allodynia after stem cell transplantations into the injured spinal cord using Veterans Affairs BLR&D merit funding from 2006 to 2009; and imaging of SCI using diffusion tensor imaging (DTI) funded by Veterans Affairs RR&D merit grants from 2009 to present. He has served as a consultant for several imaging start-up companies based in the Milwaukee area and was awarded NIH SBIR funding as principal investigator for these efforts. He is the clinical principal investigator at MCW for all Phase I–III SCI clinical trials (8 trials since 2008 encompassing both neuroprotective and neural regeneration strategies) and has participated as a member of the National SCI Consortium for Translational Therapies for SCI from 2009 to present. As a surgeon actively involved in the care of SCI patients at the Clement J. Zablocki Veterans Affairs Medical Center, he is interested in translating laboratory findings rapidly to clinical applications to establish new and innovative diagnostic paradigms for patients with spinal disorders using novel MRI-based technology.
Disclosures: Dr Kurpad has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr James Lah, MD, PhD
Dr James Lah, MD, PhD is Associate Professor and Vice Chair of the department of Neurology at Emory University. He directs the Cognitive Neurology Program, serves as Associate Director and Clinical Core Leader of the NIA-funded Emory Alzheimer’s Disease Research Center, and holds the Alice and Roy Richards Chair for Alzheimer’s Research. Dr Lah completed his dissertation project studying basic mechanisms of membrane traffic in the Department of Neurobiology and Cell Biology and earned his MD-PhD through the Medical Scientist Training Program at the Ohio State University College of Medicine. Following Residency training in Neurology, he remained on the faculty at Emory University where he has continued to pursue research in the field of Alzheimer’s and other neurodegenerative disorders, and has built a multidisciplinary team to care for individuals living with these disorders. Dr Lah has published over 100 articles in peer-reviewed journals and has conducted basic and clinical research funded through the NIH, Alzheimer’s Association, Hartford Foundation, Rotary CART Fund, American Federation for Aging Research, AHAF/Bright Focus Foundation, Goizueta Foundation, and numerous industry-sponsored clinical trials. His current research is focused on the development of improved biomarkers and identification of new therapeutic targets in Alzheimer’s and related disorders.
Disclosures: Dr Lah serves as a site PI or site Investigator for clinical trials sponsored by Biogen, Eisai, Eli Lilly, Merck, Hoffman-La Roche, Avanir, Abbvie, Novartis, and Genentech.
Ilya Laufer is an Associate Attending Neurosurgeon at Memorial Sloan Kettering Cancer Center and Associate Professor of Neurological Surgery at the Weill Cornell Medical College. He serves as the Director of the Minimally Invasive Spine Tumor Surgery Program. His practice focuses on the treatment of primary and metastatic spinal tumors and cancer pain. His research interests include implementation of novel technology for treatment of spinal tumors, patient-reported outcome research and clinical pathways and guidelines development.
Dr Laufer completed his residency in neurological surgery at the Weill Cornell Medical College and an instructorship in Spine Oncology and Complex Reconstruction at the Johns Hopkins Hospital. He also has a master of biostatistics degree from the Mailman School of Public Health at Columbia University.
Disclosures: Dr Laufer is a consultant for Medtronic, Globus, Depuy/Synthes, Spinewave, and Brainlab.
Dr Edward Laws
Dr Edward Laws received his bachelor's degree from Princeton University with honors in Economics and Sociology in the Special Program in American Civilization, and then attended the Johns Hopkins University School of Medicine in Baltimore, Maryland. He did his surgical internship and neurosurgical residency at Johns Hopkins under A. Earl Walker. After completing his residency, he joined the faculty at the Johns Hopkins Medical School. In 1972, he joined the staff of the Mayo Clinic in Rochester, Minnesota, where ultimately he became Professor of Neurosurgery and developed major interests in pituitary surgery and epilepsy surgery along with a continuing interest in the metabolism and pathophysiology of primary brain tumors. In 1987 he became Professor and Chairman of the Department of Neurosurgery at the George Washington University in Washington, DC, and in 1992 joined the faculty of the University of Virginia as Professor of Neurosurgery and Professor of Medicine, establishing a Neuro-Endocrine Center there. Subsequently, he was Professor of Neurosurgery at Stanford University, and in 2008 established the Pituitary/Neuroendocrine Center at the Brigham and Women's Hospital in Boston where he currently is Professor of Neurosurgery at Harvard Medical School. During his surgical career he has operated upon more than 7000 brain tumors, of which 5400 have been pituitary lesions.
Dr Laws has served as President of the World Federation of Neurosurgical Societies, President of the Congress of Neurological Surgeons, Editor of Neurosurgery, Chairman of the Board of Trustees of the Foundation for International Education in Neurosurgery, Director of the American Board of Neurological Surgery, President of the American Association of Neurological Surgeons, and President of the Pituitary Society. He has authored over 500 scientific papers and book chapters, and is co-editor of the encyclopedic volume Brain Tumors, which is in its third edition. He has been the fifth neurosurgeon to become President of the American College of Surgeons, and was elected to membership in the Institute of Medicine of the National Academy of Science. He remains actively involved in pituitary tumor and neuroendocrine research and surgery.
Disclosures: Dr Laws has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Michael Lawton, MD
Michael Lawton, MD, is the Tong-Po Kan Endowed Chair, Professor of Neurological Surgery, and Vice-Chairman of the department at the University of California, San Francisco. He is chief of Vascular Neurosurgery, specializing in the surgical treatment of aneurysms, arteriovenous malformations, arteriovenous fistulas, cavernous malformations, and cerebral revascularization, including carotid endarterectomy. As chief of one of the busiest cerebrovascular services on the west coast for over 17 years, he has experience in surgically treating over 3500 brain aneurysms and over 650 AVMs. He is also trained in the endovascular treatment of aneurysms.
Dr Lawton directs and conducts his research at the UCSF Center for Cerebrovascular Research (CCR), a collaborative research group funded by grants from the National Institutes of Health that investigates the physiology of cerebral circulation and the pathophysiology of vascular malformations. His basic science investigations study the formation, underlying genetics, and rupture of brain AVMs, as well as the hemodynamics, rupture, and computational modeling of brain aneurysms. His clinical investigations study the anatomy of microsurgical approaches to vascular lesions and efficacy of aneurysm, AVM, and bypass surgery. He is the principal investigator of a U54 grant and program director of the Brain Vascular Malformation Consortium (BVMC), a multicenter group studying malformations associated with Hereditary Hemorrhagic Telangiectasia, cavernous malformations, and Sturge Weber Syndrome.
He has published over 300 peer-reviewed articles, over 50 book chapters, and 3 textbooks, including Seven AVMs: Tenets and Techniques for Resection and Seven Aneurysms: Tenets and Techniques for Clipping, which has won numerous awards and sold more copies than Yasargil’s Microneurosurgery. His awards include the Young Neurosurgeon Award from the World Federation of Neurological Societies, the Harold Rosegay Teaching Award, and the Diane Ralston Clinical and Basic Science Teaching Award. He has given over 500 invited lectures nationally and internationally, including visiting professorships at over 40 neurosurgical institutions. He has been active in resident teaching courses, directing the CNS Anatomy Course for Senior Residents, developing and co-directing the AANS Vascular Skills Course, and directing industry-sponsored anatomy courses and teaching programs for residents nationally and internationally to observe vascular neurosurgery. He co-founded Mission:BRAIN, a teaching mission to raise the level of neurosurgical technique practiced in developing countries, and has conducted missions in Mexico and the Philippines.
Disclosures: Dr Lawton is a consultant for Zeiss, Medtronic, and Stryker; he receives royalties from Mizuho and Thieme Medical Publishers, Inc
Jeffrey Leonard, MD
Jeffrey Leonard, MD, is Chief of Neurosurgery at Nationwide Children’s Hospital and Professor of Neurosurgery at the Ohio State College of Medicine. He did his training in Neurosurgery at Washington University. He also completed a fellowship in pediatric neurosurgery there in 2003 before joining the faculty where he spent the next 11 years. During that time, he served as Co-Director of the Pediatric Neurocritical Care Program and a Co-Director of the Neuro-Oncology Program at St. Louis Children’s Hospital. While at Washington University, he maintained a lab studying the genetics of pediatric low-grade gliomas, and he ran the brain tumor bank for St. Louis Children’s Hospital. He has published over 100 papers focused mainly on pediatric neuro-oncology. Recently, he moved to Columbus with his wife and two children where he has continued his research in pediatric brain tumors. He has recently been named the Robert F & Edgar T. Wolfe Foundation Endowed Chair in Neurosurgery. He has served on multiple governmental grant review committees and is co-director of neuro-oncology at Nationwide Children’s Hospital. His clinical interests include pediatric neuro-oncology, spasticity, and spine trauma in the pediatric population.
Disclosures: Dr Leonard has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Allan Levi
Dr Allan Levi is a tenured Professor and Chair of Neurosurgery at the University of Miami MILLER School of Medicine. He has a very busy clinical practice that focuses on complex spinal cord, spine and peripheral nerve disorders. He has been at the University of Miami for the last 25 years including completing a PhD in neurosciences. He graduated from the University of Ottawa medical school and completed his residency at the University of Toronto, as well as a spine fellowship at the Barrow Neurological Institute in Phoenix. He has served as national director of the AANS Oral Board course for the last 12 years. He is an elected member of two of our most prestigious neurosurgical societies – the American Academy of Neurosurgery and the Senior Society of Neurological surgeons. His clinical research interests have focused on developing cellular transplantation strategies to repair injuries within both the human central and peripheral nervous system. His current research interests involve serving as (1) PI on intravascular hypothermia after human cervical spinal cord injury (2) co-PI on the FDA approved trial of “The Safety of Autologous Human Schwann Cells in Subjects with a. Sub-acute Spinal Cord Injury (SCI)” and b. chronic SCI (3) Site PI of a Phase II Proof-of-Concept Study of the Safety and Efficacy of HuCNS-Stem Cell Transplantation in Cervical SCI (4) PI on the clinical development and characterization of the use of autologous human Schwann cells for peripheral nerve injuries with a lengthy gap.
Disclosures: Dr Levi receives teaching honorarium from Medtronic and the AANS; he has research grant support from the NIH and DOD.
Dr Elad Levy
Dr Elad Levy is the Chairman of Neurological Surgery and Professor of Neurosurgery and Radiology at State University of New York at Buffalo, who joined the department in 2004. He is Board Certified by the American Board of Neurological Surgeons. Dr Levy is the Director of Stroke Research, Co-Director of Kaleida Health Stroke Center and Cerebrovascular Surgery, Director of Endovascular Stroke Treatment and Research, and Director of the Toshiba Neuroendovascular Cath Lab.
Prior to his professorship at the University, Dr Levy graduated from Dartmouth College and received his Doctor of Medicine degree with distinction from George Washington University. He completed a surgical internship and his neurosurgical residency at the University of Pittsburgh and his fellowship at UB. He also received his MBA from Northeastern University in 2013.
Dr Levy has participated in several clinical research studies on synthetic bone, carotid artery revascularization, and stents. Recently, he has become involved with a study investigating concussion injury as it relates to blood flow physiology of the brain. Companies such as Boston Scientific, Cordis, Micrus, ev3, and Abbott Vascular have solicited Dr Levy for research projects, consultant roles, symposium speaker, and training of other physicians. He has had numerous publications in peer-reviewed journals and has presented at both national and international meetings. Additionally, he has trained several physicians throughout the world in using complex Endovascular neurosurgical techniques. Dr Levy is also the principal investigator for flow diverting technologies.
In 2011, Dr Levy spearheaded a local non-profit organization called PUCCS (Program for Understanding Childhood Concussion and Stroke). Dr Levy, who serves as president and founder, has led the organization in raising more than $290,000, which has been used to fund concussion research and education in the Western New York area.
Clinical Interests: Dr Levy's research interests focus on developing new and better treatments for patients with stroke and stroke symptoms due to atherosclerotic disease of intracranial and extracranial vessels. He has published and lectured extensively on endovascular techniques for stroke and other cerebrovascular disorders.
Professional Highlights: George Thorn Young Investigator Award from UB School of Medicine (2012); MDx Medical Inc. Patients' Choice Recognition (2010); Top 50 Doctors in WNY, Business First (2009); Thomas J. Linnemeir Young Investigator Award-Runner Up (2008); Louise Eisenhardt Award, American Association of Neurological Surgeons (2005); Best Paper-Basic Science Category, Southern Neurosurgical Society (2003); Cerebrovascular/Endovascular Fellowship Award (2003); AANS/CNS Joint Cerebrovascular Section Mullen Endovascular Fellowship Award (2002).
Memberships: American Association of Neurological Surgeons; Congress of Neurological Surgeons; Ex officio member, Executive Council, AANS/CNS Cerebrovascular Section; Fellow of the American College of Surgeons; Fellow of the American Heart Association/American Stroke Association; Congress of Neurological Surgeons, Compliance & Ethics Committee Chair.
Disclosures: Dr Levy owns shareholder interest in NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care (formerly the Stroke Project), Rebound Therapeutics, StimMed, and Three Rivers Medical; he is a National PI for Medtronic (merged with Covidien Neurovascular); he is part of the Steering Committees for SWIFT Prime and SWIFT Direct Trials (merged with Covidien Neurovascular); he receives honorarium for training and lectures from Medtronic (formerly Covidien Neurovascular); he is a consultant for Claret Medical, GLG Consulting, Guidepoint Global, Imperative Care (formerly the Stroke Project), Medtronic (formerly Covidien Neurovascular), Rebound Therapeutics, and StimMed; he is a member of the Advisory Boards for Stryker (AIS Clinical Advisory Board), NeXtGen Biologics, MEDX, Cognition Medical, and Endostream Medical; he is a Site PI for Microvention (CONFIDENCE Study). Dr Levy renders medical/legal opinion as an expert witness.
Dr Simon Lo
Dr Simon Lo is an internationally renowned radiation oncology expert in brain and spine tumors, stereotactic radiosurgery and stereotactic body radiotherapy. Dr Lo earned his medical degree from the Faculty of Medicine, The Chinese University of Hong Kong. He completed a residency in Clinical Oncology under the Fellowship of Royal College of Radiologists, UK curriculum at Queen Elizabeth Hospital, Hong Kong before performing a second residency in Radiation Oncology at University of Minnesota. He is currently Professor of Radiation Oncology and Vice Chair for Strategic Planning of Radiation Oncology as well as Professor of Neurological Surgery at University of Washington School of Medicine. He was previously the Director of Neurologic Radiation Oncology and Radiosurgery Services at University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center as well as Professor of Radiation Oncology at Case Western Reserve University in Cleveland, OH. He has been inducted as a Fellow of American College of Radiology (FACR) and is currently the President-elect for the Council of Affiliated Regional Radiation Oncology Societies, the radiation oncology chapter of the American College of Radiology (ACR). He is also a Fellow of American Society for Radiation Oncology (FASTRO). He has participated in or led international/ national practice guidelines in brain, bone and spinal metastases. He has been invited as a panel member to serve on the American Academy of Neurological Surgeons (AANS)/ Congress of Neurological Surgeons (CNS) Taskforce in Brain Metastases to help develop evidence cased practice guidelines for brain metastases. Dr Lo is the lead editor for 3 textbooks with one dedicated to stereotactic body radiotherapy for spinal metastasis and a co-editor of a 4th textbook dedicated to brain and spine radiosurgery. He has published over 180 peer reviewed papers and has given numerous lectures or training courses in prestigious meetings/ conferences in the US, Canada, Europe and Asia and numerous prestigious universities in the US, Canada, Germany and Asia.
Disclosures: Dr Lo is a member of the Elekta ICON Gamma Knife Group.
M. Beatriz Lopes
M. Beatriz Lopes received her MD and PhD degrees at the University of São Paulo in São Paulo, Brazil. She completed her Anatomic Pathology and Neuropathology training at the University of São Paulo followed by a Clinical and Research Neuropathology Fellowship at the University of Virginia in Charlottesville, Virginia, USA. She joined the faculty of the Department of Pathology at the University of Virginia in 1993 where she is now the Harrison Distinguished Teaching Professor of Pathology and Neurological Surgery and the Chief of the Neuropathology and Autopsy Services. Dr Lopes has been the Director of the ACGME-accredited Neuropathology Fellowship Program at that Institution since 2003. Her clinical and research expertise is in brain tumors and pituitary pathology with over 160 peer-reviewed manuscripts, 40 textbook chapters, and one book in these areas. She has co-authored several chapters in both the WHO Classification of Brain and Pituitary Gland Tumors since 2000 and 2004, respectively, and was a member of the WHO Consensus and Editorial Meeting of the upcoming 4th Edition of the WHO Classification of Tumors of the Pituitary Gland.
Disclosures: Dr Lopes has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Robert H. Lustig, MD, MSL
Robert H. Lustig, MD, MSL. is Professor emeritus of Pediatrics, Division of Endocrinology at the University of California, San Francisco (UCSF). He specializes in the field of neuroendocrinology, with an emphasis on the regulation of energy balance by the central nervous system. His research and clinical practice has focused on childhood obesity and diabetes. Dr Lustig holds a Bachelor’s in Science from MIT, a Doctorate in Medicine from Cornell University. Medical College, and a Master’s of Studies in Law from U.C. Hastings College of the Law.
Disclosures: Dr Lustig has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Andrew I.R. Maas, MD, PhD
Andrew I.R. Maas, MD, PhD, is Professor and Chairman of the Department of Neurosurgery at the Antwerp University Hospital and University of Antwerp. He holds positions as Chairman of the Neurotraumatology Committee of the World Federation of Neurosurgical Societies, Chairman of the section on Neurotrauma and Critical Care of the EANS, Co-Chairman of the European Brain Injury Consortium and Past President of the International Neurotrauma Society. He graduated from Medical School in 1977 and was certified as a neurosurgeon in 1985. He is a general neurosurgeon with specific interest in Traumatic Brain Injury and neuro-intensive care. His main research interests are: clinical trial design and analysis in Traumatic Brain Injury, prognosis in Traumatic Brain Injury, individualized targeted management in Neurocritical care, quality of life after brain injury, and standardization of data collection. Dr Maas was the principal investigator of the IMPACT study group (International Mission on Prognosis and Clinical Trial design in TBI), which was awarded an NIH grant (2003-2013) on the research project: “Clinical Trial Design and Analysis in Traumatic Brain Injury.” The IMPACT project consisted of a collaborative venture between the Erasmus University Rotterdam, Antwerp University Hospital, the University of Edinburgh, and the Medical College of Virginia, Richmond, Virginia, USA. The IMPACT studies have resulted in over 55 publications and recommendations for improved trial design, have set the standard for prognostic analysis in TBI, and proposed formats for standardization of data collection in TBI studies. Dr Maas has also received funding from the Flemish Institute for Science and Technology for a project concerning Individualized Targeted Management in Neurocritical care (2009-2011). Currently he is Coordinator of a large collaborative project CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI, supported by the Framework 7 program of the European Union. Dr Maas is member of various editorial boards, review committees, and is a reviewer for over 35 international journals. In total, he has authored over 200 publications in peer-reviewed international journals, most of these focusing on research in Traumatic Brain Injury.
Disclosures: Dr Maas is coordinator of CENTER-TBI, a large-scale observational study on traumatic brain injury supported by the EU 7th Framework Program; he receives consulting fees from Integra LifeSciences Corporation, NeuroTrauma Sciences, LLC, and PressuraNeuro
Dr Joel D. MacDonald
Dr Joel D. MacDonald is an academic neurosurgeon at the University of Utah in Salt Lake City. He began his career at University of North Carolina in Chapel Hill, where he earned his Medical Degree. He subsequently completed his General Surgery internship at Carolinas Medical Center in Charlotte, North Carolina and then his Neurosurgical Residency at University of Utah in Salt Lake City, Utah. Thereafter, he completed a vascular and skull base fellowship with Dr Arthur Day at the University of Florida in Gainesville, Florida. He was then appointed to the faculty at the University of Arizona in Tucson where he practiced until moving to Salt Lake City in 1999.
Since joining the faculty in Utah, he has maintained a complex and varied tertiary neurosurgical clinical practice involving cerebrovascular, skull base, epilepsy, movement disorder, peripheral nerve, complex spine, trauma, and pain. He has served on the board of the American Association of Neurological Surgeons, The Congress of Neurological Surgeons, as well as the Rocky Mountain Neurosurgical Society. He has held numerous elected leadership positions in each of these organizations. He continues to participate actively in the residency training process and is the Associate Program Director for the residency training program at the University of Utah. He is an active member of the Society of Neurological Surgeons and has served as an Associate Editor for Neurosurgery for many years.
Disclosures: Dr MacDonald has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Andre Machado, MD, PhD
Andre Machado, MD, PhD, is the Director of the Center for Neurological Restoration at the Cleveland Clinic Neurological Institute. This center houses all clinical activities related to movement disorders at Cleveland Clinic as well as functional and stereotactic neurosurgery, deep brain stimulation and other forms of neuromodulation. Dr Machado performs deep brain stimulation (DBS) surgery for patients with Parkinson’s disease, tremor, dystonia and psychiatric disorders as well as surgical procedures for patients with intractable pain syndromes and spasticity.
Dr Machado received his medical degree from the University of Sao Paulo in 1997. He completed his residency in the same institution in 2003 and obtained his PhD in 2004. He came to the Cleveland Clinic in 2004, and completed two years of fellowship in Stereotactic and Functional Neurosurgery in 2006. He then joined the Cleveland Clinic staff in 2006 and has been the director of the program since 2009.
Dr Machado routinely teaches medical students, residents, and neurosurgery fellows. He is the program director for education in Stereotactic and Functional Neurosurgery and won the “Teacher of the year award” from the Department of Neurosurgery in 2009. Dr Machado is Full Staff in the Department of Neurosurgery and directs with Dr Richard Schlenk the academic and research activities for Neurosurgery Residents. He also has Joint Appointments at the Department of Neuroscience and Department of Biomedical Engineering at the Cleveland Clinic Lerner Research Institute.
Dr Machado leads deep brain stimulation and neuromodulation clinical trials as well as laboratory research. His research in deep brain stimulation for thalamic pain syndrome was awarded the National Institutes of Health Director’s New Innovator’s Award. In addition, he participates in deep brain stimulation research for treatment refractory depression as well as obsessive compulsive disorder. His laboratory in the Lerner Research Institute is dedicated to developing new strategies for neuromodulation- and neuroprosthetic-based therapies for post-stroke rehabilitation. His current research is funded by an NIH R01 grant and is aimed at evaluating the effects of deep cerebellar stimulation on post-stroke perilesional plasticity and recovery of function.
Dr Machado lectures frequently at national and international meetings on deep brain stimulation, emerging applications of neuromodulation, and chronic pain management. He serves as vice-chair for the pain section of the CNS/AANS and has been on that executive committee since 2008. He has authored several articles and book chapters in stereotactic and functional neurosurgery and neuroscience.
Disclosures: Dr Machado has distribution rights to Enspire and Cardionomics related to intellectual property: they are spin-offs of the Cleveland Clinic; he has research support from Enspire and St. Jude Medical; he has fellowship support from Medtronic; he has research support from the NIH.
Susan E. Mackinnon, MD, FRCS(C)
Susan E. Mackinnon, MD, FRCS(C), graduated from medical school at Queen’s University in Kingston, Ontario, Canada, in 1975. She trained in general surgery at the same institution and completed her plastic surgery training at the University of Toronto. She then completed a year of peripheral nerve research at the University of Toronto in the Division of Neurosurgery and a hand surgery fellowship in Baltimore at the Raymond Curtis Hand Center. Dr Mackinnon joined the surgical staff at the University of Toronto in 1982. In 1988 she was awarded the Medal Prize in Surgery from the Royal College of Physicians and Surgeons for her work on nerve regeneration. In 1991 Dr Mackinnon joined the Department of Surgery at the Washington University School of Medicine. Her research work in St. Louis has been funded through the National Institute of Health since 1993 and has investigated nerve allotransplantation and nerve regeneration. This work has resulted in new strategies of nerve transfers to reconstruct nerve injuries. She has been Chief of Plastic Surgery since 1996. She has published a classic textbook, Surgery of the Peripheral Nerve, 520 peer reviewed publications, 173 book chapters and the new comprehensive text Nerve Surgery. Her open access website provides surgical videos with all the “secret ingredients” and are used globally to improve the care of nerve injured patients. Dr Mackinnon is Past President of the American Society for Peripheral Nerve, American Association of Hand Surgery, American Association of Plastic Surgery, and Plastic Surgery Research Council and is a member of the National Academies of Medicine. She is the recipient of the Jacobson Innovation Award from the American College of Surgeons in 2013 for her pioneering work on nerve transfers. Dr Mackinnon married Dr Alec Patterson in 1972 and has four talented children. Lachlan, a James Beard award winning Chef, Megan, an Orthopaedic hand surgeon, Brendan is an Orthopaedic resident and Caitlan, a hospital administrator. She has ten adorable grandchildren.
Disclosures: Dr Mackinnon has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
John Magnotti, PhD
John Magnotti, PhD, is currently an assistant professor in the Department of Neurosurgery at Baylor College of Medicine in Houston, TX. He started his journey to neuroscience as a computer science and psychology major at James Madison University in the Shenandoah Valley of Virginia. He received a doctorate in cognitive and behavioral sciences and a masters in statistics from Auburn University. After graduate school, John moved to the Texas Medical Center to join Michael Beauchamp's laboratory as a postdoctoral fellow, studying the neural basis of multisensory integration using a combination of computational modeling of behavior and intracranial EEG. During his postdoc, he was awarded an NLM T15 Fellowship through the Gulf Coast Consortia in the area of biomedical informatics and data science. John was promoted to faculty in 2017 and his lab now focuses on developing statistical software for data analysis as well as addressing fundamental questions about multisensory computations in the human brain. Apart from his research, John is passionate about statistics education, teaching courses through the MD Anderson Cancer Center / UT Health Graduate School of Biomedical Sciences and providing statistical support for medical residents and graduate students around the Texas Medical Center.
Disclosures: Dr Magnotti has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Mark A. Mahan
Mark A. Mahan specializes in complex peripheral nerve surgery, spine surgery and neurologic reconstruction for diseases such as spasticity, spinal cord injury, nerve injury and stroke. Dr Mark Mahan is a neurosurgeon who specializes in peripheral nerve and spinal disorders. He completed his residency at the internationally recognized Barrow Neurologic Institute and did fellowship training at the Mayo Clinic and University of California in San Diego. He is an active researcher in spinal and nerve disorders, publishing scholarly articles routinely and pursuing laboratory research to improve patient outcomes. He is the only neurosurgeon in the Rocky Mountains who performs complex nerve surgery. Dr Mahan treats nerve tumors, whether malignant, benign or related to genetic syndromes such as neurofibromatosis; nerve entrapments, such as carpal tunnel syndrome, cubital tunnel syndrome, thoracic outlet syndrome or patients with prior surgery needing revision; nerve injuries, such as brachial plexus injuries, nerve lacerations or trauma, or iatrogenic (related to other surgery) nerve injuries; nerve pain, such as meralgica paresthetica, occipital neuralgia or other conditions requiring nerve stimulation; functional nerve reconstruction, including for post-stroke spasticity or palsy and dystonia; as well as many other conditions. Dr Mahan also performs the complete range of spinal surgery, including oncologic, deformity, minimally invasive and spinal trauma. Outside of work, Dr Mahan relaxes by getting out into the wilderness with his family. He can often be found running early in the morning.
Disclosures: Dr Mahan is a consultant for AxoGen, joimax, and Gecko Biomedical.
Martijn Malessy is Professor of Nerve Surgery and head of the Nerve Center at the Leiden University Medical Center, the Netherlands. He is clinical-scientific advisor for nerve regeneration research at the Netherlands Insitute for Neuroscience in Amsterdam. He has a vast experience in the nerve surgical treatment of complex nerve lesions, nerve tumours, complex nerve entrapment syndromes and neuropathic pain due to a nerve lesion. Additionally, he is a member of the skull-base team and operated numerous cerebello-pontine-angle tumours. He was the 2016-2017 President of the American Society for Peripheral Nerve and he is member of the Peripheral Nerve Surgery Committee of the World Federation of Neurosurgical Societies. He received the H. Verbiest prize of the Dutch Society of Neurosurgeons for scientific work on the brachial plexus. In 2013 he was the Visiting Interdisciplinary Professor in Peripheral Nerve Surgery at Mayo Clinic. In 2014 he was the awarded Kline Lecturer at the meeting of the American Association of Neurological Surgeons in San Fransisco.
Disclosures: Dr Malessy has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr. Justin Mascitelli
Dr. Justin Mascitelli received his undergraduate degree at the University of Pennsylvania and medical education at Weill Cornell Medical College. He trained in Neurological Surgery at Mount Sinai Hospital and received fellowship training in Endovascular Neurosurgery at Mount Sinai Hospital and Cerebrovascular Surgery at the Barrow Neurological Institute. He currently is an Assistant Professor of Neurosurgery at UT Health San Antonio and the Medical Stroke Director at St. Luke’s Baptist Hospital in San Antonio. He has authored numerous peer reviewed publications and book chapters on cerebrovascular neurosurgery. He is the principle investigator of a prospective, multi-center aneurysm registry and is actively participating in other research endeavors studying both aneurysms and stroke.
Dr. Justin Mascitelli has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Courtney McCracken currently serves as the Director of the Pediatric Biostatistics Core in the Department of Pediatrics at Emory University. Dr McCracken graduated from the University of Georgia with a B.S in Mathematics in 2006, and in 2009, she completed her Masters in Biostatistics from Augusta University (formerly Medical College of Georgia). In 2013, Dr McCracken completed her PhD in biostatistics from Augusta University under the direction of Dr Stephen W. Looney. Since 2011, Dr McCracken has been consulting with pediatric researchers in the Department of Pediatrics at Emory University. She has over 150 peer-reviewed publications spanning a wide-range of pediatric diseases and conditions. Her research interests include survival analysis, regression modeling strategies, and meta-analysis. She currently resides in Atlanta Georgia with her husband, a Neurosurgical Oncologist, and their two children.
Disclosures: Dr McCracken has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Michael McDermott, M.D.
Michael McDermott, M.D., is a neurosurgeon and the chief medical executive of Miami Neuroscience Institute. He is a world-renowned leader in neurosciences and has clinical expertise in the field of meningioma research and Gamma Knife radiosurgery. Dr. McDermott is widely known for advancing neurosurgical techniques and pioneered the surgical management of meningioma, a slow-growing tumor that affects the brain. He is an expert in the treatment of a wide variety of neurological disorders. Dr. McDermott joined Baptist Health South Florida from the University of California San Francisco (UCSF) Medical Center, where he served as co-director of the Gamma Knife radiosurgery program and Skull Base Surgery programs, vice chairman of clinical programs and Wolfe Family Endowed Professor in Meningioma Research. Throughout his career, Dr. McDermott's research has generated more than 400 peer-reviewed publications. In addition to his clinical and research leadership, he is an accomplished educator. As residency program director at the UCSF Medical Center, he trained young surgeons from around the world. Dr. McDermott has been recognized with several professional awards, and numerous visiting professor invitations.
Disclosures: Dr. McDermott has no conflicts of interest or disclosures relevant to service on the Editorial Review Board
Guy McKhann II
Guy McKhann II has over 20 years of experience as a neurosurgeon/neuroscientist at Columbia University/New York Presbyterian Hospital, combining clinical skill and compassionate care to maximize patient outcomes. He directs the clinical programs in epilepsy surgery, brain tumor surgery with awake and asleep brain mapping, movement disorder surgery, and adult hydrocephalus. Dr McKhann also works as a translational neuroscientist, directing the Epilepsy Neurophysiology Laboratory and within the multidisciplinary program in Cognitive Neuroscience and Neuromodulation.
Disclosures: Dr McKhann receives grant funding from the NIH; he is an investigator for the Medtronic SLATE trial (Stereotactic Laser Ablation Temporal Lobe Epilepsy); he is a consultant for Koh Young Technologies.
Matthew J. McPheeters, MD, MBA
Matthew J. McPheeters, MD, MBA is a neurosurgery resident at the University at Buffalo. Dr McPheeters grew up in Minneapolis, MN, and completed his undergraduate education at Baylor University in Waco, Texas, where he graduated magna cum laude. He received his Medical Doctorate and Master of Business Administration at the University of Minnesota, where he served as the president of the medical student council and worked as a health and medicine content creator at Khan Academy. Dr McPheeters also serves as an officer in the US Army Reserves.
Dr McPheeters clinical and research interests include open and endovascular neurosurgery as well as neurotrauma and neurocritical care medicine. In addition to his clinical interests, Dr McPheeters focuses on improving medical education through digital media and promoting quality scholarly publication.
Financial disclosures: none
Eric A. Mellon
Eric A. Mellon is an Assistant Professor in the Departments of Radiation Oncology and Bioengineering at the University of Miami, Sylvester Comprehensive Cancer Center, Miller School of Medicine. He is a graduate of the Physician Scientist Training Program of the University of Pennsylvania where he earned his PhD in MRI Physics. He is a board-certified radiation oncologist after completion of residency training at the H. Lee Moffitt Cancer Center in Tampa, FL. Dr Mellon has published over fifty peer-reviewed articles on emerging MRI techniques for cancer and clinical radiation oncology--mostly in brain, spine, and pancreatic cancers. Clinically, he specializes in radiotherapy for tumors of the central nervous system and serves as co-leader of the neurologic clinical research group at the Sylvester Cancer Center. He is principal investigator and co-investigator on two NIH-funded trials for magnetic resonance spectroscopy guided radiotherapy of glioblastoma and assessment of response to therapy for brain metastases. His current basic research interests utilize MRI to probe the tumor microenvironment during therapy, giving information beyond just tumor size to evaluate early treatment response.
Disclosures: Dr Mellon is a former full-time employee of Elekta (manufacturer of the Gamma Knife system). He received travel funding from Viewray for presentation of data on the Viewray MRI-guided radiotherapy system in 2018. He is on the speaker's bureau for the Varian Hyperarc radiosurgery system.
L. Madison Michael II
L. Madison Michael II received his BS from the University of the South and graduated from the University of Tennessee College of Medicine. As a medical student, he was an active member of the Medical Student Executive Committee and was elected to the Alpha Omega Alpha academic honor society and the Imhotep Leadership Society. Upon completion of internship in general surgery, he began his neurosurgical residency at the University of Tennessee in Memphis. Under the influence of Dr Jon Robertson, he developed a significant interest in skull base neurosurgery. Following graduation, he completed an international fellowship in skull base and open cerebrovascular neurosurgery in Bristol, England, under the guidance of Professor Hugh Coakham and Mr Richard Nelson. He is currently Program Director and Professor in the neurosurgical residency program at the University of Tennessee. He is also medical director and director of cranial base surgery for the Methodist Brain and Spine Institute. Dr Michael specializes in skull base surgery, vascular compression syndromes, and open cerebrovascular surgery.
Disclosures: Dr Michael has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Rajiv Midha
Dr Rajiv Midha was born in India in 1962 and immigrated to North America in 1972. He received his medical degree (1987), MSc (under Susan Mackinnon’s supervision in 1991), and neurosurgical training (completed in 1995), all from the University of Toronto. He obtained clinical fellowships in peripheral nerve neurosurgery at St. Michaels’ Hospital in Toronto, and at Louisiana State University (under David Kline). Dr Midha has published over 115 peer-reviewed articles, as well as in textbooks, with over 300 total publications, mostly related to peripheral nerve neurobiology and surgery. He has co-edited two textbooks on peripheral nerve surgery. Dr Midha runs an AI-HS funded basic science laboratory investigation of nerve regeneration, and is a Neuroscientist member of the Hotchkiss Brain Institute (HBI) at the University of Calgary. He has a special interest in peripheral nerve function, injury, repair, grafting, and regeneration. In the recent past, the main thrust of the research lab has been on developing novel cell-based therapies to improve outcome from nerve repair.
Dr Midha is presently Professor and Head of the Department of Clinical Neurosciences (and was recently the Chief, Division of Neurosurgery) at the University of Calgary. The Department of Clinical Neurosciences is highly academic, composed of 95 Faculty members, and is organized into the Divisions of Neurology, Neurosurgery, Physical Medicine and Rehabilitation and Translational Neurosciences All areas of sub- specialization in neurology, neurosurgery, and physiatry are covered, and each clinical Division has a strong residency training program as well as multiple Fellowships.
Disclosures: Dr Midha has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Jonathan Miller, MD
Jonathan Miller, MD, is Associate Professor and Director of the Functional and Restorative Neurosurgery Center at University Hospitals Case Medical Center/Case Western Reserve University in Cleveland, Ohio, where he also holds the George R. and Constance P. Lincoln Master Clinician Chair. He completed residency training at University Hospitals and fellowship training in functional neurosurgery at Oregon Health & Science University.
He has published over 50 peer-reviewed papers and has received 15 national awards. His clinical and research interests include movement disorders, epilepsy surgery, and development of novel treatments for a variety of disorders using neuromodulation.
Disclosures: Dr Miller has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr J Mocco, MD, MS
Dr J Mocco, MD, MS, obtained his Bachelor of Science degree with honors at the University of Miami. He then attended Columbia University, College of Physicians and Surgeons, where he completed his medical degree. After finishing his internship in general surgery at New-York Presbyterian Hospital, he spent one year performing a post-doctoral research fellowship evaluating the pathophysiologic mechanisms of stroke under Drs David Pinsky and E. Sander Connolly at Columbia University. Following this year he entered and completed a residency in neurological surgery at the New York Neurological Institute, part of the Columbia University Medical Center. Simultaneous to completing his neurosurgical training, Dr Mocco completed a Masters of Science degree in Biostatistics at Columbia University, with a concentration on clinical research methodology and analysis. Following the conclusion of his residency, Dr Mocco completed an endovascular neurosurgery fellowship under the tutelage of Dr L. Nelson Hopkins at the world-renowned Gates Stroke Center, while concurrently studying the inter-relationship between cerebrovascular biology and intravascular hemodynamics at the Toshiba Stroke Research Laboratory.
Dr Mocco has received numerous local, regional, and national grants in support of his research efforts and has had continual funding over his entire career. Dr Mocco has over 235 accepted peer-reviewed publications, 26 solicited editorials, and 16 book chapters. He is also co-Editor of two books on neurosurgical operative technique. He currently serves on the executive committee of the AANS/CNS Joint Cerebrovascular Section as secretary.
Dr Mocco’s major areas of clinical and research interest are stroke, brain aneurysms, subarachnoid hemorrhage, arteriovenous malformations (AVMs), cavernous malformations, carotid artery stenosis, intracranial stenosis, and endovascular treatment of tumors. Dr Mocco performs both open surgical procedures and minimally invasive endovascular procedures for cerebrovascular disorders and tumors.
Dr Mocco is happily married to Wendy Mocco. The Moccos have three sons, Finn, Michael, and Conall.
Disclosures: Dr Mocco receives research support from Stryker, Penumbra, Medtronic, and Microvention; he is a consultant with ownership interest for Imperative Care, Cerebrotech, Viseon, Endostream, Rebound Therapeutics, and Vastrax; he is an investor/stockholder/owner of BlinkTBI, Serenity, NTI, Neurvana, and Cardinal Consulting.
Fadi Nahab, MD
Fadi Nahab, MD, recently completed his tenure as the Medical Director of the Emory University Hospital Comprehensive Stroke Center (2008-2018) and the Emory University Hospital Midtown Primary Stroke Center (2013-2018). He is currently assisting the Emory Johns Creek Stroke Primary Stroke Center as their new Stroke Director. Dr Nahab was born in Baghdad, Iraq and immigrated with his family to the US during his childhood. He graduated from La Sierra University in California with a BS in Biology and obtained his MD at Loma Linda University. He completed his internship at UCLA before coming to Georgia for neurology residency and vascular neurology fellowship at Emory University. In combination with an outstanding stroke team, he led Emory University Hospital to becoming the 1st certified Comprehensive Stroke Center in Metro Atlanta and the 1st to successfully recertify in Georgia. His clinical practice is focused on the treatment of cerebrovascular disease and his research interests include biomarkers to guide the treatment of cryptogenic stroke patients, acute stroke treatment, dietary behaviors in stroke prevention and the treatment of intracranial atherosclerosis with more than 60 publications. He is a previous chief resident in Neurology, Neurology Teacher of the Year at Emory University and enjoys traveling with his family and golfing.
Disclosures: Dr Nahab has a patent pending on markers of coagulation and hemostatic activation to guide antithrombotic therapy in patients with cardiovascular and cerebrovascular disease.
Dr Anil Nanda
Dr Anil Nanda is the Peter W. Carmel MD chair of neurological surgery, professor and chair of the Department of Neurosurgery at Rutgers-New Jersey Medical School and Robert Wood Johnson Medical School, chair and chief of service for the department of neurosurgery at University Hospital and senior vice president of neurosurgical services at RWJBarnabas Health.
A New York native, Dr Nanda earned his medical degree with honors from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Madras University, in India. He completed an internship in surgical oncology from Memorial Sloan Kettering Cancer Center, followed by a residency in general surgery at Rush–Presbyterian–St. Luke’s Hospital in Chicago (now Rush University Medical Center); in neurosurgery at Hahnemann University School of Medicine, Philadelphia; and in pediatric neurosurgery at Children’s Hospital of Philadelphia. He completed his fellowship in microneurosurgery and cranial base surgery at the University of Pittsburgh Medical Center (UPMC) Presbyterian Hospital in Pittsburgh. In 2012, Dr Nanda earned his Master of Public Health degree from the Harvard School of Public Health. As part of his curriculum, he contributed to passing the Louisiana Youth Concussion Law, which requires all schools, clubs and any organization sponsoring youth athletics to provide athletes and their parents with information about concussions and the potential long-term effects of playing after a head injury. Dr Nanda served for 27 years as professor and chair at the Louisiana State University Health Sciences Center in Shreveport, where in 2003 he established a residency training program, currently the largest in the state, as well as helped facilitate the department’s Gamma Knife Radiosurgery and Neuroendovascular programs. In July 2018, he assumed his current position at Rutgers University. Dr Nanda has published more than 485 articles and 45 commentaries in peer-reviewed journals, in addition to authoring over 75 book chapters. He has published four books including the recent “Complications in Neurosurgery”. Dr Nanda has held significant leadership roles in professional organizations, including the American Association of Neurological Surgeons, for which he serves as Secretary; the North American Skull Base Society (past president); Southern Neurosurgical Society (past president); the Society of University Neurosurgeons (past president); the Louisiana State Neurosurgical Society (past president). Dr Nanda also has served as director and vice chair of the American Board of Neurological Surgery (ABNS). Dr Nanda has performed more than 16,000 surgeries, 2,000 of which were performed for skull base tumors and aneurysms. He has been married to his wife Laura, a practicing attorney, for 29 years. Together they have three children and reside in Westfield, NJ.
Disclosures: Dr Nanda has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Mika Niemelä
Dr Mika Niemelä graduated from Helsinki Medical School in 1989 and finished his neurosurgical training in 1997. He finished his PhD on Hemangioblastomas and von Hippel-Lindau disease in 2000. He became an Associate Professor in Neurosurgery and Head of Section at the Department of Neurosurgery at Helsinki University Hospital in 2006; since 2012 he has been the Vice-Chairman.
His clinical and research focus with several PhD students is on vascular lesions and skull-base tumors. He is an internationally acknowledged author of numerous papers, a lecturer, an active surgeon, and a member of several Neurosurgical Societies and Editorial Boards.
Disclosures: Dr Niemelä has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Eric Karl Oermann, MD
Eric Karl Oermann, MD is an Instructor of Neurological Surgery in the Mount Sinai Health System and the Director of AISINAI, Mount Sinai’s artificial intelligence research group. He studied mathematics at Georgetown University with a focus on differential geometry. Prior to attending medical school, Dr Oermann spent six months with the President’s Council on Bioethics studying human dignity under the mentorship of physician-philosopher Edmund Pellegrino, MD. Dr Oermann has won numerous awards for his scholarship including fellowships from the American Brain Tumor Association and Doris Duke Charitable Research Foundation where he was first exposed to neural networks and deep learning. He has published over eighty manuscripts spanning basic research on machine learning, deep learning, and the philosophy of medicine. As a resident Dr Oermann was selected as one of Forbes Magazine’s 30 Under 30 for his work in using machine learning to develop prognostic models for cancer patients. Dr Oermann completed a postdoctoral fellowship at Google (Google Health / Verily Life Sciences). He is interested in weakly supervised learning, reinforcement learning with imperfect information, and in building artificial neural networks that more accurately model biological neural networks (“machines that think like humans”). As a physician, he is also interested in the application of deep learning to solve a wide range of practical problems in the medical sciences for improving clinical care.
Disclosures: Dr Oermann is a former employee of Verily Life Sciences; his spouse is an employee of Merck; he is a consultant for Whiteboard; he receives grant funding from Intel Inc.
John O'Toole, MD, MS
John O’Toole, MD, MS, is an Associate Professor of Neurosurgery at Rush University Medical Center in Chicago, IL. He received his medical degree from Harvard Medical School and completed a residency in Neurological Surgery at the Neurological Institute of New York at Columbia-Presbyterian Medical Center in New York City followed by a fellowship in Spine Surgery at the University of Chicago. He received his Master of Science degree in Clinical Research from Rush University Graduate Medical College and serves as a lecturer for both the medical and graduate student programs. He serves as Co-Director of the Comprehensive Spine Tumor Clinic at Rush University Medical Center in conjunction with Radiation, Medical, and Neuro-Oncology staff.
Dr O’Toole’s clinical specialties include minimally invasive spine surgery, spinal oncology (including spinal column and spinal cord tumors), spinal radiosurgery, complex spinal reconstruction, and spinal arthroplasty. His research interests are clinical outcomes for spinal surgery, evidence-based clinical practice guideline development, image-guided spinal surgery, and development of new spinal surgical techniques and devices. He is an investigator on a number of investigator-initiated as well as multicenter and industry-sponsored research protocols.
Dr O’Toole has presented and published on a wide variety of topics in spinal surgery and has served as an advisor and peer reviewer for several interdisciplinary education and research organizations and journals. He is an active member of multiple neurosurgical and spinal surgical societies and has served on numerous national committees and workgroups including the AANS/CNS Guidelines Committee; the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves Guidelines, Outcomes and Executive Committees; the North American Spine Society Evidence-Based Guideline Development Committee; the Orthopaedic Research and Education Foundation Spine Prospective Clinical Research Grant Committee; and the Neurosurgical Research and Education Foundation Development Committee.
Disclosures: Dr O'Toole is a consultant for RTI Surgical, Globus Medical, Amendia/Spinal Elements, and the FDA; he receives royalties from RTI Surgical and Globus Medical; he has stock ownership in Theracell; he has fellowship support from AOSpine, NREF, and Globus Medical; he is an officer/committee member with the AANS, CNS, NASS, and AOSpine.
Paul Park was born in Los Angeles, CA and attended UCLA for college where he earned bachelor and master's degrees in biology. Dr Park subsequently obtained a MD degree from the University of Michigan and completed a neurosurgical residency at the University of Michigan.
Given his interest in the spine, Dr Park completed an enfolded fellowship at the Cleveland Clinic Spine Institute as well as a post-residency fellowship in minimally invasive spinal surgery at the Semmes-Murphey Clinic. He is now an Associate Professor of Neurosurgery at the University of Michigan, treating all spinal pathologies, with a particular interest in minimally invasive approaches.
Disclosures: Dr Park is a consultant for Globus Medical, NuVasive, Medtronic, and Allosource; he receives royalties from Globus Medical; he receives grant support from Pfizer and Vertex.
has been in sports medicine practice for over 25 years, is an Associate Professor in the Wits Faculty of Health Sciences and Director of the Wits Initiative for Sport and Health (WISH). He is currently also Director of Waterfall Sports Orthopaedic Surgery in Johannesburg and founder and Director of Sports Concussion South Africa, sports concussion consultant to World Rugby, a board member of the international Concussion in Sports Group and on the scientific committee for the International Consensus Conference on Concussion in Sport. He is a Fellow of the American College of Sports Medicine, the Faculty of Sports & Exercise Medicine (UK) and the International Sports Medicine Federation. Jon serves on the Advisory Board of the University of Washington, Seattle Sports Health and Safety Institute. He is a senior associate editor of the British Journal of Sports Medicine and Current Sports Medicine Reports (USA) and served 2 terms as President of the South African Sports Medicine Association. Jon has been team physician to school, club, provincial and international sports teams in rugby, cricket, soccer, athletics and basketball, has been member of the Cricket South Africa and SA Rugby medical committees, the Discovery Rockies Comrades Marathon Panel of experts and has served on tribunals for the South African Institute for Drug Free Sport.
Disclosures: Dr Patricios is a board member of the Concussion in Sport Group (est. 2002), a Sports Concussion Advisor to South African Rugby, a Senior Associate Editor of BJSM, an Associate Editor of Current Sports Medicine Review, and a Director of Sports Concussion South Africa.
Suzanne Penna is an Assistant Professor in the Department of Rehabilitation Medicine, Neuropsychology Division at Emory University School of Medicine. She completed her PhD in clinical and neuropsychology at Georgia State University, and completed her neuropsychology internship at Yale University School of Medicine, and Fellowship training at University of Alabama Birmingham. Dr Penna is Board Certified in neuropsychology by the American Board of Professional Psychology/American Board of Clinical Neuropsychology. She is the director of training for Emory’s neuropsychology program, from graduate to fellowship levels. Dr Penna serves as the Traumatic Brain Injury Clinical Director for Emory Veterans Program. Her research focus is on examining cognitive changes associated with chronic medical illness. She also has a strong interest in research on individuals with traumatic brain injury (TBI). This includes both outcome research in severe brain injury, and clinical profile of mild TBI. Specific populations include veterans with mTBI from blast injury and sports concussion.
Disclosures: Dr Penna has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Pier Paolo Peruzzi
Dr Pier Paolo Peruzzi is an Assistant Professor of Neurosurgery at the Brigham and Women’s Hospital in Boston and Principal Investigator in the Harvey Cushing Neuro-oncology Laboratories at the Harvard Medical School.
He attended medical school in Rome, Italy, and received his neurosurgery training at the Ohio State University, where he also obtained a PhD in molecular biology.
Dr Peruzzi is primarily focused on the care of patients with brain tumors. He is involved in multiple trials investigating the use of oncolytic viruses for the treatment of gliomas and he is also the principal investigator for a Phase 1 clinical trial studying the use of drug-releasing microdevices for in situ, patient-specific characterization of tumor sensitivity to different chemotherapics.
Dr Peruzzi runs a basic science laboratory investigating the role of non-coding RNAs in malignant brain tumors, with a particular interest in exploiting their biological properties to modulate the tumor epigenetic landscape and adaptive response to therapy. For his work, he has received a K12 and K08 Career Development Award from NIH in 2016 and 2017, respectively. He has also been awarded the Neurosurgery Research and Education Foundation Award in 2011 and the American Academy of Neurological Surgery Award in 2018.
Disclosures: Dr Pier Paolo Peruzzi has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Martin Piazza
Dr Martin Piazza is a neurosurgery resident at UNC Hospitals in Chapel Hill, North Carolina. He graduated from Princeton University with a degree in Chemistry and Materials Science. He then moved to North Carolina for medical school at Wake Forest School of Medicine, where he cultivated his interest in neurosurgery. During his medical school career, he spent a year in the Surgical Neurology Branch at the NIH in the Medical Research Scholars Program where he participated in and began to appreciate the importance of clinical, translational, and basic science research to the advancement of neurosurgery. As a resident, Dr Piazza has a wide array of interests, particularly early and accessible neurosurgical education, pediatric neurosurgical trauma, as well as adult and pediatric spinal deformity.
Nader Pouratian, MD, PhD
Nader Pouratian, MD, PhD, is Associate Professor of Neurosurgery, Radiation Oncology, and Bioengineering at UCLA where he is the Director of Neuromodulation, Stereotactic Radiosurgery, and Peripheral Nerve Surgery programs. He specializes in surgeries to restore and preserve brain function, including deep brain stimulation for movement disorders (and other emerging indications) and surgeries that require brain mapping. In addition, he treats peripheral nerve and brachial plexus injuries and tumors. His research focuses on developing novel interventions and technologies for neurological restoration, with a specific interest in the physiology of Parkinson's disease and motor control. He serves is an active member of the Congress of Neurological Surgeons as well as the American Society of Stereotactic and Functional Neurosurgery (ASSFN).
Disclosures: Dr Pouratian consults for Medtronic, Abbott, Boston Scientific, and Second Sight Medical Products, Inc.; he has received an educational grant from Medtronic and Abbott, as well as a research grant from BrainLab.
Roshan Prabhu, MD, MS
Roshan Prabhu, MD, MS, is a practicing radiation oncologist with Southeast Radiation Oncology and Levine Cancer Institute in Charlotte, NC. He specializes in treatment of malignant and benign conditions of the central nervous system for adults and children. He has a primary interest in the neurocognitive effects of cranial radiotherapy and novel methods for mitigating these risks.
He earned his medical degree from the University of Florida in Gainesville, FL, and completed his residency in radiation oncology at Emory University in Atlanta, GA. He also earned a master’s degree in clinical research at Emory University.
He is active in several professional organizations, including the Congress of Neurologic Surgeons (CNS), American Society of Therapeutic Radiation Oncology (ASTRO), and American Society of Clinical Oncology (ASCO). He also serves on the CNS brain tumor committee for RTOG/NRG.
Disclosures: Dr Prabhu has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Charles Prestigiacomo
Dr Charles Prestigiacomo is a 1993 graduate of Columbia University College of Physicians and Surgeons and completed his residency in Neurological Surgery at The Neurological Institute of New York, Columbia Presbyterian Medical Center, and subsequent fellowship in Endovascular Neurosurgery at Beth Israel Medical Center’s Institute of Neurology and Neurosurgery in New York City.
A Professor of Neurological Surgery, Radiology and Neurology & Neuroscience, Dr Prestigiacomo serves as Chair and Residency Program Director for Rutgers New Jersey Medical School. Dr Prestigiacomo has pursued clinical and basic science research in the surgical and endovascular treatment of cerebrovascular disease. His interests and accomplishments have earned him a position as Research Professor at the New Jersey Institute of Technology’s Department of Biomedical Engineering. His recent work in the biomathematics of aneurysm development has dovetailed with his current research in computational fluid dynamics.
With over 115 peer-reviewed publications, 50 chapters, and a recently published textbook, Dr Prestigiacomo has also served as founding Associate Editor of a neurointerventional journal. An avid historian, Dr Prestigiacomo regularly contributes to understanding the history of neurological surgery and cerebrovascular disease. His involvement in organized neurosurgery and neurointerventional surgery through numerous societies as the Congress of Neurosurgeons, American Association of Neurological Surgery, American Academy of Neurological Surgeons, and Society of Neurosurgeons provides Dr Prestigiacomo the opportunity to diligently work in developing practice and training policies in the field of cerebrovascular disease in particular and in neurological surgery in general.
Disclosures: Dr Prestigiacomo is a member of the DSMB for Cerenovus; a consultant for Aesculap and Edge Therapeutics; and is a board member of the International Brain Research Foundation.
Nabiha Quadri, MD
Nabiha Quadri, MD, is a PGY 3 neurosurgery resident at Saint Louis University. She is originally from Chicago, IL, and obtained her undergraduate degree in neuroscience from University of Illinois at Chicago. She completed her medical training at Saint Louis University School of Medicine. She has a wide range of clinical interests including pediatrics and functional neurosurgery.
Dr Alfredo Quiñones-Hinojosa
Dr Alfredo Quiñones-Hinojosa received a medical degree from Harvard University, where he graduated cum laude. He completed his residency in neurosurgery at the University of California, San Francisco, where he also completed a postdoctoral fellowship in developmental and stem cell biology. At Johns Hopkins University in Baltimore, Maryland, Dr Quiñones is a Professor of Neurosurgery and Oncology, Neuroscience and Cellular and Molecular Medicine. In addition to directing the Brain Tumor Surgery Program at Johns Hopkins Bayview Hospital, and the Pituitary Surgery Program at the Johns Hopkins Hospital, Dr Quiñones leads the Brain Tumor Stem Cell Laboratory. His efforts have produced the first and only model of the organization of the human subventricular zone, as well as the elucidation that astrocytes in this region are stem cells. Clinically, he focuses on the surgical treatment of primary and metastatic brain tumors, with an emphasis on motor and speech mapping during surgery as well as in the treatment of patients with pituitary and skull base tumors using transphenoidal endonasal and minimally invasive surgical approaches.
Dr Q is an internationally renowned neurosurgeon and neuroscientist who leads cutting edge research to cure brain cancer. He has published over 250 peer-reviewed articles and over 60 book chapters and has edited two books on stem cells. He is the lead editor for the 6th edition of Schmidek and Sweet's Operative Neurosurgical Techniques, the world's preeminent encyclopedia of neurosurgery, as well as an upcoming Video-Atlas of Neurosurgery: Tumors and Contemporary Skull Base Surgery.
Furthermore, Dr Q is regularly listed as one of the Best Doctors in America and America’s Top Surgeons as well as Baltimore Top Docs. He has been the recipient of “Health Care Heroes Award,” which recognizes doctors who make a difference in the lives of their patients. In 2014, he was the recipient of Voices Against Brain Cancer’s Neurosurgeon of the Year Award for his patient care and research strides to find a cure for brain cancer.
Disclosures: Dr Quiñones-Hinojosa has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Carolyn Quinsey
Dr Carolyn Quinsey is a board eligible pediatric and adult neurosurgeon who specializes in minimally invasive surgery and endoscopy. Dr Quinsey is fellowship trained in pediatric neurosurgery and operates on children and adults using innovative techniques which include endoscopic, endonasal, eyebrow craniotomy, and microscopic approaches. She is one of a very few specialists using flexible neuroendoscopy, the newest technology and technique to effectively remove tumors and treat hydrocephalus without a shunt. Dr Quinsey is also a specialist in skull base and pituitary tumor surgery and performs endonasal tumor removal along with the ENT skull base team.
Dr Quinsey is also devoted to training the next generation of neurosurgeons both in the United States and abroad. She is currently the associate program director of the UNC Department of Neurosurgery where she directs the skull base lab for residents. Medical students and residents are mentored by Dr Quinsey in research and surgical training. She travels to Africa regularly and is currently developing a program to train neurosurgeons in Malawi. Dr Quinsey’s international public health initiative is to provide ongoing education in subspecialty areas, and to help doctors in Africa find the resources and support they need to provide self-sustaining neurosurgical care.
Dr Quinsey is a member of the Congress of Neurological Surgeons, the American Association of Neurological Surgeons, the Pediatric Section of the AANS/CNS, and the North American Skull Base Society. She has presented her research at several national and international meetings. She also completed a medical journalism rotation with ABC News and continues to be active in utilizing new ways to inform her patients about their health using media and online resources. Dr Quinsey has no conflicts of interest.
Craig H. Rabb, MD
Craig H. Rabb, MD, was born and raised in southern Oklahoma. After attending the University of Oklahoma in Norman, Dr Rabb went on to study at the University of Oklahoma College of Medicine in Oklahoma City, where he received the L.J. Moorman Award, given each year to the top graduating student. Following medical school, Dr Rabb entered residency in Neurological Surgery at the University of Southern California, in Los Angeles. During this time, he also served as a visiting scientist at the Laboratory for Experimental Brain Research at the University of Lund in Sweden, from 1993 to 1994, having been awarded an American-Scandinavian Foundation fellowship. In 1995, Dr Rabb was appointed Assistant Professor of Neurological Surgery at the Oregon Health Sciences. In 2005, Dr Rabb was appointed Associate Professor of Neurosurgery at the University of Colorado School of Medicine, where he was Chief of Neurosurgery at Denver Health Medical Center. In 2008, Dr Rabb was recruited back to the University of Oklahoma in 2008, and later joined the faculty of the University of Utah School of Medicine in 2017.
Disclosures: Dr Rabb has no conflicts of interest or disclosures relevant to service on the Editorial Review Board
Dr. P.B. Raksin
Dr P. B. Raksin is a graduate of Yale University and the University of Maryland School of Medicine. She completed training in Neurological Surgery at Rush University Medical Center in 2002 and achieved ABNS certification in 2005. She is certified in Neurocritical Care through both the United Council for Neurologic Subspecialties (UCNS) and the Society of Neurological Surgeons (SNS) Committee on Advanced Subspecialty Training (CAST).
Dr Raksin currently holds the titles of Section Chief of Neurotrauma and Director of the Neurosurgery ICU at Cook County Hospital in Chicago, where she is also Vice-President of the Executive Medical Staff. She is a founding member of the Joint Guidelines Committee and chairs the Guidelines Subcommittee for the AANS/CNS Trauma Section Executive Committee. She is also a long-time faculty member for the Goodman Oral Boards review course.
Dr Raksin is co-Editor of the forthcoming Atlas of Emergency Neurosurgery (Thieme, anticipated publication Spring 2015). She is in her second term as the ranking officer for the Yale Class of 1992 and was recently named to the inaugural McDonogh School Board of Visitors. She is working toward a 12th marathon finish this Fall.
Disclosures: Dr Raksin has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Otto Rapalino, MD
Otto Rapalino, MD, is an assistant professor in the Department of Radiology at Harvard Medical School and staff neuroradiologist at the Massachusetts General Hospital. He is also the director of advanced MR neuroimaging and brain tumor imaging in the Department of Radiology at Massachusetts General Hospital. Dr Rapalino's clinical practice encompasses brain, spine, and head and neck imaging of adult and pediatric patients. His radiological expertise includes all aspects of Diagnostic Neuroradiology, with emphasis on stroke, brain tumors, neurodegenerative disorders, CSF disorders, CNS infections, and pediatric CNS disorders. His research focuses on the development of rapid MR neuroimaging techniques and advanced brain tumor imaging.
Disclosures: Dr Rapalino has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Raju R. Raval, MD, DPhil
Raju R. Raval, MD, DPhil, is an Assistant Professor of Radiation Oncology at The Ohio State University Wexner Medical Center specializing in CNS and GU radiation therapy. He has received prior research support from an ASCO Young Investigator Award, the Johns Hopkins Brain Science Institute, and through an NIH CRTA. He completed his residency in Radiation Oncology at the Johns Hopkins Hospital and worked closely with Dr Theodore L. DeWeese (Professor and Chairman, Department of Radiation Oncology), Dr Lawrence Kleinberg (Associate Professor and Director of Stereotactic Radiosurgery), and with Johns Hopkins neurosurgeons Dr Michael Lim (Director of Brain Tumor Immunotherapy), Dr Daniele Rigamonti, and Dr Daniel Sciubba.
Dr Raval completed his doctorate in Molecular Oncology (graduate research in angiogenesis and tumor hypoxia) at the University of Oxford as a Rhodes Scholar, and completed his medical training at the University of Pennsylvania School of Medicine. His laboratory focus is translational cancer research utilizing combinations of immunotherapy, immune modulation, targeted radiosensitization, and radiation therapy.
Disclosures: Dr Raval has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Laura K. Reed, MD
Laura K. Reed, MD, is currently a neurosurgery resident physician at Baylor Scott & White in Temple, TX. She completed her undergraduate education at University of Maryland and her medical education at Virginia Commonwealth University. She was exposed to the field of neurosurgery at an early age and developed a strong passion for the specialty, especially cerebrovascular.
Daniel Refai, MD
Daniel Refai, MD, is the director of spinal oncology at the Emory Spine Center. Dr Refai focuses on both intradural and extradural spinal tumors as well as metastatic and primary tumors of the spine. He performs complex spine tumor surgery and spine reconstruction surgery. He also treats complex degenerative, cervical, and thoracic spine conditions.
Dr Refai directs the stereostatic radiosurgery division of the Emory Spine Center for spine tumor treatment. His research interests include outcome analysis following surgery and radiosurgery for spine tumors. He has published extensively on the treatment of spinal disorders and has developed innovative multidisciplinary approaches for treatment.
Dr Refai completed neurosurgical residency at Washington University in Saint Louis under the tutelage of Ralph Dacey, MD. He spent six months as a specialist registrar in neurosurgery at Beaumont Hospital in Dublin, Ireland. He completed a combined orthopaedic and neurosurgery spine fellowship at the Cleveland Clinic.
Disclosures: Dr Refai receives honoraria from Medtronic, Stryker, DePuy, and Globus; he receives royalties from Aesculap and Stryker.
Dr Joshua M. Rosenow
Dr Joshua M. Rosenow is the Director of Functional Neurosurgery and Epilepsy Surgery and Professor of Neurosurgery, Neurology and Physical Medicine and Rehabilitation in the Northwestern University Feinberg School of Medicine Department of Neurosurgery, as well as at Northwestern Memorial Hospital. He specializes in the surgical treatment of movement disorders such as Parkinson’s disease, tremor, and dystonia, as well as the surgical treatment of epilepsy and chronic pain.
Dr Rosenow graduated from Yale University School of Medicine, completed neurosurgical training at New York Medical College and a fellowship in stereotactic, functional, restorative neurosurgery and epilepsy surgery at the Cleveland Clinic Foundation. He was awarded the 2003 Ronald Tasker award for pain research by the AANS/CNS Joint Section on Pain. He was one of the members of the team that developed frameless deep brain stimulation surgery. In addition, he was one of the founding members of the Functional Neurosurgery Working Group of the Parkinson’s Study Group and is the principal investigator for Northwestern’s participation in the RAD-PD DBS database.
He is a past Chair of the AANS/CNS Joint Section on Pain, as well as a past member of the Executive Council of the ASSFN and the Board of Directors of NANS. He is currently Past Chair of the Council of State Neurosurgical Societies and was elected President of the Illinois State Neurosurgical Society. He is an elected fellow of the American College of Surgeons and a frequent lecturer and instructor at national and international neurosurgical meetings.
Dr Rosenow provides counsel to organized Neurosurgery delegations to the AMA CPT panel and RUC meetings for functional neurosurgery and epilepsy surgery matters and works with Neurosurgery’s Washington staff and regionally with insurers to advocate for policies to expand and maintain access to advanced neurosurgical therapies. In addition, he represents the AANS as part of the neurosurgical delegation to the AMA House of Delegates.
Dr Rosenow currently conducts research into the areas of stereotactic and image guided surgery, neurostimulation for the enhancement of neurologic recovery after brain injury and stroke, imaging biomarkers in pain, socioeconomic factors in neurosurgery and neuromodulation, opioid policy, exploration of brain function using implanted electrodes, brain-machine interface and new devices for the treatment of neurologic disorders. He has been site PI for numerous national clinical trials of novel therapies such as new implantable devices, gene therapy and stem cell products for the treatment of neurologic diseases.
Disclosures: Dr Rosenow has a consulting contract with Boston Scientific Neuromodulation.
K. Daniel Riew
K. Daniel Riew is a Professor of Orthopedic Surgery at Columbia University Medical Center’s College of Physicians and Surgeons in NYC. He is also the Co-Chief, Spine Division, Director of Cervical Spine Surgery and Co-Director of the Columbia Spine Fellowship. He joined the Columbia Faculty in July of 2015. Previously, he was at Washington University in St. Louis where he was the Mildred B. Simon Distinguished Professor in the Department of Orthopaedic Surgery, Professor of Neurological Surgery, and Chief of Cervical Spine Surgery. Dr Riew graduated from Harvard College, where he was awarded the Class Ames Award for Character and Leadership; and from Case Western Reserve University Medical School, where he was inducted into the Alpha Omega Alpha honorary medical society for top students in his junior year. He finished residency in Internal Medicine at Cornell Medical Center and Orthopedics at George Washington University. He then completed fellowship training under the world-renowned cervical spine surgeon, Dr Henry Bohlman, in Cleveland. He is board-certified in Internal Medicine as well as Orthopaedic Surgery.
In 1995, he was recruited by Washington University School of Medicine to start the cervical spine service in the newly formed Department of Orthopaedic Surgery. Starting with only a dozen or less cervical procedures in 1994, he developed it into one of the largest cervical spine practices in the world. His practice is exclusively devoted to the operative treatment of the cervical spine, a rarity among spine surgeons. He has been recognized in the lists of America’s Top Doctors and Best Doctors in America since 2002. He is also listed as a Vitals Top 10 Doctor (top 1%, based on patient ratings and reviews); Orthopedics This Week Journal’s Top 28 Spine Surgeons in North America 2012, 2013 (“He is an outstanding surgeon, teacher, and researcher. He is a leader in the cervical spine world, has done great research in this area, and has great vision. If someone says, ‘cervical spine surgery,’ you think of Dan.”), Top 18 Spine Surgeons in North America 2014 (“A brilliant cervical spine surgeon, he has defined many of the techniques we are utilizing. He has lectured extensively nationally and internationally, improving the treatment of these disorders in other portions of the globe.”).
He is active in research and has published over 240 peer-reviewed papers and over 60 chapters and other manuscripts. He has received multiple outstanding research paper awards from the Cervical Spine Research Society and the North American Spine Society, as well as the Hibbs Outstanding paper award from the Scoliosis Research Society. He has operated in several countries and has served as a visiting professor, grand rounds speaker, key or named lecturer over 95 times in more 17 countries on six continents. He has served and has been the Director or Chair of over 35 surgical courses, including those sponsored by the Cervical Spine Research Society, American Academy of Orthopaedic Surgeons, North American Spine Society and the Scoliosis Research Society. He serves on the Board of Directors of the Cervical Spine Research Society and was President from 2012-13. He also serves on the board of AOSpine International, served as its International Research Commission Chair (2012-15) and currently is the Chair of the International Board (2015-18). He is a member of the American Orthopaedic Association, the Interurban Orthopedic Club, and the Association of Bone and Joint Surgeons, all honorary orthopaedic societies. He serves as a Deputy or Associate Editor of the Global Spine Journal, Clinics in Orthopedic Surgery, Spine, and Neurosurgery journals.
Disclosures: Dr Riew is a board member of AOSpine and a consultant for Advance Medical; he owns stock in Spinal Kinetics but has never used their product or done research using their device; he owns stock in Axiomed but has never used their product or done research using their device; he owns stock in Spineology, PSD, Osprey, Expanding Orthopedics, Vertiflex, Amedica, Benvenue, and Paradigm Spine; he receives royalties from Zimmer-Biomet for fusion devices as well as benefits for a competing technology; he will be receiving royalties for a competing technology from Nuvasive for fusion devices at some point in the future but does not use, teach courses, or do research regarding the cervical disc arthroplasty device; he has taught industry courses for Medtronic, Biomet, and Depuy.
Howard A. Riina
Howard A. Riina is Professor and Vice Chair of the Department of Neurosurgery as well as Director of the Neurosurgery Residency Training Program and Director of Endovascular Neurosurgery at New York University Langone Medical Center. He was born in Brooklyn, New York. He received undergraduate degrees from both Franklin and Marshall College and the University of Pennsylvania in a dual degree 5-year bioengineering program in 1987. He graduated from Temple University School of Medicine in 1993. Between his third and forth years of medical school he obtained an M.Phil in Biology (molecular neurobiology) from the University of Cambridge. He completed his surgical internship and trained in neurological surgery at the Hospital of the University of Pennsylvania with Drs Eugene S. Flamm and M. Sean Grady. Dr Riina has completed three fellowships: Diagnostic Neuroradiology with Robert Grossman, MD, at the Hospital of the University of Pennsylvania, Interventional Neuroradiology with Alejandro Berenstein, MD, at the Institute of Neurology and Neurosurgery Beth Israel Medical Center, and Cerebrovascular and Skull Base Surgery with Robert F. Spetzler, MD at the Barrow Neurological Institute. In 2001, Dr Riina was recruited to Weill Medical College of Cornell University, New York Presbyterian hospital to perform both open cerebrovascular surgery and interventional neuroradiology. He was Professor of Neurological Surgery, Neurology and Radiology and Residency Program Director of the Department of Neurological Surgery at the Weill Medical College of Cornell University, New York Presbyterian Hospital. He was Co-Director of Interventional Neuroradiology at New York Presbyterian Hospital prior to joining the faculty of the NYU School of Medicine.
Dr Riina specializes in the surgical and endovascular treatment of cerebrovascular disorders of the brain and spinal cord. He has particular interest in the treatment of intracranial aneurysms and arteriovenous malformations of the brain and spinal cord. He has also been involved in new treatments for acute stroke. Most recent interests involve the development of new minimally invasive devices and treatments for cerebrovascular and skull base disorders as well as intra-arterial chemotherapy for recurrent malignant brain tumors.
Disclosures: Dr Riina owns stock interest in Medtel, eVasc Neuro, eLum Technologies, and MediVis; he is a part of the Stryker speakers bureau.
Russell Romano, MA, ATC
Russell Romano, MA, ATC, is a health care professional who has dedicated his career to the health and well-being of student athletes. Working as a certified athletic trainer in the collegiate setting since 1991, his focus has been providing the best possible medical care and application of injury prevention. He is daily tasked with on-field management of injuries, evaluation and injury diagnosis, rehabilitation with focus on therapeutic exercise, and various administrative duties.
In 1998, Russ became the head athletic trainer at the University of Southern California. He currently oversees 14 staff who provide medical care to 21 sports and approximately 650 student athletes. His desire to improve rehabilitation from old standards to those that challenge the neuromuscular system in the three planes of movement led him to become a 2008 graduate of the Gray Institute of Functional Transformation (GIFT) Fellowship. The GIFT Fellowship combined with an extensive background in proprioceptive neuromuscular facilitation (PNF) and a Master’s in Biomechanics has allowed athletes in his care to experience smooth transitions from acute injury rehabilitation to return to play exercise progression.
Understanding the importance of staying current with research and advancing the field is always a focal point to improve the quality of care. In addition to being lead author on a paper published in theJournal of Athletic Training that described an MRSA outbreak and provided solutions to minimize risk, Russ continues to be involved with ongoing research to educate the field and improve injury outcomes. Working closely with team neurosurgeons, understanding concussions, minimizing risk, educating student athletes, and evaluating return to play guidelines has been a priority.
Reviewing manuscripts for Neurosurgery, WorldNeurosurgery, theBritish Journal of Sports Medicine, and Journal of Athletic Traininghas been a privilege and a gift to remain on the cutting edge of the research. Russ is honored to serve as an Associate Editor in the Sports and Rehabilitation Section for Neurosurgery.
His personal interests include spending time with family, travel, movies, and training in Gracie Jiu Jitsu.
Disclosures: Dr Romano has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Guy Rosenthal is Associate Professor of Neurosurgery at the Hadassah-Hebrew University School of Medicine. He serves as Director of Neurotrauma and Neurointensive Care at the Hadassah-Hebrew University Medical Center coordinating the care of traumatic brain injury patients at Hadassah and managing the Neurointensive Care Unit. He directs the clinical and translational traumatic brain injury research program at Hadassah. His clinical research interests include advanced cerebral monitoring in brain injured patients, novel monitoring technologies, and cranial reconstruction. He also has an interest in penetrating brain injuries and has authored several chapters on this topic. His translational research focuses on a swine model of the injured brain that studies cerebral physiology with advanced cerebral monitoring techniques. Dr Rosenthal earned his undergraduate and medical degrees at the University of Michigan in Ann Arbor. He completed his neurosurgical training in 2004 at the Hadassah-Hebrew University Medical Center, developing a keen interest in traumatic brain injury. He pursued a clinical and research fellowship in Neurotrauma and Neurointensive care at the University of California, San Francisco under the mentorship of Geoffrey Manley, MD, PhD and served as an attending neurosurgeon at the San Francisco General Hospital. In 2008, Dr Rosenthal returned to Hadassah to lead the Neurotrauma program. Dr Rosenthal serves on the Research Committee of the European Association of Neurological Surgeons and has served on the Guidelines Committee for the Brain Trauma Foundation’s Guidelines for the Management of Severe Traumatic Brain Injury. He has taken an active role in neurosurgical education in Israel and chairs the Israel Neurosurgical Society’s Written Board Examination Committee. He serves as an Associate Section Editor for Trauma for Youmans and Winn’s Neurological Surgery. Dr Rosenthal lives just outside Jerusalem with his wife, 2 boys, Yonadav (born 2007), Netanel (Nelki, born 2010), and daughter Naya (born 2016).
Disclosures: Dr Rosenthal serves on the Medical Advisory Board of SynCath Neuroscience Ltd.
Dr Arjun Sahgal
Dr Arjun Sahgal is an international clinical and research leader in the field of high precision stereotactic radiation to the brain and spine for both metastases and primary tumors. After training at the University of Toronto in radiation oncology, he completed a radiosurgery fellowship at the University of California San Francisco with Professor Dr David Larson. He has published over 200 peer-reviewed papers, including in high-impact journals like the Journal of Clinical Oncology and Lancet Oncology. He is the editor and writer of several books/book chapters on brain and bone metastases research, the recipient of several distinguished visiting professorships, past-meeting chairman and board member of the International Stereotactic Radiosurgery Society (ISRS), and current steering committee member for the AOSpine Tumor Knowledge Forum. He is the principle investigator for a national Phase 2 randomized trial (SC-24) evaluating spine SBRT to conventional radiation. Currently, he serves as deputy chief of the department of radiation oncology at the University of Toronto affiliated Sunnybrook Odette Cancer Centre. His current major projects involve directing the Sunnybrook Cancer Ablation Therapy program, which involves the installation and integration of MR Brachytherapy, MR Linac, and Gamma Knife ICON technology. His next phase of research and development is focused on integrating MR in radiation therapy and the application of MR Guided Focused Ultrasound Technology with radiation.
Disclosures: Dr Sahgal is an advisor/consultant for Abbvie, Merck, Roche, Varian (Medical Advisory Group), Elekta (Gamma Knife Icon), and Brainlab; he is an ex officio board member of the International Stereotactic Radiosurgery Society (ISRS); he has done education seminars with Elekta AB, Accuray Inc., Varian (CNS Teaching Faculty), BrainLAB, and Medtronic Kyphon; he has a research grant with Elekta AB; he has received travel accommodations/expenses from Elekta, Varian, and BrainLAB; Dr Sahgal also belongs to the Elekta MR Linac Research Consortium, Elekta Spine, Oligometastases and Linac Based SRS Consortia.
Amit M. Saindane, MD
Amit M. Saindane, MD, is an associate professor in the department of radiology and imaging sciences at the Emory University School of Medicine in Atlanta, Georgia. He received his BA in biology and psychology from The Johns Hopkins University in Baltimore, Maryland, in 1998, followed by his MD from the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania, in 2002. After an internship year at Presbyterian Medical Center in Philadelphia, he completed both his diagnostic radiology residency and neuroradiology fellowship at New York University. He joined the faculty at Emory University School of Medicine in 2008, where he currently serves as the director of the Division of Neuroradiology, Chair of the MRI Quality and Safety committee, and associate director of clinical affairs for the department. Dr Saindane’s clinical interests include applications of advanced MRI techniques for neurological and neurosurgical diseases. His research interests include noninvasive imaging assessment of intracranial pressure disorders. He is an active member in the American Society of Neuroradiology, American College of Radiology, and Southeastern Neuroradiological Society, and is a reviewer for numerous radiology publications.
Disclosures: Dr Saindane has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
David Schiff received his BA and MD from Harvard, completed an internship at the Brigham and Women’s Hospital, and did his Neurology residency in the Harvard-Longwood Neurology Training Program. After completing Neuro-Oncology fellowships at Memorial Sloan-Kettering Cancer Center and Mayo Clinic, he joined the Mayo faculty. He spent five years on staff at the University of Pittsburgh before moving to the University of Virginia to develop their medical Neuro-Oncology program. He now serves as the Harrison Distinguished Teaching Professor of Neurology, Neurological Surgery, and Medicine.
He has published more than 150 peer-reviewed manuscripts, many relating to brain tumor clinical trials, as well as several textbooks and almost 100 chapters. He is an Associate Editor for Neuro-Oncology, sits on the editorial board for Neurology, and serves on the International Advisory Board for Lancet Oncology.
Disclosures: Dr Schiff serves on DSMCs for Orbus and Monteris; he receives royalties from UpToDate.
Dr Michael Schlüssel
Dr Michael Schlüssel graduated with a BSc in nutrition from the Federal University of Rio de Janeiro in 2003, followed by an MSc (2006) and PhD (2010) at the same institution; both focused on epidemiology with a strong component of statistics. His background as a researcher includes collaborations with several universities and research centers worldwide, focusing mainly on the data analysis of large population-based epidemiological studies. Michael joined the Centre for Statistics in Medicine (CSM) in 2014 to work as a medical statistician within the Oxford Clinical Trials Research Unit (OCTRU). In his current role, Michael is mainly involved with the planning, conduction, and analysis of randomized clinical trials of non-pharmacological interventions. Michael is also involved with systematic literature reviews and meta-analyses and the development and validation of prognostic models, and he is a lecturer in several courses offered by CSM, OCTRU, and the EQUATOR Network. In 2015, Michael became a fellow of the UK EQUATOR Centre, with the aim of developing and applying strategies to improve medical research methods.
Disclosures: Dr Schlussel is funded by a grant from the Cancer Research UK.
Michael Schulder, MD
Michael Schulder, MD, is Vice Chair and Residency Program Director for the Department of Neurosurgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also Vice Chair and Professor of Neurosurgery at the Hofstra North Shore-LIJ School of Medicine, Co-director for the Center for Radiosurgery and Stereotactic Radiation of the North Shore-LIJ Health System, and Director of the Cushing Neuroscience Institute Brain Tumor Center.
Prior to joining North Shore-LIJ, Dr Schulder was Professor and Vice Chairman of the Department of Neurological Surgery at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School. He was the Director of Image Guided Neurosurgery and the Co-director of the Stereotactic Radiosurgery Center at University Hospital.
Dr Schulder received his medical degree from the College of Physicians and Surgeons of Columbia University in 1982. He completed his residency training in neurosurgery at the Albert Einstein College of Medicine/Montefiore Medical Center and subsequently was a Fellow in Stereotactic Neuro-oncology at the Brigham and Women’s Hospital of Harvard Medical School.
Dr Schulder is Past President of the American Society for Stereotactic and Functional Neurosurgery, founding Vice President of the Intraoperative Imaging Society, Vice President of the World Society for Stereotactic and Functional Neurosurgery, Past President of the Section on History of the American Association of Neurological Surgeons, and an elected member of the American Academy of Neurological Surgery and the Society of Neurological Surgeons.
Dr Schulder has been the lead author or co-author of more than 70 peer-reviewed articles, 31 abstracts, 17 book chapters, and over 200 presentations at national and international meetings. He is the editor of the Handbook of Stereotactic and Functional Neurosurgery, an editorial board member of Neurosurgery and of Stereotactic and Functional Neurosurgery, and a reviewer for many other peer-reviewed journals.
Dr Schulder has received the Leonard Tow Award for Humanism in Medicine and has been elected to the Gold Humanism Honors Society. He has been named as one of the top doctors in the New York metropolitan area annually for over a decade.
Dr Schulder has been the principal investigator on trials pioneering new methods of image guidance for neurosurgery, including the incorporation of functional MRI as well as intraoperative MRI. He has received substantial foundation and industrial grant support for his research. Dr Schulder continues his research projects with the support of full-time research assistants.
Disclosures: Dr Schulder has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Jason M. Schwalb, MD
Jason M. Schwalb, MD is the Surgical Director of the Movement Disorder and Comprehensive Epilepsy Centers at Henry Ford Health System and Clinical Professor of Neurosurgery at Wayne State University. He also holds an appointment as a Research Scientist in the Center for Health Policy and Health Services Research at Henry Ford.
Dr Schwalb obtained his BA in Classical Greek summa cum laude from CUNY Brooklyn College, spurring a lasting interest in how the structure of language influences thought. He obtained his MD from Yale University. He completed his surgical internship at Johns Hopkins University and his neurosurgical residency at the University of Pennsylvania with an infolded fellowship in spine surgery. He then completed a fellowship in Stereotactic and Functional Neurosurgery at the University of Toronto, during which time he also obtained additional training in epilepsy and peripheral nerve surgery.
He has served on multiple committees in national organizations. He has served as the President of the AANS/CNS Joint Section on Pain and Chair of the Functional Neurosurgical Working Group of the Parkinson's Study Group. He is a co-Director for the Michigan Spine Surgery Improvement Collaborative (MSSIC) and has been in the leadership of the Michigan Association of Neurological Surgeons.
Areas of interest include novel technologies in surgery for movement disorders and epilepsy, laser interstitial thermal therapy, robotic surgery, complex peripheral nerve surgery, normal pressure hydrocephalus, pain (including facial pain and cancer-related pain), racial and economic disparities, health care delivery, quality improvement and registry science.
Disclosures: Dr Schwalb has received research funding directly to Henry Ford via Medtronic; consulting funding via Guidepoint, LLC and Bluerock; salary support directly to Henry Ford via Blue Cross Blue Shield of Michigan for role as co-Director of the Michigan Spine Surgery Improvement Collaborative.
Dave Segar is a PGY-5 resident in the Brigham and Women’s & Boston Children’s neurosurgery residency, pursuing a career in functional neurosurgery and epilepsy. Originally from Northern California, Dave obtained both his undergraduate and medical training at Brown University, and now works as a visiting scientist at both MIT and Brown. His clinical and research goals align around developing and improving translational technologies to improve outcomes for patients with intractable epilepsy, movement disorders, psychiatric diseases and brain tumors, with a particular focus on advancing brain stimulation and improving stereotactic procedures.
Soma Sengupta completed her MD-PhD at the University of Cambridge, U.K. She received Membership in the Royal College of Physicians (U.K.) before moving to the U.S. for an internship in medicine; residency in Neurology, Beth Israel Deaconess Medical Center-Harvard; and clinical and research fellowships at Massachusetts General Hospital, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital. Soma is board certified in Neurology and Neuro-Oncology and recently elected (2020) a Fellow of the Royal College of Physicians (FRCP).
Soma’s Post-doctoral research training included a fellowship at Yale with Prof. Carolyn Slayman (deceased); training in immunology research at the Cambridge Institute of Medical research (U.K.) with Dr Paul Lehner; and training in pediatric brain tumor research with Drs. Scott Pomeroy at Boston Children’s Hospital and Frances Jensen (currently Chair, Dept. Neurology, Univ. of Pennsylvania).
Soma was an attending at BIDMC-Harvard in neuro-oncology before moving to Emory Univ. and the Winship Cancer Institute. She has a long-standing research interest in membrane transport proteins and a major part of her lab is studying such proteins as anti-cancer targets as well as their role in development of disparate cancers. Clinically, Soma manages adult brain tumors and adult survivors of pediatric brain cancers. She has a strong clinical interest in investigator-initiated trials, to bring much needed new treatments for these patient populations.
Disclosures: Dr Sengupta has consulted for Novocure.
Lubdha M. Shah
Lubdha M. Shah is Associate Professor of Radiology and serves as the director of Advanced Spine Imaging. She completed her Neuroradiology Fellowship at Duke University Medical Center. Her research interests include clinical application of advanced imaging techniques, including functional MRI (fMRI) and diffusion tensor imaging(DTI) in the brain and spine. Dr Shah has served on the NINDS K-award study section for over 6 years. In addition to reviewing for several Radiology, Neuroradiology, and Neurosurgery journals, she holds the role of a Neuroradiology Panel chair in the American College of Radiology Neuroradiology and has authored Appropriateness Criteria and Practice Parameter guidelines. Dr Shah is currently Vice-President of the American Society of Spine Radiology.
Disclosures: Dr Shah has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Jason Sheehan was born in Mount Carmel, Pennsylvania. He graduated with highest distinction in chemical engineering at the University of Virginia. Later, he completed a master's of science in biomedical engineering and a doctorate in biological physics at the University of Virginia. He received his medical degree from the University of Virginia. He completed his neurosurgical residency at the University of Virginia along with fellowships in stereotactic and functional neurosurgery at the University of Pittsburgh and microsurgery at the Auckland Medical Center in New Zealand. After his neurosurgical training, he joined the faculty of the University of Virginia’s department of neurological surgery; he currently serves as the Vice Chair and Harrison Distinguished Professor of Neurological Surgery. He also is the director of the University of Virginia neurosciences service line and director of stereotactic radiosurgery. Dr Sheehan's research effort focuses on translational and clinical studies for minimally invasive intracranial and spinal surgery. In his laboratory, he studies various topics including radiosurgery and MR guided Focused Ultrasound. He has published more than 400 peer reviewed papers and served as the editor for several books. He has received the National Brain Tumor Foundation’s Translational Research Award, Young Neurosurgeon Award from the World Federation of Neurological Surgeons, the Integra Foundation Award, Robert Florin Award, Brainlab Neurosurgery Award, the Leksell Award, the Synthes Skull Base Award, and the Crutchfield Gage Research Award. He serves on the editorial boards of Neurosurgery, Journal of Neurosurgery, Journal of Neuro-Oncology, and the Journal of Radiosurgery and SBRT. He is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, the Society for Neuro-Oncology, the Society of Pituitary Surgeons, the American Society of Therapeutic Radiology and Oncology, the International Stereotactic Radiosurgery Society, and the Neurosurgical Society of the Virginias. He serves on the executive committee for the AANS/CNS section on Tumors, chair of the radiosurgery committee for the AANS/CNS section on Tumors, and an officer for the NeuroPoint Alliance and the International Gamma Knife Research Foundation. He is listed in Best Doctors of America.
Disclosures: Dr Sheehan has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Kevin Sheth, MD
Kevin Sheth, MD, graduated from Johns Hopkins University and University of Pennsylvania School of Medicine. He was a neurology resident and chief resident at Partners Neurology (Massachusetts General and Brigham & Women's Hospitals). After a fellowship in vascular neurology and neuro-critical care at Harvard, he was appointed the first neurology-trained neuro-intensivist at the University of Maryland and R Adams Cowley Shock Trauma Center. He subsequently moved to Yale as the founding chief of the Division of Neurocritical Care and Emergency Neurology and Chief of Clinical Research for the Department of Neurology. Dr Sheth is also the fellowship director in neurocritical care at Yale New Haven Hospital.
His interests are in the advancement of therapies and care of patients with devastating acute neurological syndromes, especially those complicated by brain swelling, ischemia and hemorrhage. He is a nationally recognized clinical and translational scientist and has directed a number of multicenter studies testing novel therapies. His research group also develops novel imaging and serum-based biomarkers for the neuro-ICU and furthers understanding of prognosis formation.
He is the winner of the prestigious Robert Siekert Award from the American Heart Association, and his research has been supported by the NIH, American Academy of Neurology, American Heart Association, US Army, and the Passano Foundation. Dr Sheth has served on study sections for NIH and NASA and is a member of the AHA Stroke Get With the Guidelines Science Executive Committee. He is the co-chair of several national working groups developing guidelines in malignant infarction and serves on several editorial boards including Neurosurgery, Stroke and Neurocritical Care. He has published over 60 papers in critical care neurology and lectured internationally.
Disclosures: Dr Sheth receives research support from AHA and the NIH; he receives grant support from BARD, Novartis, Biogen, and Hyperfine.
Jay L. Shils, PhD
Jay L. Shils, PhD, is currently the Director of Intra-operative Neurophysiology in the Department of Anesthesiology at Rush University Medical Center in Chicago, IL, and Associate Professor of Anesthesiologist at Rush University in Chicago, IL. He received his Bachelor of Science degree in electrical engineering from Syracuse University, and both his masters and PhD in Bio-Engineering at The University of Pennsylvania. He began his work in the field of intraoperative neurophysiology in 1995, specializing in single unit recordings during surgery for movement disorders in the department of Neurology at the University of Pennsylvania School of medicine, Graduate Hospital. Since that time he has built programs at two other institutions as well as taking over the Intraoperative Neuomonitoring program at Rush. Dr Shils’ research interests include investigating methods for improving real-time intraoperative neurophysiologic techniques as well as theoretical research into neuromodulation mechanisms of action. Dr Shils has published over 40 peer reviewed papers and multiple chapters on intraoperative neurophysiologic surgical technique, post-operative management of movement disorders patients, and computational modeling as related to neuromodulation effects on various neural circuits. He also co-edited the book Neurophysiology in Neurosurgery: A modern approach with Dr Vedran Deletis and both Essential Neuromodulation and Innovative Neuromodulation with Dr Jeffrey E. Arle. Prior to entering the field of neurophysiology, Dr Shils was an electrical engineer at the Electric Boat division of General Dynamics where he was involved in various modifications to existing systems and investigating new technology. Dr Shils is the past President of the International Society for Intraoperative Monitoring and was the founding secretary of the society. He is a past President of the American Society of Neuophysiological Monitoring, past board member, past chairman for the American Society of Neurophysiologic Monitoring ethics committee, a member of the technology committee, and the present secretary of the society. He a fellow of both ASNM and the ACNS. He is an associate editor for the journal Neurosurgery and Journal of Clinical Neurophysiology.
Disclosures: Dr Shils is a consultant for Medtronic, Depuy Synthes, and Globus; he has a research project with Abbott-St. Jude; he is an editor/author with Elsevier; he is a partial owner of Engineurix and Intellihat; he provides expert legal opinions; he is employed by Rush University Medical Center, Rush University, and Rush Anesthesia; he serves on the journal board as an associate editor/reviewer for Neurosurgery, Neuromodulation, Clinical Neurophysiology, Journal of Clinical Neurophysiology, Anesthesia, Pain, and The Electrodiagnostics Journal.
John H. Shin, MD
John H. Shin, MD is an attending neurosurgeon and Director of Spine Oncology & Spinal Deformity Surgery at the Massachusetts General Hospital in Boston. He is the Director of Spine Research and Associate Professor of Harvard Medical School. Dr Shin completed his neurosurgery residency training at the University of Illinois at Chicago and complex spine fellowship at the Cleveland Clinic. He currently serves as Co-chair of the Media committee for the AANS/CNS Spine Section.
Disclosures: Dr Shin is a consultant for Carbofix, Depuy, Medtronic, and Nuvasive.
Hui-Kuo G. Shu, MD, PhD
Hui-Kuo G. Shu, MD, PhD, is a professor in the Department of Radiation Oncology at Emory University. He received his BA in biology at Washington University in St. Louis, MO, in 1986 and MD/PhD in molecular biology at Case Western Reserve University in Cleveland, OH, in 1993. His training included completion of an internship in Internal Medicine at University Hospitals of Cleveland in 1994 and residency in Radiation Oncology at the University of California, San Francisco in 1999. During his time in San Francisco, he also completed a two year research fellowship at the Brain Tumor Research Center at UCSF. He was appointed to the Radiation Oncology faculty at the University of Pennsylvania as a physician-scientist where he remained until he was recruited to join the Department of Radiation Oncology at Emory University in 2005. Dr Shu specializes in the treatment of CNS malignancies with radiation in adults and children and has published extensively in these areas. He is actively involved many brain tumor clinical trials including as PI for investigator-initiated trials examining a novel histone deacetylase inhibitor for glioblastoma therapy and innovative use of volumetric modulated arc therapy for treatment of brain metastasis. Overall, he has published, as lead/senior author or co-author, more than 100 peer-reviewed manuscripts and 120 abstracts presented at national or international meetings. His most recent research interests have been in the development of spectroscopic magnetic resonance imaging (sMRI) for use in glioblastoma imaging with particular focus on its use to better guide radiation treatment planning for disease that may otherwise not be appreciated on standard MRI sequences. He is co-PI of the Emory Brain Tumor Imaging team that is funded by the National Institutes of Health (NIH) as a U01 to develop sMRI for glioblastoma imaging as one of approximately 25 teams that make up the National Cancer Institute (NCI) Quantitative Imaging Network (QIN). He also has active funding in the form of an R01 from the NCI to pilot use of dose escalation for glioblastoma guided by sMRI. He serves as co-Chair of the NCI – Quantitative Imaging in Radiation Therapy (QIRT) Working Group, a group dedicated to promoting use of quantitative imaging in radiation oncology through collaboration, since its inception in 2017. He is also active in many professional/scientific societies including the American Society for Therapeutic Radiology and Oncology (ASTRO), the Radiological Society of North America (RSNA), the Society for Neuro-Oncology (SNO), among others.
Disclosures: Dr Shu owns stock in Akebia Therapeutics Inc. and Medtronic PLC; he has received honorariums from Varian Medical Stystems for speaking on the clinical utility of Velocity AI, a Varian imaging analysis interface.
Dr Anthony Sin
Dr Anthony Sin is presently Professor, Vice-Chair and Director of Complex Spinal Disorders, Dr Donald and Kathryn Smith Endowed Chair for Department of Neurosurgery in Ochsner-LSU Health in Shreveport, LA. He completed his undergraduate degree in physics at Johns Hopkins University. Dr Sin received medical doctorate from Emory University School of Medicine. He completed an internship in general surgery at SUNY-Stone Brook and a residency in neurological surgery at LSUHSC-Shreveport. He has also spent an additional post-graduate year studying minimally invasive spine surgery under Dr Kevin Foley at University of Tennessee in Memphis. His clinical interests include pediatric and adult deformity disorders, degenerative, trauma, craniocervical junctional problems, spinal oncology, and revision surgeries. Dr Sin has been treating pediatric patients with congenital and idiopathic spinal deformity problems, early onset and idiopathic scoliosis, Scheuermann’s kyphosis, high-grade spondylolisthesis through Shriners Hospital for Children in Shreveport since 2011 as their primary spine surgeon. He is an active member for AANS, CNS, Spine section of AANS/CNS, and executive committee for the Society of University Neurosurgeons, Louisiana Neurosurgical Society. He also serves as an associate editor for Neurosurgery and ad hoc reviewer for World Neurosurgery and Neurospine.
Disclosures: Dr Sin has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Konstantin Slavin, MD
Konstantin Slavin, MD, is Professor, Chief of Stereotactic and Functional Neurosurgery section, and Fellowship Director for Stereotactic and Functional Neurosurgery in the Department of Neurosurgery at the University of Illinois at Chicago (UIC).
Dr Slavin graduated from medical school in Baku, the Soviet Union and completed his neurosurgery residency in Moscow. He completed his second neurosurgery residency at UIC and a fellowship in functional and stereotactic neurosurgery at Oregon Health Sciences University in Portland, Oregon.
Dr Slavin is an Immediate Past President of the American Society for Stereotactic and Functional Neurosurgery and Vice-Secretary/Treasurer of the World Society for Stereotactic and Functional Neurosurgery. He is also the Director-at-large of both the North American (NANS) and the International Neuromodulation Societies (INS). For many years, he was an Executive Committee member of the Joint Section on Pain of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.
Dr Slavin is published in many books and peer-reviewed journals and is an associate editor or editorial board member for a number of publications, including Neurosurgery, Neuromodulation,Stereotactic and Functional Neurosurgery, Surgical Neurology International, and others. His book on Peripheral Nerve Stimulationwas published in 2011; another book, co-edited with Sam Eljamel on Neurostimulation: Practice and Principles, came out in 2013.
Disclosures: Dr Slavin receives grant/research support from Medtronic, Abbott, Boston Scientific, Nuvectra, ATI, Pfizer, and Neuros; he receives honoraria or consultation fees from Medtronic, Abbott, Boston Scientific, MESI, Nuvectra, Nevro, Stimwave, Karger, and Wiley; he is a stock/stock options shareholder of Vycor medical, Higgs Boson, Neuramodix, Stimwave, and Thermaquil.
Brandon Smith is currently a 3rd year medical student at King’s College London with student with a deep-seated interest in neurosurgery, preparing to pursue an academic neurosurgical career path in the future. He has special interests in the fields of medical technology & education, working on a number of web-based education resources, and is keen to pursue a surgical PhD studentship in the coming years.
Disclosures: Brandon Smith has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Justin Smith
Dr Justin Smith completed the combined MD-PhD program at Mayo Clinic in Rochester, MN and a neurosurgery residency at the University of California, San Francisco. He has completed spine surgery fellowships in the areas of adult and pediatric spinal deformity (University of Virginia) and minimally invasive spine surgery (Northwestern University). He is currently professor in the Department of Neurological Surgery at the University of Virginia. He serves as faculty for neurosurgery residents and fellows and as co-director of the spine fellowship program and co-director of the UVA Spine Center.
Dr Smith's practice is predominantly spinal surgery and includes cervical and thoracolumbar deformity reconstruction, oncology, trauma, degenerative disease, and complex revision surgery. He is an active member in multiple societies, including the Scoliosis Research Society and Cervical Spine Research Society, and is a founding member of the International Spine Study Group (ISSG). His research interests focus on clinical outcomes of spinal surgery, and he has published extensively in this and other areas, with more than 250 peer-reviewed manuscripts and more than 750 presented abstracts at national and international meetings.
Disclosures: Dr Smith is a consultant for Zimmer Biomet, Nuvasive, K2M, AlloSource, and Cerapedics; her receives royalties from Zimmer Biomet; he receives honoraria for teaching from Zimmer Biomet, Nuvasive, and K2M; he receives researching funding from DePuy Synthes/ISSGF and AOSpine; he receives fellowship support from AOSpine and NREF; he is on the executive committee off the ISSGF and the Cervical Spine Research Society (CSRS) and is on the editorial board for both Neurosurgery and Operative Neurosurgery.
Gary S. Solomon, PhD
Gary S. Solomon, PhD, is a board certified clinical neuropsychologist who has practiced in Nashville since 1984, specializing in neuropsychological assessment and treatment. After 27 years in private practice, Dr Solomon joined the Vanderbilt University School of Medicine in February of 2011 as a Co-Director of the Vanderbilt Sports Concussion Center and as an Associate Professor in the Departments of Neurological Surgery, Orthopaedic Surgery & Rehabilitation, and Psychiatry.
Dr Solomon has served as the Team Neuropsychologist for the Nashville Predators since 1998, and has been the Consulting Neuropsychologist for the Tennessee Titans since 1999. He also serves as the Consulting Neuropsychologist for Athletic Departments at Vanderbilt University, Belmont University, Tennessee Tech University, University of Tennessee, and the National Steeplechase Association.
Dr Solomon has published more than 50 articles in professional journals, two book chapters, and several reviews of professional textbooks. He has published a book (with Drs Karen Johnston and Mark Lovell) titled The Heads-Up on Sport Concussion (Human Kinetics, 2006).
Dr Solomon has served as Principal Investigator on four pharmaceutical company research grants focusing on Alzheimer’s disease and related dementias. He has served as an Editorial Reviewer for eight professional journals, as a Principal Reviewer for the American Journal of Sports Medicine, and serves on the Editorial Board of Archives of Clinical Neuropsychology.
Disclosures: Dr Solomon has received honoraria and expense reimbursements from government, professional, and scientific organizations for presenting research relating to sport-related concussion at meetings, scientific conferences, and symposiums; he is a full-time employee of the Vanderbilt University Medical Center, where he has a clinical practice in sports neuropsychology involving patients who have sustained concussions; he is the consulting neuropsychologist for the Nashville Predators, Tennessee Titans, and the athletic departments of the University of Tennessee, Tennessee Tech University, and Vanderbilt University (fees via institution); he is the Senior Medical Advisor for the National Football League Department of Health and Safety.
Maria Vittoria Spampinato, MD
Maria Vittoria Spampinato, MD, is a professor of radiology and the director of the Neuroradiology Division at the Medical University of South Carolina in Charleston, South Carolina. Dr Spampinato completed a diagnostic radiology residency at the Universita Cattolica del Sacro Cuore, Rome, Italy. Following a research fellowship at the National Institute for Neurological Diseases and Stroke, she completed a neuroradiology fellowship at the University of North Carolina. Dr Spampinato joined the radiology faculty at the Medical University of South Carolina in 2005 and was appointed director of neuroradiology at MUSC in 2013. She is on the editorial board of the American Journal of Neuroradiology and of theNeurovascular Imaging Journal. Her research interests include the use of structural and diffusion MRI in stroke outcome prediction and in neurodegenerative disorders.
Disclosures: Dr Spampinato is an investigator in two research grants sponsored by Bracco and has received salary support.
Robert J. Spinner, MD
Robert J. Spinner, MD, is the Burton M. Onofrio, MD Professor of Neurologic Surgery at the Mayo Clinic where he is also Professor of Orthopedics and Anatomy. He is chair of the Academic Appointments and Promotions Committee at Mayo. He is board certified in both orthopedics and neurosurgery. His clinical practice is limited to peripheral nerve surgery.
He completed full residency programs in orthopedics (Duke University) and neurosurgery (Mayo Clinic) and a 1 year peripheral nerve fellowship with David Kline and a 6 month traveling fellowship to several international centers as a CNS Cushing Fellow. He recently served as the President of the American Society for Peripheral Nerve.
Disclosures: Dr Spinner is a consultant for Mayo Medical Ventures and J&J.
Dr Martina Stippler
Dr Martina Stippler is Director of Neurotrauma at Beth Israel Deaconess Medical Center. She completed her neurosurgery Training at the University of Pittsburgh Medical Center. Her has busy complex spine and endoscopic pituitary practice. Her research interests are in multimodal TBI management, triage of mild TBI and end of life discussion and goal of care discussion in the urgent setting. She has participated in many landmark TBI studies such as PROTECT, RESCUE acute SDH trial and coming soon BOOST III. She is member at large of the AANS/CNS section of Neurotrauma and Chair Elect of Women in Neurosurgery and on the CSN EC.
Disclosures: Dr Stippler has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Jennifer Sweet, MD
Jennifer Sweet, MD, is an Assistant Professor of Neurological Surgery at Case Western Reserve University, and a Stereotactic and Functional Neurosurgeon at University Hospitals Cleveland Medical School. She received her medical degree from Georgetown University School of Medicine, and underwent her neurosurgery residency training at George Washington University. She then completed a fellowship training in functional neurosurgery at University Hospitals/Case Western Reserve, where she stayed as faculty in the Neurosurgery Department. Dr Sweet’s clinical practice includes deep brain stimulation and other forms of neuromodulation for the treatment of chronic pain and epilepsy, Additionally, she performs surgery for facial pain syndromes and peripheral nerve disorders, as well as radiosurgery and general neurosurgery. Dr Sweet is also involved in numerous research endeavors, and has an NIH KL2 grant investigating the application of novel imaging technologies, including tractography, for surgical targeting via DBS in bipolar disorder. She is an investigator in multiple clinical trials, including the multicenter BrainGate study, and is a research and clinical mentor to residents, fellows, graduate and undergraduate students. In addition to her clinical and research activities, Dr Sweet frequently lectures at national and international meetings on topics pertaining to neuromodulation. She also serves on numerous committees in organized neurosurgery, neuromodulation, and engineering societies, including Secretary/Treasurer of the AANS/CNS Pain Section, President Elect of WINS, and Member-at-Large of the CNS Executive Committee
Disclosures: Dr Sweet receives grant support from the NIH and serves on the scientific advisory board of Koh Young Inc.
Philip Theodosopoulos was born in Thessaloniki, Greece on September 10, 1970. He received a BS degree in Biology and in Political Science from the Massachusetts Institute of Technology in 1991 and 1992, and his MD degree from Stanford University in 1996. Under the tutelage of Charles Wilson and Mitchel Berger he completed his neurosurgical residency at the University of California San Francisco and then completed a fellowship in Cerebrovascular and Skull Base Surgery at the Brigham and Women’s Hospital, Harvard University under the direction of Arthur Day. He is board certified in Neurological Surgery. Following his post-graduate training he joined the faculty of the Department of Neurological Surgery at the University of Cincinnati where he served as Director of Skull Base Surgery and Residency Program Director from 2008-13. Dr Theodosopoulos is currently the Khatib Professor, Director of Skull Base Surgery and Vice Chairman of the Department of Neurosurgery at the University of California, San Francisco where he serves as the Director of Cranial Programs. Dr Theodosopoulos is interested in brain tumor surgery with a specific focus on skull base lesions and endoscopy. His research interests center on anatomy and its role in the development of minimally invasive surgical approaches, as well as on outcomes research in neurosurgery. He is the author of over sixty peer reviewed publications and has been faculty in over 100 national and international courses. He is married to Dr Josefa Rangel an integrative medicine physician. They have three daughters, Petra, Sky and Tèa.
Disclosures: Dr Theodosopoulos has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Jasmine Thum
Dr Jasmine Thum is a PGY 6 neurosurgery resident at UCLA, originally from Austin, TX. She went to the University of Southern California for her BS and MS degrees in biomedical engineering/ neuroengineering. She then attended the Health Sciences and Technology program at Harvard Medical School / Massachusetts Institute of Technology. She is interested in functional neurosurgery and peripheral nerve, and engages in neurophysiology research on networks for consciousness.
Shelly D. Timmons, MD, PhD
Shelly D. Timmons, MD, PhD, is a neurological surgeon at the Geisinger Health System (GHS) in Pennsylvania (2010 to present). She is Director of Neurotrauma for the Geisinger Health System, which includes a Level I Trauma Center in Danville, PA and two Level II trauma Centers in Wilkes-Barre, PA and Scranton, PA. She is Associate Director for Neurosciences of the Adult Intensive Care Unit at Geisinger Medical Center in Danville, PA. Dr Timmons also serves as the Program Director for a new residency training program in neurological surgery at GHS, recently accredited by the Accreditation Council on Graduate Medical Education. She is a Clinical Associate Professor in the Department of Neurosurgery at Temple University.
Dr Timmons is board certified by the American Board of Neurological Surgery. She holds a variety of professional organizational positions, including Director-at-Large for the American Association of Neurological Surgeons (AANS) Board of Directors, AANS Representative to the Board of Governors of the American College of Surgeons, Chair of the Neurosurgery Advisory Council of the American College of Surgeons, Past Chair of the Joint Section on Neurotrauma and Critical Care of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS), Neurotrauma Liaison to the Washington Committee and Chair of the Emergency Neurosurgery Task Force for that organization, Chair of the Ad Hoc State and Regional Advocacy Committee of the Council of State Neurosurgical Societies, Regional Director of the Pennsylvania Neurosurgical Society, and Immediate Past Chair of the Neurotrauma and Emergency Neurosurgery Committee of the Council of State Neurosurgical Societies.
Dr Timmons has been a clinical researcher for a number of years, and has participated as principal investigator in numerous clinical trials related to traumatic brain injury through local, industry, and NIH funding mechanisms. She has published and lectured on a variety of topics related to traumatic brain injury, neurocritical care, spinal cord injury, blunt vascular injury, and health care delivery throughout her career. Her primary research interests include clinical trials in traumatic brain injury, multi-modality monitoring in neurocritical care (in particular traumatic brain injury), prognostication in traumatic brain injury, diagnosis and treatment of blunt vascular injury, and optimal organization of healthcare delivery for brain-injured patients.
Dr Timmons obtained undergraduate degrees from the University of Illinois at Urbana-Champain in Honors Biology (BS 1987) and Rhetoric (BA 1988). She obtained her medical degree from the University of Illinois College of Medicine at Peoria in 1991. She completed her residency training in neurological surgery at the University of Tennessee Health Science Center-Memphis from 1991 to 1997, during which time she served as Administrative Chief Resident from 1996-97. She later (2002) earned her PhD, also at UTHSC, in the Department of Anatomy and Neurobiology where she studied noradrenergic modulation of calcium channels in rat sensorimotor cortical pyramidal neurons via G-proteins in the laboratory of Robert C. Foehring, PhD.
Prior to assuming her current position, she practiced for thirteen years as a neurological surgeon with Semmes-Murphey Clinic in Memphis, TN. During that time, she was Assistant (1997-2008) and then Associate Professor of Neurosurgery (2008-2011), Chief of the Neurotrauma Division of the University of Tennessee Health Science Center Department of Neurosurgery (1997-2010), and Chief of Neurosurgery at the Regional Medical Center at Memphis/Elvis Presley Memorial Trauma Center (1997-2010).
Dr Timmons is married to a cardiothoracic surgeon and has two teenaged sons.
Disclosures: Dr Timmons has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Staša Tumpa is a second year Graduate Medicine student at the University of Cambridge. She was awarded BSc(Hons) in Neuroscience from University of St Andrews and MSc in Clinical Neuroscience from UCL. Her particular interests are in pediatric neurosurgery and epilepsy surgery. Outside of medicine she does fencing for Cambridge University first team.
Disclosures: Ms Tumpa has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Jorge F. Urquiaga, MD
Jorge F. Urquiaga, MD is a PGY3 Neurosurgery resident at Saint Louis University, originally from Lima, Peru. After completing his medical training at Universidad Peruana Cayetano Heredia and working one year as a physician for the Peruvian Army, he moved to St. Louis, Missouri and spent one year as a Skull Base and Cerebrovascular Research Fellow at Saint Louis University Department of Neurosurgery. Dr. Urquiaga then accepted a 2-year position as a Pre-Residency Clinical Fellow at the same institution prior to beginning his training as a Neurosurgery resident. Dr. Urquiaga is interested in spinal MIS and deformity surgery. He is also committed to leadership and organizational development, and he currently serves as president of the Saint Louis University Resident and Fellow Association.
ORCID ID: 0000-0001-7091-093X
Alex Valadka, MD
Alex Valadka, MD, is Chairman and Chief Executive Officer of the Seton Brain and Spine Institute in Austin, Texas, and Adjunct Professor of Psychology at the University of Texas at Austin. He maintains a strong clinical and research interest in neurotrauma and critical care, including numerous papers, presentations, research grants, courses, seminars, and visiting professorships. He co-edited the textbook Neurotrauma: Evidence-Based Answers to Common Questions. He has served as Chair of the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons Section on Neurotrauma and Critical Care; as Chair of the Neurosurgical Specialty Group of the American College of Surgeons (ACS) Committee on Trauma; and on the Boards of Directors of the AANS and the Coalition for American Trauma Care. He has chaired the Washington Committee for Neurosurgery and served as Vice President of the AANS. He served as a standing Study Section member for NINDS and continues to be a frequent ad hoc reviewer. Current responsibilities include Treasurer of the AANS and Governor of the ACS.
Dr Valadka attended the University of Dallas and went on to medical school at the University of Chicago. His interest in neurotrauma and critical care led him to pursue his neurosurgical residency at the Medical College of Virginia. He returned to Texas in 1993 to join the faculty of the Department of Neurosurgery at Baylor College of Medicine. In 2006, he accepted a position as Professor and Vice Chairman of the Department of Neurosurgery at the University of Texas Medical School at Houston. In 2009, he moved to Austin to help create an academic medical center in Central Texas.
Disclosures: Dr Valadka has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Michael A. Vogelbaum, MD, PhD
Michael A. Vogelbaum, MD, PhD, is Associate Director of the Rose Ella Burkhardt Brain Tumor and NeuroOncology Center, Director of the BTNC’s Center for Translational Therapeutics at the Cleveland Clinic, and Professor of Surgery (Neurosurgery) at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr Vogelbaum also holds the Robert W. and Kathryn B. Lamborn Chair in NeuroOncology. He is Board Certified in Neurological Surgery.
In addition to his active neurosurgery and radiosurgery practice, Dr Vogelbaum has been Primary Investigator of numerous local and national clinical trials of new drugs and surgical techniques and devices for brain tumors. He also has an externally funded basic science and translational research laboratory which focuses on various aspects of drug delivery to brain tumors, and he is currently developing novel devices for delivering therapeutics directly to the brain. He is Chair of the Neurosurgery Committee for RTOG, and he has been a member of the ACoSOG and ACRIN Brain Tumor steering committees. Dr Vogelbaum was the Scientific Program Chair for the 2008 Society for NeuroOncology (SNO) Annual meeting, was Secretary-Treasurer of SNO (2009-2011), and SNO’s Vice President (2011-2013). He is a founding member of RANO (Response Assessment in NeuroOncology), which has recently redefined the endpoints to be used in glioma clinical trials. He also is a member of the Executive Committee of the AANS/CNS Section on Tumors and is Scientific Chair of the 2011 Tumor Section Satellite Meeting. He also is on the editorial board for the journals Neuro-Oncology and Neurosurgery. He is co-Editor of the first comprehensive textbook in neuro-oncology, Principles and Practice of Neuro-Oncology (2011).
Disclosures: Dr Vogelbaum has indirect equity and patent-related royalty interests in Infueson Therapeutics, Inc.; he has received honoraria from Tocagen, Blue Earth DiagNostics, and Celegene.
Beverly C. Walters
Beverly C. Walters is a neurosurgeon and clinical epidemiologist who is retired from a full time clinical practice in general neurosurgery, focusing on spine, brachial plexus, and peripheral nerve, to pursue her interest in applied evidence-based medicine. She is an Adjunct Professor of Neurological Surgery and Director of Clinical Research in the Division of Neurosurgery at the University of Alabama at Birmingham and Visiting Professor of Neurosurgery at the University of Zagreb, Croatia. She also holds the position of Director of Clinical Research at the Henry Ford Health Sciences Department of Neurosurgery in Detroit. Previously, she held academic appointments that included Clinical Professor of Neurological Surgery at New York University School of Medicine and Adjunct Professor of Surgery at the Uniformed Services University of the Health Sciences in Bethesda, and was also Director of Outcomes Research in the Department of Neurosurgery at Walter Reed Army Medical Center. She was formerly an Associate Professor and the Neurosurgery Residency Program Director at Brown University School of Medicine. Her experience in clinical research involves the design and implementation of randomized controlled trials, case-control studies, meta-analyses, and outcome measure evaluation, and she has written extensively on study design and assessment of the quality of medical literature, including being the author/co-author of eighteen monographs on critical appraisal, as well as editorials and book chapters on methodological and statistical aspects of neurosurgical research. She has extensive experience in survey methodology and has developed a statistical technique for use in generating evidence for use in algorithms when randomized controlled trials cannot be done. She has been a lecturer, tutor, and course designer for several educational programs on critical appraisal of the medical literature for practicing clinicians, graduate students, postgraduate trainees, and medical students. She has published over 230 articles in the medical literature and is the co-editor of the neurosurgical textbook, Evidence-based Neurosurgery. For many years, Dr Walters was the chairperson of the Practice Guidelines Committee of the American Association of Neurological Surgeons, a member of the Outcomes Committee of the AANS/CNS, and a member of the Committee for the Assessment of Quality of the AANS/CNS. Her guidelines activities have included the development of the Guidelines for the Management of Severe Head Injury, the Guidelines for Prehospital Management of Traumatic Brain Injury, Guidelines for the Surgical Management of Traumatic Brain Injury, Guidelines for Penetrating Brain Injury, Acute Spinal Cord Injury Guidelines, Guidelines for the Treatment of Low Grade Gliomas, Guidelines for the Management of the Neurobehavioral Consequences of Traumatic Brain Injury and the Lumbar Fusion Guidelines. Her work on the Spinal Cord Injury Guidelines was recognized by the United States Congress for its achievement in The Congressional Record, first in 2002 and then again in 2013. She was also honored by the Congress of Neurological Surgeons for her guideline work with their Exceptional and Distinguished Service Award. She was the 2011 recipient of the Anthony Marmarou Lectureship in Neurotrauma at the CNS, and the first recipient of the Haines Family Lectureship in Neurosurgery Clinical Research at the University of Minnesota in 2012. She gives courses on guideline development, and writes frequently on outcome measurement for neurosurgeons. In addition, she has been involved with research on women in medicine and surgery, including undergraduate medical education, and is author or co-author of several publications on this topic, including the Annotated Bibliography of Women in Medicine. Dr Walters’ company, EBM Advisors, provides medical and clinical epidemiological consulting services to universities and hospitals, as well as medical device and pharmaceutical companies planning clinical trials, analyzing data, and preparing for submissions to the NIH and FDA. EBM Advisors also provides clinical data due diligence services for venture capital firms considering investment in medical device and pharmaceutical companies.
Disclosures: Dr Walters has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Songfeng Wang received his PhD in Biostatistics from the University of South Carolina, as well as a MS in Biostatistics from the University of Iowa. Currently he works as a senior quantitative analyst for Wells Fargo bank in the San Francisco bay area. His research interests are in the field of survival analysis and meta-analysis, with experience in both developing novel statistical approaches in these areas as well as their application in the areas of medicine, health sciences and economic research in real world. His research has resulted in publications in leading journals such as JACC and Statistical Methods in Medical Research. He’s been actively serving as a referee for more than 20 medical and clinical journals, and he is also on the editorial board of several academic journals, including the Journal of American Heart Association.
Disclosures: Dr Wang has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Tony J. C. Wang, MD
Tony J. C. Wang, MD, is the Co-Director of the Center for Radiosurgery and an Associate Professor of Radiation Oncology (in Neurological Surgery) at New York Presbyterian/Columbia University Medical Center. He is recognized nationally for his extensive expertise in malignant and benign brain tumors. His research interests are in Gamma Knife stereotactic radiosurgery and brain tumors resulting in over 50 peer-reviewed publications. He has given over 50 invited lectures and visiting professorships nationally and internationally.
He serves on several national and international working groups developing guidelines for brain tumor management and stereotactic radiosurgery. He is an editor for 2 radiation oncology textbooks and a writer for over 15 book chapters. He serves as an Editor of Translational Cancer Research, Associate Editor on the Radiation Oncology Section of Neurosurgery, the official journal of the Congress of Neurological Surgeons, and as a reviewer for International Journal of Radiation Oncology, Biology, and Physics, Practical Radiation Oncology, and Journal of Neuro-Oncology as well as many others.
Dr Wang received his B.A. and MD degrees from University of Missouri Kansas City Medical School, during which time he was also a Clinical Research Training Program Fellow at the National Institutes of Health, Bethesda, Maryland. He received internship training at Flushing Hospital Medical Center. Dr Wang received his radiation oncology training at New York Presbyterian Hospital (Columbia campus), where he was Chief Resident from 2011-2012.
As a member of the Brain Tumor Center and Pituitary Tumor Center at Columbia, Dr Wang is part of a multidisciplinary team that brings expertise from multiple specialties, including neurosurgery, neuro-oncology, neuroradiology, and neuro-endocrinology.
Disclosures: Dr Wang reports personal fees and/or non-financial support from Abbvie, AstraZeneca, Elekta, Merck, Doximity, Wolters Kluwer, and Novocure.
Dr Babu Welch
Dr Babu Welch is originally from the Washington, DC area and completed his medical training at the Howard University College of Medicine. After completing his neurosurgical residency at George Washington University Medical Center, he pursued extensive training at the UT Southwestern Medical Center that allows him to treat vascular lesions of the brain, carotid arteries, and acute ischemic stroke using a combination of surgical and endovascular techniques. Dr Welch was recruited to the faculty at UT Southwestern for this expertise. While he maintains interests in general and skull base neurosurgery, a majority of his practice is dedicated to the urgent and elective management of cerebrovascular disease.
He serves as the Director of the UT Southwestern Microvascular Laboratory and routinely instructs residents and colleagues alike in surgical and endovascular approaches to vascular diseases of the brain. His routinely publishes in the national and international literature on topics related to endovascular device use and surgical technique. He has a developing interest in the development of public policy as it relates to the provision of care to patients with stroke in our nation.
Dr Welch maintains fluency in the Spanish language. He is married to Dr JoAnn Welch. They have two daughters. He enjoys photography, cycling and educating himself on world cultures through travel.
Disclosures: Dr Welch reports personal fees from Stryker Corporation (Neurovascular Division), Medtronic, Peter Lazic, and Microvention.
Christopher Edward Wolfla
Christopher Edward Wolfla was born on December 3, 1964. He graduated with High Honors from Indiana University and received his medical degree from Indiana University School of Medicine. He completed his Neurosurgery residency at Indiana University Medical Center under the direction of Drs Robert L. Campbell and Paul B. Nelson. After residency, Dr Wolfla completed a Fellowship in Spinal Neurosurgery at the Medical College of Wisconsin under the direction of Drs Sanford J. Larson and Dennis J. Maiman. Upon completion, he joined the faculty of the University of Oklahoma Health Sciences Center Department of Neurosurgery, where he held the Greenberg Endowed Chair. In 2005, Dr Wolfla returned to the Department of Neurosurgery at the Medical College of Wisconsin. He is currently Professor of Neurosurgery and Director of the Neurosurgery Residency Program.
Dr Wolfla has an active clinical practice centered on spinal neurosurgery. He has authored more than 35 scientific articles and chapters in medical texts. His research interests have focused on spine biomechanics and spinal cord physiology.
Dr Wolfla is a member of Beta Theta Pi, Phi Beta Kappa and Alpha Omega Alpha.?Dr Wolfla served on the Executive Committee of the Congress of Neurological Surgeons Executive Committee from 2000 to 2013 and has held the offices of Member at Large, Education Committee Chair, Scientific Program Chair, Annual Meeting Chair, Secretary, Vice President, President-Elect, President, and Past President. In addition, Dr Wolfla has served on the Executive Committee of the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves, where he has held the offices of Member at Large, Treasurer, Chair Elect, and Chair.
Dr Wolfla has a wide variety of hobbies and outside interests. He lives in Brookfield, Wisconsin and has two children – Andrew (21) and Julie (15).
Disclosures: Dr Wolfla has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Julian Wolfson is Associate Professor and Director of Graduate Studies in the Division of Biostatistics, School of Public Health at the University of Minnesota. Dr Wolfson's research lies at the intersection of causal inference and machine learning, particularly as applied to large, messy datasets. He has applied my methods to problems such as finding surrogate endpoints in clinical trials, identifying relevant explanatory variables in the presence of correlation and measurement error, predicting the risk of heart attacks using electronic health record data, and understanding human behavior patterns using smartphone sensor data. His collaborative work spans multiple disciplines, including neurology, infectious disease (HIV/Ebola), cardiovascular health, nutrition and obesity, and pediatrics.
Disclosures: Dr Wolfson has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Dr Chenguan Wu
Dr Chenguan Wu is currently an Associate Professor of Neurosurgery and Radiology within the Division of Epilepsy and Neuromodulation Neurosurgery at the Vickie and Jack Farber Institute for Neuroscience at Thomas Jefferson Neurosurgery. He also serves as the Clinical Director of the Jefferson Integrated Magnetic Resonance Imaging Center (JIMRIC). He completed a combined degree program at Tufts University, where he earned his Bachelor of Science in Computer Engineering and Biomedical Engineering, his Master’s degree in Biomedical Engineering, and his Medical Degree. He went on to complete his residency in neurosurgery at Thomas Jefferson University before pursuing a fellowship in Stereotactic and Functional Neurosurgery. During his fellowship, he trained under Dr Ashwini Sharan at Thomas Jefferson University, Dr Kim Burchiel at Oregon Health and Science University, and Dr Marwan Hariz at the National Hospital for Neurology and Neurosurgery in London, UK. Dr Wu has a special interest in the use of surgical robotics, particularly in applications for stereotactic and functional neurosurgery. For more than five years now, he has routinely used surgical robots for applications in epilepsy surgery and in deep brain stimulation.
Disclosures: Dr Wu is a consultant for Abbott Corp, Boston Scientific, Medtronic, Inc., Neuropace, Inc., Nevro Corp. and is on the advisory board for Micro Systems Engineering, Inc.
Isaac Yang MD
Isaac Yang MD is a Board Certified Neurosurgeon and Director of Medical Student Education in the UCLA Department of Neurosurgery, Associate Professor in Neurosurgery, Head and Neck Surgery, and Radiation Oncology in the David Geffen School of Medicine at UCLA, and a Principal Investigator in the UCLA Brain Tumor Laboratory. As the son of South Korean immigrants, Dr Yang grew up in the small town of Lodi, California. Dr Yang’s interest in neurobiology started as an undergraduate as he received his bachelor’s degree with Phi Beta Kappa from the University of California Berkeley. His training followed with a medical degree from the University of California Los Angeles Geffen School of Medicine. Dr Yang completed a neurological surgery residency at the University of California San Francisco, as well as an NRSA NIH funded F32 post doctoral brain tumor research fellowship.
Dr Yang’s clinical focus has been primarily on brain tumors both glioblastoma and skull base tumors. His research efforts have examined antigen expression and manipulation of the immune response to glioblastoma. He has previously been recognized with a UCSF Clinical and Translational Scientist Training Award and the CNS Dandy Clinical Research Fellowship. Dr Yang has been the recipient of several distinguished regional and national awards including the UCSF Medical Center 2010 Exceptional Physician Award, the AANS Integra Brain Tumor Research Award, San Francisco Neurological Society Edwin Boldrey Award for Basic Science Research, American Academy of Neurological and Orthopedic Surgeons Research Award, Kaiser Award for Clinical Research, the national AANS Leksell Radiosurgery Award, and the Tumor Section Ronald L. Bittner Award on Brain Tumor Research.
Dr Yang has published over 200 publications in peer-reviewed journals, authored over a dozen book chapters, and edited over half a dozen published textbooks. Dr Yang is highly sought out by peers, patients and the media for his expertise in neurological diseases and brain health. He has made multiple TV appearances on CBS The Doctors, CNN Dr Drew On Call, and national news outlets. At UCLA, he is currently investigating the utilization of nanoparticles and nanotechnology for the application in brain tumor immunotherapy and vaccines, investigating the role of radiosurgery and Adaptive Hybrid Surgery for skull base tumors, identifying novel biomarkers for meningiomas, and redefining the treatment outcomes for successful skull base surgery in Superior Semicircular Canal Dehiscence. His career is dedicated to improving the care and treatment of all patients with skull base pathology and brain tumors, and he is deeply indebted to his wife Nancy for her support and all of his teachers and mentors who have guided him on this path.
If interested please follow Dr Yang on Facebook at Isaac Yang UCLA Neurosurgery or find his most recent book Service Minded Physician on Amazon.
COI: Consultant for BrainLab and Baxter, Research Grant from BrainLab and Stryker
Dr Lynda Yang
Dr Lynda Yang received her medical research training through the NIH-Medical Scientist Training Program at the Johns Hopkins School of Medicine. She obtained her Neurosurgery training from the University of Michigan, and her peripheral nerve and brachial plexus surgery training from Dr John McGillicuddy (Neurosurgery, U Michigan), Dr David Kline (Neurosurgery, LSU), Dr Rolfe M. Birch (Orthopedic Surgery, Royal National Orthopedic Trust, UK), Dr Martijn Malessy (Neurosurgery, Leiden University Medical Center, NL), and Dr Willem van Ouwerkerk (Vreiste University, Amsterdam, NL).
Dr Yang’s research interests currently involve the structuring of evidence-based practice and research in peripheral nerve and brachial plexus surgery. Her projects have focused on epidemiology studies and clinical outcomes to derive the best evidence to guide treatment for brachial plexus palsies.
Dr Yang is a general neurosurgeon, sub-specializing in peripheral nerve and brachial plexus surgery, who performs a wide variety of procedures in the fields of peripheral nerve and brachial plexus injuries, entrapments, and tumors. Dr Yang has been a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, Section of Spine and Peripheral Nerve Surgery, and the American Society for Peripheral Nerve Surgery and is currently the Chairperson for the AANS/CNS Peripheral Nerve Division. She serves as the chairperson for the Neurological Devices Advisory Committee in the Center for Devices and Radiological Health of the FDA. In addition, she is on the task force addressing Neonatal Brachial Plexus Palsy at the American College of Obstetricians and Gynecologists. She has published many peer-reviewed manuscripts and book chapters, and edited a textbook addressing the Practical Management of Adult and Pediatric Brachial Plexus Palsies.
Disclosures: Dr Yang has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Stephen Yip, MD, PhD
Stephen Yip, MD, PhD, is a board-certified neuropathologist clinically appointed at Vancouver General Hospital and is an Assistant Professor of Medicine at the University of British Columbia. He is also trained in molecular genetics pathology and has an active research interest in brain tumour genomics. He is very interested in the practical adoption of next generation sequencing or NGS technology in clinical pathology and as an accessible investigative tool in research.
Dr Yip completed his combined MD-PhD training at the University of British Columbia and completed four years of neurosurgical training at VGH prior to switching to neuropathology. He obtained his FRCPC certification in 2006 and then completed two years of research fellowship with Dr David Louis at the Massachusetts General Hospital. He then underwent an additional year of molecular genetic pathology training in Boston prior to returning to Vancouver. Initially he performed mainly neuropathological consultations of brain tumour cases at the BC Cancer Agency and has since moved to Vancouver General Hospital to take on full clinical duties in neuropathology. He maintains his brain tumour research at BCCA and also works closely with Drs Brian Toyota, David Huntsman, and Marco Marra on dissecting the molecular pathogenesis of gliomas using next generation sequencing technologies.
Disclosures: Dr Yip is a member of the advisory board for Bayer, Pfizer, and Roche; he received travel allowance and honorarium from Bayer, Pfizer, and Roche.
Daniel Yoshor, MD
Daniel Yoshor, MD, received a BA in Philosophy from Yeshiva University and graduated from medical school at the University of Chicago Pritzker School of Medicine. He then completed a neurosurgical residency at Baylor College of Medicine under Dr Robert G. Grossman, where he developed a research interest in neurophysiology. Following residency, he completed a clinical fellowship in epilepsy and brain tumor surgery at the University of California San Francisco with Nicholas Barbaro and Mitchel Berger. After training, he returned to Houston to join the faculty at Baylor College of Medicine.
As a junior faculty member at Baylor, Dr Yoshor received a K08 Mentored Clinical Scientist Development Award from the NIH and was mentored in the laboratory by Dr John H.R. Maunsell in systems neuroscience research. He then established a research program in human neurophysiology, applying scientific techniques used in monkey neurophysiology research to study the physiological basis of visual perception in human patients. This research has been supported by grants from the NIH and the VA, and has resulted in publications in leading journals including Nature Neuroscience, Current Biology, PNAS, and the Journal of Neuroscience.
Dr Yoshor has an active clinical practice focused on complex intracranial surgery, with a particular emphasis on epilepsy surgery, clinical brain mapping, brain tumor microsurgery, and endoscopic pituitary and skull base surgery. He currently serves as Professor of Neurosurgery, Neurology, and Neuroscience at Baylor College of Medicine and Chief of Neurosurgery at Baylor St. Luke’s Medical Center. He is also Director of the Neurosurgery Residency program at Baylor and PI for the program’s NINDS Research Education Grant (R25). The program includes 21 residents, with rotations at five major hospitals in the Texas Medical Center. In January of 2015, he will succeed Dr Raymond Sawaya as Chair of the Department of Neurosurgery at Baylor College of Medicine.
Disclosures: Dr Yoshor received research grants and funding from the NIH, DARPA, and the VA Merit Award; he is a site PI for Second Sight Medical Products.
Jiajia Zhang is professor of the Department of Epidemiology and Biostatistics at the Arnold School of Public Health at the University of South Carolina. Dr Zhang received her PhD in Statistics specialized in semiparametric estimation for statistical models from Memorial University, Canada in 2007. Her research interests focus on developing methodologies for analyzing epidemiological data, such as South Carolina Cancer Registration data set, South Carolina HIV data set, Women Health Initiative data set, NHANES III data set, SEER data set, geographic data set from census tract. Dr Zhang has cumulated extensive experience in statistical analysis, methods, and interpretation. Till now, she has published more than 100 statistical methodology and consulting papers, and was the PI on NIH-funded grants in methodologies development and Co-I in many NIH grants as the core biostatistician.
Disclosures: Dr Zhang has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.
Edie E. Zusman, MD, MBA
Edie E. Zusman, MD, MBA, is a board certified neurosurgeon who began her medical training at the age of 19 in the Northwestern Honors Medical Program. She is recognized nationally for both her neurosurgical skills and her expertise in health systems.
After completing residency at UC Davis, in Sacramento, California, fellowship training at UCSF, and practicing neurosurgery for more than a decade, Dr Zusman completed her MBA at George Washington University. She is widely acknowledged as an expert on the impact of the Affordable Care Act of 2010 on physicians and health systems. She writes and lectures on healthcare forecasting and the impact of vertically integrated Accountable Care Organizations.
Beyond analysis and teaching, Dr Zusman applies this knowledge practically to facilitate successful negotiations between physician groups and hospitals to align in developing high quality and financially successful programs. In 2013, Edie joined the Centers for Disease Control - National Leadership Academy for the Public’s Health along with her colleagues forming Design 4 Active Sacramento to champion the health benefits of active design recognizing that population health measures and disease prevention will be the key for profitability of health systems in the future.
Prior to accepting her current position as Medical Director for the Sutter Health East Bay Neuroscience Institute at Eden Medical Center, Edie was on faculty at UC Davis in Sacramento, California where she led the Brain Tumor and Epilepsy Programs and was named Physician of the Year. As Medical Director for Sutter Sacramento, Edie lead her program to be ranked among America’s Best Hospitals in Neurology and Neurosurgery by US News & World Report in 2007 and 2008.
She has served on the Boards of the California Association of Neurological Surgeons, the Council of State Neurosurgical Societies, the Congress of Neurological Surgeons, and the American Association of Neurological Surgeons.
Disclosures: Dr Zusman has no conflicts of interest or disclosures relevant to service on the Editorial Review Board.